Índice

• • ·Scientific Programme Committee

    Página :A1

    
• • ·Aim and Scope

    Página :A2

    
• • ·Editorial Board

    Página :A3

    
• • ·Table of Contents

    Página :A4

    Esquema Esquema

• Podium Sessions

  • ·POD-01.01: Image guided I¹²⁵ prostate brachytherapy in the community setting: six year results

    Página :1

    D.A. Roszhart, T.G. Shanahan, W. Severino, D. Lieber, P.W. Mueller, S. Markwell, R.B. Maxey

    Esquema Esquema
  • ·POD-01.02: Hybrid interactive prostate brachytherapy: increasing the role of the urologist in the or

    Página :1

    D.A. Roszhart, T.G. Shanahan

    Esquema Esquema
  • ·POD-01.03: The impact of first repeated biopsy in predicting progression in a cohort of prostate cancer patients managed with active surveillance

    Página :1-2

    M.F. Al Otaibi, N. Fahmy, P. Ross, W. Kassouf, S. Jeyaganth, J. Steinberg, L.R. Begin, K. Sircar, A. Aprikian, S. Tanguay

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :2

    
  • ·POD-01.04: High-intensity focused ultrasound for the treatment in 503 patients with localized prostate cancer

    Página :2

    T. Uchida, M. Nitta, S. Hongo, S. Shoji, Y. Nagata, Y. Usui, T. Terachi

    Esquema Esquema
  • ·POD-01.05: The advanced learning curve in robotic-assisted laparoscopic radical prostatectomy: a multi-institutional survey

    Página :2

    H.J. Lavery, T. Ahlering, A. Tewari, J.A. Smith, A. Shalhav, D. Albala, P. Wiklund, A.J. Costello, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Esquema Esquema
  • ·POD-01.06: Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients

    Página :2-3

    F.J. Gómez Veiga, A. Sousa, A. Alcaraz, J. Areal, N. Hannaoui, L.A. Aparicio, B. Mellado, E. Gallardo, P. Gascón, A. Font

    Esquema Esquema
  • ·POD-01.07: Laparoscopic radical prostatectomy: minimum 5 year follow-up of the first 100 UK cases

    Página :3

    D. Merilees, C. Chabert, C. Eden

    Esquema Esquema
  • ·POD-01.08: Curtain dissection of the lateral prostatic fascia and potency following laparoscopic radical prostatectomy – a veil of mystery

    Página :3

    D. Merilees, C. Chabert, C. Eden

    Esquema Esquema
  • ·POD-01.09: A validation/evaluation of 5 postoperative prostate cancer prognostic tools

    Página :3-4

    B.A. Inman, S. Siddiqui, B.C. Leibovich, I. Frank

    Esquema Esquema
  • ·POD-01.10: Oncological and functional outcomes with sutureless vesicourethral alignment in open and laparoscopic radical prostatectomy: 6 years experience

    Página :4

    N. Simforoosh, A. Tabibi, A. Javaherforooshzadeh

    Esquema Esquema
  • ·POD-01.11: Increased incidence of urosepsis following transrectal prostate biopsies: a possible solution

    Página :4

    D. Pode, I. Golan, G. Lorber

    Esquema Esquema
  • ·POD-01.12: High intensity focused ultrasound therapy for clinically localized prostate cancer: efficacy and morbidity of the minimally invasive procedure

    Página :4-5

    S. Mallick, L. Taksin, S. Le Toquin, A. Dufour, Y. Fouques, H. Bensadoun

    Esquema Esquema
  • ·POD-01.13: Minimally invasive therapy using high intensity focused ultrasound for localized recurrence of prostate cancer after radiation failure

    Página :5

    S. Mallick, L. Taksin, S. Le Toquin, A. Dufour, Y. Fouques, H. Bensadoun

    Esquema Esquema
  • ·POD-02.01: Holmium: YAG incompatibility between lasers and fibers

    Página :5

    A. Marks, A.C. Mues, B.E. Knudsen, J.M.H. Teichman

    Esquema Esquema
  • ·POD-02.02: The assessment of clinical efficacy of intranasal desmopressin spray and suppository diclofenac in the treatment of renal colic in comparison with suppository diclofenac alone

    Página :5-6

    A. Roshani, Z. Atrkar Roshan, T. Zarkami, M. Palizkar

    Esquema Esquema
  • ·POD-02.03: Risk factors for urinary stone formation in the morbidly obese

    Página :6

    M. Monga, B. Duffey, R. Pedro, D. Weiland, J. Melquist, C. Kriedberg, S. Ikramuddin, T. Kellogg, B. Slusarek, M. Stessman

    Esquema Esquema
  • ·POD-02.04: CT visible internal stone structure—but not Hounsfield unit value—of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro

    Página :6-7

    J.C. Williams, C.A. Zarse, T.A. Hameed, M.E. Jackson, Y.A. Pishchalnikov, J.E. Lingeman, J.A. McAteer

    Esquema Esquema
  • ·POD-02.05: Percutaneous nephrolithotomy versus extracorporeal shockwave lithotripsy for the treatment of lower calyceal stones

    Página :7

    G.A. Al-Atrach, A.M. El-Nashar, M.E. Sherief, E.A. El-Gawad, M. Hassan Ali

    Esquema Esquema
  • ·POD-02.06: Coherent-scatter computed tomography of urinary calculi: a novel technique to identify mineral composition at stone core

    Página :7

    G. Wignall, J. Denstedt, I. Cunningham

    Esquema Esquema  
  • ·POD-02.07: Management of proximal ureteric calculi: pre and post holmium laser era

    Página :7-8

    A. Bhandarkar

    Esquema Esquema
  • ·POD-02.08: Aid to percutaneous renal access by virtual projection of the ultrasound puncture tract onto fluoroscopic images

    Página :8

    P. Conort, P. Mozer, A. Leroy, M. Baumann, G. Chevreau, J. Troccaz, E. Chartier-Kastler, F. Richard

    Esquema Esquema
  • ·POD-03.01: Development and application of mixed vaccines in renal cell carcinoma: combining autologous tumor cells with dendritic cells derived from autologous or allogeneic origin

    Página :8

    D.S. Park, H.J. Cho, M.Y. Han, S.J. Lee, D.Y. Oh, S.K. Hwang

    Esquema Esquema
  • ·POD-03.02: Minimally invasive management of upper tract transitional cell carcinoma at a tertiary care center

    Página :8-9

    M. Nomikos, D.A. Tolley, S. Sowter

    Esquema Esquema
  • ·POD-03.03: Surgical management and outcome of renal cell carcinoma with level III IVC thrombus: a single center experience

    Página :9

    M. Manoharan, R. Ayyathurai, R. De Los Santos, M.S. Soloway, G. Ciancio

    Esquema Esquema
  • ·POD-03.04: Percutaneous radiofrequency ablation (PRFA) of small renal tumors under ultrasound (US) in high risk patients: three year follow-up

    Página :9

    M. Brausi, M. Gavioli, G. Peracchia, G. De Luca, G. Verrini, M. Viola, G. Simonini, G.L. Giliberto, F. Ferrari

    Esquema Esquema
  • ·POD-03.05: The role of thrombospondin-1 in angiogenesis and patients survival after radical nephrectomy for clear cell renal cell carcinoma

    Página :9-10

    D.P. Zubac, L. Bostad, C. Gestblom, T. Seidal, T. Wentzel-Larsen, S. Haukaas

    Esquema Esquema
  • ·POD-03.06: Renal insufficiency is not a contraindication for renal cryoablation

    Página :10

    J.C. Vestal, B.F. Schwartz, T.B. Manny, J.C. Rewcastle

    Esquema Esquema
  • ·POD-03.07: High tumor expression of KI-67 is an independent predictor of poor outcome among patients treated surgicaly for clear cell renal cell carcinoma

    Página :10-11

    M.K. Tollefson, Y.M. Sheinin, J.C. Cheville, B.C. Leibovich, M.L. Blute, C.M. Lohse, E.D. Kwon

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :11

    
  • ·POD-04.01: Postoperative nomogram for clinical unilateral T3a prostate cancer

    Página :11

    C.Y. Hsu, S. Joniau, R. Oyen, T. Roskams, H. van Poppel

    Esquema Esquema  
  • ·POD-04.02: The percentage of positive biopsies is an independent predictor of survival at the onset of hormonal treatment for advanced prostate cancer

    Página :11

    G. Normand, O. Celhay, B. Merlet, F. Ouaki, C. Pirès, B. Doré, J. Irani

    Esquema Esquema
  • ·POD-04.03: NeuroD1 expression in human prostate cancer

    Página :12

    L. Cindolo, R. Franco, M. Cantile, P. Chiodini, L. Salzano, M. Falsaperla, C. Cillo

    Esquema Esquema
  • ·POD-04.04: Serum selenium level and prostate cancer: case-control study

    Página :12

    G. Pourmand, A. Emamzadeh, K. Moradi, M. Taherimahmoudi, A. Mehrsai, M. Nikoobakht

    Esquema Esquema
  • ·POD-04.05: Semaphorin4D and plexinB1 expression in clinically localised prostate cancer

    Página :12

    J. Nariculam, A. Freeman, M. Feneley, M. Williamson, J.R. Masters

    Esquema Esquema
  • ·POD-04.06: Hedgehog signalling in advanced prostate cancer

    Página :12-13

    G. Shaw, P. Purkis, T. Oliver, D. Prowse

    Esquema Esquema
  • ·POD-04.07: A gene expression profile predictive of outcome in men at high-risk of systemic progression and death from prostate cancer following radical prostatectomy

    Página :13

    R.J. Karnes, J. Cheville, G. Vasmatzis

    Esquema Esquema
  • ·POD-04.08: Treatment outcome of immediate versus delayed hormone therapy in patients with lymph node metastases following radical prostatectomy

    Página :13

    Y. Fradet, R. Tiguert, D. Chautard, L. Lacombe, F. Harel

    Esquema Esquema
  • ·POD-05.01: Effect of gas flow on postoperative analgesic use in laparoscopic varicocelectomy

    Página :13-14

    R. Maghsoudi, A. Elahian, H. Aliasgharpour

    Esquema Esquema
  • ·POD-05.02: A novel form of the “Whitaker” test for ejaculatory duct obstruction

    Página :14

    M.L. Eisenberg, K. Shinohara, M. Garcia, P.J. Turek

    Esquema Esquema
  • ·POD-05.03: Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double blind placebo-controlled, fixed dose, randomized study

    Página :14

    M.R. Safarinejad

    Esquema Esquema
  • ·POD-05.04: A congenital factor in the development of erectile dysfunction: pelvic artery variations

    Página :14-15

    Y. Kawanishi, H. Muguruma, H. Sugiyama, J. Kagawa, M. Yamanaka, K. Kojima, A. Numata

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :15

    
  • ·POD-05.05: Efficacy and safety of dapoxetine for premature ejaculation (PE): Results from a placebo-controlled, double-blind, randomized, parallel-group study in 22 countries

    Página :15

    Jacques Buvat, Francois Giuliano, Fisseha Tesfaye, Margaret Rothman, David Rivas

    Esquema Esquema
  • ·POD-05.06: The peripheral role of serotonin reuptake inhibitors on the human seminal vesicle: in vitro study

    Página :15

    P. Birowo, S. Ückert, G. Kedia, C. Keil, M. Meyer, H.J. Mägert, S. Machtens, W.F. Thon, F. Scheller, U. Jonas, A. Taher, D. Rahardjo

    Esquema Esquema
  • ·POD-05.07: Efficacy and tolerability of sildenafil citrate 100-mg titration compared with continued 50-mg dose treatment in men with erectile dysfunction

    Página :15-16

    J. Buvat, D. Hatzichristou, M. Maggi, I. Farmer, J.M. Martinez-Jabaloyas, P.J. Miller, G. Schnetzler

    Esquema Esquema
  • ·POD-05.08: Efficacy and patient satisfaction associated with first time and revision penile prosthesis surgery

    Página :16

    P.G. Barboglio, C.T. Soloway, Y.Y. Yang, B.R. Kava

    Esquema Esquema  
  • ·POD-05.09: A 6 month interim analysis of the effect of nightly intraurethral alprostadil vs sildenafil on penile morphometrics after nerve sparing radical prostatectomy (NSRRP)

    Página :16-17

    D. Fenig, D. Robbins, D. Brassil, B. Goodwin, A. McCullough

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :17

    
  • ·POD-05.10: Efficacy of sildenafil citrate in treatment of erectile dysfunction: impact of associated co-morbidities

    Página :17

    A.I. El-Sakka

    Esquema Esquema
  • ·POD-05.11: The soluble guanylyl cyclase stimulator BAY 41-2272 reverses endothelial and nerve dysfunction in corpus cavernosum from spontaneously diabetic (db/db -/-) mice

    Página :17

    C.E. Teixeira, F.B.M. Priviero, R.C. Webb

    Esquema Esquema
  • ·POD-06.01: Profile and management of patients treated for the first time for LUTS/BPH in four European countries

    Página :17-19

    R.O. Fourcade, N. Théret, C. Taïeb

    Esquema Esquema
  • ·POD-06.02: The effects of dutasteride, tamsulosin, and combination therapy on lower urinary tract symptoms and Qmax in men with BPH and prostatic enlargement: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Página :19

    C. Roehrborn, P. Paul Siami, J. Jack Barkin, R. Ronaldo Damião, F. Montorsi, CombAT Study Group

    Esquema Esquema  
  • ·Abstract Withdrawn

    Página :19

    
  • ·POD-06.03: Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over a wide range of baseline prostate size: data from MTOPS and PLESS

    Página :19-20

    S.A. Kaplan, A.G. Meehan, S. Suryawanshi, J.W. Kusek, L.M. Nyberg

    Esquema Esquema  
  • ·POD-06.04: Efficacy and duration of symptom improvement after prostate botulinum toxin injection for BPH

    Página :20

    Y.C. Chuang, P.H. Chiang, N. Yoshimura, M. Chancellor

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :20

    
  • ·POD-06.05: BPH: gyrus loop TURP versus conventional TURP: prospective trial - 3 years follow up

    Página :20

    A. Tan, R. Chean, S. Murray

    Esquema Esquema
  • ·POD-06.06: Holmium laser prostatectomy: Indian experience

    Página :21

    A. Varshney, A. Agarwal, B.S. Bansal, P. Joshi, S. Yadu

    Esquema Esquema
  • ·POD-06.07: TUNA therapy: improvement in technical device - better clinical outcome

    Página :21

    D.P. Zubac, T. Wentzel-Larsen, T. Østrem

    Esquema Esquema
  • ·POD-06.08: Benign prostate specific antigen: distribution and clinical correlates in a community-based sample of men

    Página :21-22

    T. Rhodes, S.J. Jacobsen, D.J. Jacobson, M.E. McGree, K. Demissie, G.G. Rhoads, C.J. Girman, M.M. Lieber, J.L. Sauver, G.G. Klee

    Esquema Esquema
  • ·POD-06.09: PVP update 3 years of data on photo selective vapourisation of the prostate

    Página :22

    S.W. Alkhayal, T.R.G. Larner

    Esquema Esquema
  • ·POD-06.10: Alfuzosin 10 mg once daily shows no deleterious effect on ejaculation components in real life practice

    Página :22-23

    J.M. Fitzpatrick, R. Rosen

    Esquema Esquema
  • ·POD-06.11: Prevalence of ejaculatory dysfunction in men with lower urinary tract symptoms (LUTS) suggestive of BPH receiving medical or surgical treatment

    Página :23

    J.M. Fitzpatrick, R. Rosen

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :23

    
  • ·POD-07.01: Do public schools teach voiding dysfunction? The results of an elementary school teachers survey in Urmia City, Iran

    Página :23

    M. Moosavi, D. Mehraban, S. Samadzadeh, M. Salehi

    Esquema Esquema
  • ·POD-07.02: Augmentation ureterocystoplasty: an outcome review in 21 cases

    Página :23-24

    R. Mahdavi, A. Taghizadeh, S. Mirsadraee, H. Shakibi, H. Patel

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :24

    
  • ·POD-07.03: The Mitrofanoff continent external urinary diversion in children: indications and results

    Página :24

    M. Hadj Slimen, W. Guedrib, M. Bouacida, I. Ben Abdellah, H. Jallouli, K. Chabchoub, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POD-07.04: Change of renal parenchymal thickness according to the age of pyeloplasty in children with unilateral ureteropelvic junction obstruction

    Página :24

    M. Baek, D.S. Park, S.H. Paick, S.J. Jeong, S.K. Hong, H. Choi

    Esquema Esquema
  • ·POD-07.05: One-day hospitalization after open pyeloplasty can be performed safely

    Página :24-25

    J.S. Palmer

    Esquema Esquema
  • ·POD-08.01: Is it appropriate to apply age-specific PSA reference to clinical practice based on PSA cutoff 3.0 ng/ml in Korean men?

    Página :25

    S.J. Jeong, J.H. Han, I.H. Chang, J.H. Yu, B.K. Han, K.H. Moon, S.K. Hong, S.S. Byun, S.E. Lee

    Esquema Esquema
  • ·POD-08.02: Prostate biopsy indications: practice patterns and the potential role of PCA3

    Página :25

    B. Tombal, H. van Poppel, C. Schulman, J. Irani, A. de la Taille, R. Berges, A. Haese, P. Mulders, T. de Reijke, M. Emberton, D. Gillatt

    Esquema Esquema
  • ·POD-08.03: Antibiotic prophylaxis in transrectal prostate biopsy in the Netherlands

    Página :25-26

    C.H.I. Pelser, M.T.W.T. Lock

    Esquema Esquema
  • ·POD-08.04: PCA3 molecular urine assay predicts tumor volume in prostatectomy

    Página :26

    H. Nakanishi, J. Groskopf, H.A. Fritsche, V. Bhadkamkar, A. Blasé, S. Vikas Kumar, J.W. Davis, P. Troncoso, H. Rittenhouse, R.J. Babaian

    Esquema Esquema
  • ·POD-08.05: The PCA3 assay is useful in guiding prostate biopsy (PB) decision in men with a prior negative biopsy

    Página :26-27

    A. Haese, H. van Poppel, M. Marberger, P. Mulders, C. Abbou, L. Boccon-Gibod, A. Stenzl, H. Huland, A. de la Taille, J. Schalken

    Esquema Esquema
  • ·POD-08.06: Does inflammation on prostate needle biopsy increase the likelihood of cancer on subsequent biopsy?

    Página :27

    W.W.B. Bassett, D.M.R. Bettendorf, J.M. Lewis, K.R. Loughlin

    Esquema Esquema
  • ·POD-08.07: A comparison of predictive nomograms for the presence of high grade prostate cancer: the PCPT risk calculator, the Spurgeon CART and the Windsor model

    Página :27

    S. Robinson, O. Karim, H. Motiwala, M. Laniado

    Esquema Esquema
  • ·POD-09.01: The value of adjuvant instillational treatments in prognosis of Ta, T1 bladder cancers

    Página :27-28

    G. Glück, O. Drăgoescu

    Esquema Esquema
  • ·POD-09.02: Staging muscle invasive bladder cancer with dynamic gadolinium enhanced magnetic resonance imaging

    Página :28

    M. Wagner, J. Prather, N. Dobos, L. Chow, D. Siamak

    Esquema Esquema
  • ·POD-09.03: Endovesical epirubicin and interferon ⍺ 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS

    Página :28

    M. Duchek, F. Wiklund, S. Jahnson, O. Mestad, P. Hellström, S. Hellsten, P.U. Malmström

    Esquema Esquema
  • ·POD-09.04: A comparison of specificity of urine cytology, urinary nuclear matrix protein 22 [NMP22] and multi-target fluorescent in situ hybridization [FISH] assay in bladder cancer patients with no recurrence at surveillance

    Página :28-29

    E.O. Kehinde, F. Al-Mulla, S. Jacob, K. Kapila, J.T. Anim, V. Jerin

    Esquema Esquema
  • ·POD-09.05: Is neo-adjuvant chemotherapy better tolerated than adjuvant chemotherapy in patients undergoing cystectomy?

    Página :29

    R. Ayyathurai, M.A. Reyes, R. Singal, M. Manoharan, M.S. Soloway

    Esquema Esquema
  • ·POD-09.06: Radical cystectomy in nonmuscle invasive bladder cancer

    Página :29-30

    S.A. El Abd, A.R. Ramadan, M.D. El-Sharaby, M.A. El-Gharbawy

    Esquema Esquema
  • ·POD-09.07: Number of lymph nodes retrieved in lymphadenectomy specimen during radical cystectomy and local disease control

    Página :30

    S.A. El Abd, A.R. Ramadan, M.D. El-Sharaby, M.A. El-Gharbawy

    Esquema Esquema
  • ·POD-09.08: The predictive role of the re-TURB in the evaluation of high-grade disease progression rate of T1G3 bladder neoplasm

    Página :30-31

    R. Giulianelli, S. Brunori, B.C. Gentile, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, T. Shestani

    Esquema Esquema
  • ·POD-09.09: Outcomes and prognostic significance of second look TURB of high risk non invasive bladder cancer

    Página :31

    R. Sanseverino, A. Campitelli, G. Napodano, A. Baio, G. Miracolo, G. Contaldo

    Esquema Esquema
  • ·POD-09.10: Prognotic factors in patients with urothelial bladder cancer submitted to radical cystectomy

    Página :31

    F.P. da Fonseca, A.L. de Godoy, G.C. Guimaraes, I.N. Nishimoto, S.C. Zequi, F.A. Soares, A. Lopes

    Esquema Esquema
  • ·POD-09.11: Fully-automated FISH-based testing using robotic microscopy: application in bladder cancer identification and recurrence monitoring

    Página :31-32

    N. Romas, M.W. Kilpatrick, T. Tafas, R. Gasparini, P. Tsipouras

    Esquema Esquema
  • ·POD-10.01: Radiofrequency ablation of renal tumors: an alternative for patients with imperative indication for nephron-sparing surgery or those with significant co-morbidities

    Página :32

    K.J. Palmer, R. Thaly, K. Shah, V. Patel

    Esquema Esquema
  • ·POD-10.02: The long-term results of laparoscopic pyeloplasty

    Página :32

    D. Merilees, C. Chabert, C. Eden

    Esquema Esquema
  • ·POD-10.03: Laparoscopic adrenalectomy for functioning and non functioning adrenal tumors: experience with 50 cases

    Página :32-33

    A.E. Abdel Maksoud, M.R. El Halaby, M.E. Ibrahim, G. Janetschek

    Esquema Esquema
  • ·POD-10.04: Autologous fibrin glue using the vivostat system for hemostasis in laparoscopic partial nephrectomy

    Página :33

    L. Cindolo, S. Gidaro, K. Lipsky, O. Dalpiaz, R. Zigeuner, L. Schips

    Esquema Esquema
  • ·POD-10.05: The prognostic impact of comorbidities in patients with renal cancer, 1985-2004: a Danish population-based study

    Página :33

    L. Lund, A. Riis, M. Nørgård, J. McLaughlin, B. Blot, H. Sørensen

    Esquema Esquema
  • ·POD-10.06: Predictors of laparoscopic adrenalectomy morbidity

    Página :33-34

    O. Castillo, F. Secin, M. Kerkebe, G. Vitagliano, R. Sanchez-Salas, M. Díaz, A. Foneron

    Esquema Esquema
  • ·POD-10.07: Analysis of the causes of nephrectomy in 1980-2005

    Página :34

    K. Kim, C. Cho

    Esquema Esquema
  • ·POD-10.08: Complications in laparoscopic transperitoneal partial nephrectomy

    Página :34

    O. Castillo, M. Diaz, G. Vitagliano, A. Foneron, R. Sanchez-Salas

    Esquema Esquema
  • ·POD-11.01: Percutaneous pudendal nerve stimulation for the treatment of urge incontinence

    Página :35

    G.H. Grier

    Esquema Esquema
  • ·POD-11.02: Improvements in incontinence and urgency are associated with reduced symptom bother and improved health-related quality of life

    Página :35-36

    S.A. Kaplan, S. Herschorn, N. Zinner, I. Hissain

    Esquema Esquema
  • ·POD-11.03: Prevalence, severity and impact on quality of life of urinary incontinence in the young and middle age adult (20-60 years old) in Greece

    Página :36

    E. Spyropoulos, C. Theodorou

    Esquema Esquema
  • ·POD-11.04: Our experience using the periurethral constrictor, a simplified silicon made device, in the male urinary incontinence treatment

    Página :36

    J.L. Schiavini, E.A. Da Silva, J.S. Toledo, R. Damiao, M.C. Dornas, J.A.D. Resende

    Esquema Esquema
  • ·POD-11.05: The effect of endogenous testosterone on urodynamic parameters in men with bladder outlet obstruction

    Página :36-37

    G. Koritsiadis, K. Stravodimos, D. Mitropoylos, C. Constantinides, I. Fokitis, G.R. Doymanis, S. Koritsiadis

    Esquema Esquema
  • ·POD-11.06: Use of the adjustable continence therapy for post prostatatectomy urodynamic stress urinary incontinence

    Página :37

    E. Kocjancic, S. Crivellaro, S. Ranzoni, B. Frea

    Esquema Esquema
  • ·POD-11.07: Evaluation of bladder sensation during cystometry: a reliable tool?

    Página :34-35

    T. Realfonso, U. Di Mauro, G. Napodano, A. Campitelli, O. Intilla, R. Sanseverino

    Esquema Esquema

• Moderated Poster Sessions

  • ·MP-01.01: CD38 expression and function in human detrusor muscle: augmentation by interleukin-8

    Página :38

    K. Bouchelouche, J. Nordling, P. Bouchelouche

    Esquema Esquema
  • ·MP-01.02: Prevalence and significance of abdomino-pelvic tenderness in men with chronic prostatitis/chronic pelvic pain syndrome

    Página :38

    D. Shoskes, R. Berger, K. Propert, A. Elmi, S. Zeitlin, The CPCRN Study Group

    Esquema Esquema
  • ·MP-01.03: Proteomic characterization of interstitial cystitis/painful bladder syndrome

    Página :38-39

    F. de Miguel, M. Chancellor, N. Yoshimura, P. Tyagi

    Esquema Esquema
  • ·MP-01.04: Intraprostatic botulinum toxin injection inhibits COX-2 expression and suppresses prostatic pain in rat prostatitis model

    Página :39

    Y.C. Chuang, C.C. Huang, P.H. Chiang, N. Yoshimura, M. Chancellor

    Esquema Esquema
  • ·MP-01.05: Bilirubin attenuates cyclophosphamide-induced cystitis in rats

    Página :39

    Y. Matsuoka, H. Masuda, M. Yokoyama, S. Yoshida, K. Kihara

    Esquema Esquema
  • ·MP-01.06: Corynebacterium urealyticum urinary tract infection (UTI): early diagnosis in radiated and immunosuppressed patients is mandatory

    Página :39-40

    C. González Enguita, F. Soriano, R. Vela Navarrete, M.C. Ponte

    Esquema Esquema
  • ·MP-01.07: Present aspects and trend of acute simple cystitis in japanese females

    Página :40

    K. Suzuki, K. Igarashi, H. Sekine, E. Nozawa, N. Yoshida, N. Ishii

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :40

    
  • ·MP-01.09: Emphysematous pyelonephritis in non diabetic patients differs from diabetic patients

    Página :40

    A.R. Pontin, R.D. Barnes

    Esquema Esquema
  • ·MP-01.10: Antibacterial treatment of asymptomatic prostatitis can not exclude prostate cancer and should not delay prostate biopsies

    Página :40-41

    D. Pode, R. Katz, O. Gofrit, A. Shapiro

    Esquema Esquema
  • ·MP-01.11: Efficacy of cefdinir against acute uncomplicated cystitis

    Página :41

    T. Yamane, H. Hayami, S. Era, Y. Uchida, K. Nishiyama, M. Nakagawa

    Esquema Esquema
  • ·MP-01.12: Intermittent pelvic floor stimulation for treatment of interstitial cystitis

    Página :41

    P. De Jong, P. Radziszewski, A. Rosamilia, H. O’Connell, B. Farnsworth, J. Nordling, M. Parsons, J. Groen, M. Cervingi, I. Nissenkorn

    Esquema Esquema
  • ·MP-01.13: Laser doppler flowmetry in patient with chronic cystitis treated by alfuzosin

    Página :42

    A. Zaitcev, P. Rasner, A. Matsaev

    Esquema Esquema
  • ·MP-01.14: Use of hyperbaric oxygenation in the treatment of patients with BPS/IC

    Página :42

    A. Zaitcev, A. Mazaev, A. Davidyanz, R. Farmanov

    Esquema Esquema
  • ·MP-01.15: Practical significance of endovesical electromotive drug administration in the multimodality treatment BPS/IC

    Página :42-43

    D. Pushkar, A. Zaitcev, I. Korsunskaya, P. Rasner

    Esquema Esquema
  • ·MP-01.16: The etiology of acute epididymitis

    Página :43

    K. Kim, H. Jung, J. Cho, S. Cho, Y. Lee

    Esquema Esquema
  • ·MP-01.17: New approach in treatment of pelvic chronic pain syndrome (CPPS)

    Página :43

    J. Tornero, P. López, P. López-Cubillana, G. Gómez, M. Pérez

    Esquema Esquema
  • ·MP-01.18: Extracellular beta-nad⁺ increases intracellular free calcium in human detrusor muscle cells and induces relaxation of human detrusor detrusor muscle

    Página :43-44

    K. Bouchelouche, J. Nordling, P. Bouchelouche

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :44

    
  • ·MP-01.20: Comparison of effect of alpha-blocker and terpene mixure on CPPS

    Página :44

    K. Mo, K.S. Lee, K.H. Kim, H.C. Jung, J.H. Seo, Y.J. Seo

    Esquema Esquema
  • ·MP-01.21: Dyspareunia in interstitial patients improves after therapeutic solution instillations

    Página :44

    B.J. Welk, J.M.H. Teichman

    Esquema Esquema
  • ·MP-01.22: Clinical features of confirmed versus suspected urogenital tuberculosis in a region with an extremely high prevalence of pulmonary tuberculosis

    Página :44-45

    A.D. Zarrabi, S.M. van Deventer, C.F. Heyns

    Esquema Esquema
  • ·MP-01.23: Chronic nonbacterian prostatitis associated with ED

    Página :45

    P. Geavlete, D. Georgescu, Gh. Nita, B. Geavlete

    Esquema Esquema
  • ·MP-01.24 (podium): Hyperbaric oxygen therapy (HOT), surgery and advanced dressings (AD), in the treatment of Fournier’s Gangrene (FG)

    Página :45

    G. Passavanti, V. Pizzuti, A. Bragaglia, F.M. Costantini, M. Brauzzi, P. Tanasi, M.R. Pagni, E. Norgini, R. Paolini

    Esquema Esquema
  • ·MP-01.25 (podium): ‘Circumcision Sunday’: a Swazi study model for mass circumcision against HIV transmission

    Página :45-46

    A.E. Groeneveld

    Esquema Esquema
  • ·MP-01.26 (podium): Use of pulsed KTP laser coagulation of submucosal telangiectatic vessels in patients with radiation cystitis

    Página :46

    B. Chapin, B. Eisner, S. Tabatabaei

    Esquema Esquema
  • ·MP-02.01: Initial results of a novel procedure for the repair of ureteropelvic junction obstruction in children

    Página :46

    H.-G. Mesrobian

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :46

    
  • ·MP-02.02: Reliability and validity assessment of society for fetal urology ultrasound grading system for hydronephrosis

    Página :46-47

    M. Keays, L. Guerra, J. Mihill, G. Raju, N. Al-Asheeri, P. Geier, I. Gaboury, M.A. Matzinger, J. Pike, M. Leonard

    Esquema Esquema
  • ·MP-02.03: Correlation between HLA system and primary vesicoureteral reflux

    Página :47

    S. Tavasoli Yousefabad, S. Falahatkar

    Esquema Esquema
  • ·MP-02.04: Can a slit-like meatus be achieved with the V incision sutured meatoplasty for onlay island flap hypospadias repair?

    Página :47

    Y. Hayashi, A. Nakane, H. Kamisawa, K. Kohri

    Esquema Esquema
  • ·MP-02.05: Ventral based dartos flap for the prevention of the urethrocutaneous fistula on hypospadias urethroplasty

    Página :47

    Y. Hayashi, A. Nakane, H. Kamisawa, K. Kohri

    Esquema Esquema
  • ·MP-02.06: Combined use of Mathieu procedure with TIP-principle as a novel technique for hypospadiasis repair: RCT preliminary results

    Página :47-48

    A.R. Aminsharifi, A.R. Taddayun, A. Assadolahpoor

    Esquema Esquema
  • ·MP-02.07: Dorsal dartos flap in Snodgrass hypospadias repair: how to use it

    Página :48

    M. Mustafa, B.S. Wadie, H.A. Abol-Enein

    Esquema Esquema
  • ·MP-02.08: Evaluation of the long-term function outcome with uroflowmetry: the meatal-based flip-flap repair for distal hypospadias

    Página :48

    M. Imura, Y. Hayash, Y. Kojima, S. Kurokawa, A. Nakane, K. Mizuno, T. Maruyama, Y. Iwase, K. Kohri

    Esquema Esquema
  • ·MP-02.09: A clinical spectrum of posterior urethral valves with long-term follow-up

    Página :48-49

    T. Mitsui, K. Moriya, H. Tanaka, T. Kitta, M. Nakamura, K. Nonomura

    Esquema Esquema
  • ·MP-02.10: Ectopic ureterocele: long-term results of open surgical therapy in 54 patients

    Página :49

    A. Beganović, A.J. Klijn, P. Dik, T.P.V.M. De Jong

    Esquema Esquema
  • ·MP-02.11: Analysis of urodynamic study in children with primary monosymptomatic nocturnal enuresis

    Página :49

    K.H. Huang

    Esquema Esquema
  • ·MP-02.12: Xanthogranulomatous pyelonephritis in children: a series of 20 cases

    Página :49

    W. Chaaben, A. Sahnoun, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·MP-02.13: Female phallic urethra with native urethral hypospadias: a rare entity

    Página :50

    U. Sathaye

    Esquema Esquema
  • ·MP-02.14: Pediatric ESWL: 15 years single centre experience (219 cases)

    Página :50

    I. Sinescu, R. Manu, M.A. Manu, M. Brânzan, G. Chiriac-Babei, C. Arion

    Esquema Esquema
  • ·MP-02.15: The investigation of calcium oxalate urolithiasis formation mechanism-the relation with the calcium oxalate urolithiasis low rate of incidence of children

    Página :50

    I. Yoshioka, A. Momohara, M. Tsujihata, A. Okuyama

    Esquema Esquema
  • ·MP-02.16: Passive dilation by ureteral stenting prior to ureteroscopy eliminates the need for active dilation

    Página :50-51

    J.S. Palmer

    Esquema Esquema
  • ·MP-02.17: Two regimens for the treatment of phimosis with topical betamethasone

    Página :51

    J.S. Palmer, L.S. Palmer

    Esquema Esquema
  • ·MP-02.18: Ungated ESWL is safe and effective in children

    Página :51

    J.S. Palmer

    Esquema Esquema
  • ·MP-02.19: Use of the adjustable continence therapy (ACT®) in pediatrics with neurogenic disorders: pilot study

    Página :51-52

    E. Kocjancic, S. Crivellaro, E. Merlini, M. Mihelic, B. Frea

    Esquema Esquema
  • ·MP-02.20: Midline scroto-perineal approach for innervation preserving sphincteroplasty and penile lengthening: a technique to improvise functional outcome of single stage reconstruction of exstrophy-epispadias

    Página :52

    S.N. Kureel, D. Dalela, V. Singh

    Esquema Esquema
  • ·MP-02.21: Botulinum-toxin injections in children after failure of conservative treatment: case report from 10 children

    Página :52

    S. Laschke, S. Carl

    Esquema Esquema
  • ·MP-03.01: Wire-based ureteral stents: Impact on tensile strength and compression

    Página :52

    M. Monga, R.N. Pedro, C. Kriedberg, K. Hendlin

    Esquema Esquema
  • ·MP-03.02: A double-blind, placebo-controlled comparison of voltaren and tramadol for acute renal colic

    Página :53

    H. Ahmadnia, M. Darabi, S. Ghanbarizadeh, M. Molaee, M. Shokohian

    Esquema Esquema
  • ·MP-03.03: In situ de novo ESWL of ureteral stones: evolution in treatment results 1990-2007

    Página :53

    G.G. Tailly

    Esquema Esquema
  • ·MP-03.04: Retrograde proximal rigid ureteroscopy and pyeloscopy: its safety and efficacy

    Página :53

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Esquema Esquema
  • ·MP-03.05: Tubeless percutaneous nephrolithotomy: five years of experience, review of 201 patients

    Página :53

    H. Karami, M. Jabbari

    Esquema Esquema
  • ·MP-03.06: Oxalate-induced nadph oxidase mediated free radical generation is protein kinase C-dependent in renal epithelial cells

    Página :53-54

    V. Thamilselvan, M. Menon, S. Thamilselvan

    Esquema Esquema
  • ·MP-03.07: Retrograde ureteroscopy for large ureteral stones: an effective first-line therapy

    Página :54

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, K. Yosri, N. Ben Sorba, A.F. Mosbah

    Esquema Esquema
  • ·MP-03.08: Predictors of blood transfusion in percutaneous nephrolithotomy (PCNL)

    Página :54

    S.R. Biyabani, A.A. Zehri, K. Siddiqui, A. Memon

    Esquema Esquema
  • ·MP-03.09: ESWL with wide focal spot – one year experience with Siemens Lithoskop^®

    Página :54-55

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-03.10: Higher efficacy of ESWL with abdominal compression belt

    Página :55

    T. Bergsdorf, C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-03.11: How much shockwave energy is mandatory for stone fragmentation with ESWL?

    Página :55

    C. Chaussy, T. Bergsdorf, S. Thueroff

    Esquema Esquema
  • ·MP-03.12: Tamsulosin effect on the peristalsis of completely and partially obstructed ureter in the anesthetized dog

    Página :55-56

    R. Seyam, W. Al-Taweel, A. Mokhtar, R. El-Sayed, K. Hanash

    Esquema Esquema
  • ·MP-03.13: Percutaneous nephrolithotomy using a novel 4-mm ballistic lithotripsy probe: a randomized trial

    Página :56

    K. Nouri-Mahdavi, M.H. Khorrami, A. Ghalamkari

    Esquema Esquema
  • ·MP-03.14: Comparative study on the efficacy of different alpha adrenergic blockers for distal ureteral stones with or without shock wave lithotripsy

    Página :56

    M. Hassan Ali, G. Elatrash, H. Hafez, M. Hegazy, O. Abd Elkader, W. Aboud, S. Shabaan

    Esquema Esquema
  • ·MP-03.15: Laparoscopic ureterocalicostomy: the reliable last resource

    Página :56-57

    O. Castillo, G. Vitagliano, M. Díaz, R. Sánchez-Salas, A. Foneron

    Esquema Esquema
  • ·MP-03.16: Difficulties in focusing during ESWL calculus treatment

    Página :57

    I. Sinescu, R. Manu, G. Glück, M.A. Manu, G. Chiriac-Babei

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :57

    
  • ·Abstract Withdrawn

    Página :57

    
  • ·MP-03.17: Comparison of the efficacy of intranasal Desmopressin and Pethidine alone and in combination for treatment of renal colic

    Página :57

    H. Tajari, M. Rabie, F. Eftekhari

    Esquema Esquema
  • ·MP-03.18 (podium): Evidence based selection of pneumatic lithotriptor probe diameter

    Página :57

    P. Shadpour, M. Masoud Etemadian, A. Abdolhossein Saidi, M.J. M. Javad Solemani

    Esquema Esquema
  • ·MP-04.01: Molecular mechanisms of the urinary bladder carcinogenesis (the intercellular proteolysis alteration) influenced by persistent, long-term, low-dose ionizing radiation in humans

    Página :58

    A.M. Romanenko, A.F. Vozianov, S. Fukushima

    Esquema Esquema
  • ·MP-04.02: Enzymatic immuno-assay quantification of C-erbB-2 oncogene expression in urinary bladder cancer

    Página :58

    A.A. Mehena, M. Wishahi, S. Hassan, N. El-Sayed

    Esquema Esquema
  • ·MP-04.03: The value of tissue polypeptide antigen (TPA) in the after care patients with bladder cancer: relationship with conventional urine cytology

    Página :58-59

    A. Bantis, A. Zissimopoulos, C. Kalaitzis, P. Sountoulides, S. Giannakopoulos, E. Patris, E. Aggelonidou, C. Voudalikakis, S. Touloupidis

    Esquema Esquema
  • ·MP-04.04: Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking

    Página :59

    H. Tsukino, T. Katoht, R. Hamasuna, K. Nose, K. Inoue, M. Nagano, H. Wakeda, T. Kamimura, Y. Hasui, Y. Osada

    Esquema Esquema
  • ·MP-04.05: Development and DNA microarray analysis of cisplatin, gemcitabine and docetaxel-resistant bladder cancer cell lines

    Página :59

    E. Lee, W. Yeo, I.G. Jeong, S.H. Kim, S.S. Byun, S.J. Jin Yoon

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :59

    
  • ·Abstract Withdrawn

    Página :59

    
  • ·MP-04.06: Gene expression profile of urine sediment for the non-invasive diagnosis of bladder cancer

    Página :59-60

    D. MacDonald, S. Henderson, D. Boumpoulia, D.C. Hanbury, T.A. McNicholas, G.B. Boustead, C. Boshoff

    Esquema Esquema
  • ·MP-04.07: CD-4⁺ CD-25⁺ regulatory T-cells in the tumor draining lymph nodes of patients with urothelial carcinoma

    Página :60

    M.K. Tollefson, B.C. Leibovich, J.C. Cheville, H. Dong, E.D. Kwon

    Esquema Esquema
  • ·MP-04.08: Clinical evaluation of NMP22 in the diagnosis of urothelial cancer

    Página :60

    H. Ikeda, Y. Ishida, S. Seko, M. Mizutani

    Esquema Esquema
  • ·MP-04.09: Usefulness of virtual cystoscopy using 64-channel multidetector-row computed tomography scanner for detecting bladder tumors

    Página :60

    S.B. Ryu, K. Park, D.D. Kwon, S.S. Shin, I.S. Hwang, T.W. Kang

    Esquema Esquema
  • ·MP-04.10: DNA repair gene polymorphisms and toxicity in chemoradiotherapy for bladder cancer

    Página :60-61

    S. Sakano, H. Matsumoto, S. Eguchi, T. Misumi, Y. Kawai, T. Hara, K. Nagao, C. Ohmi, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :61

    
  • ·MP-04.11: Non-invasive detection of bladder cancer by measurement of tumor-related transcript markers in urine

    Página :61

    C. Rippel, J. Schmidt, W.-Y. Siow, S. Fuessel, A. Meye, A. Lohse, M.-O. Grimm, O.W. Hakenberg, M.P. Wirth

    Esquema Esquema
  • ·MP-04.12: Anti angiogenic VEGF₁₆₅b is an inhibitory splice variant of VEGF in transitional cell carcinoma of the bladder

    Página :61

    S.S. Gopi, M.H. Zadeh, S.J. Harper, D.O. Bates, D.A. Gillatt

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :62

    
  • ·MP-04.13: Epirubicin and ciprofloxacin synergistically induce apoptosis in human urothelial cancer cell lines

    Página :62

    D.S. Engeler, E. Scandella, H.P. Schmid, B. Ludewig

    Esquema Esquema
  • ·MP-05.01: Retrocaval ureter: a study of 13 cases

    Página :62

    A. Yarmohamadi

    Esquema Esquema
  • ·MP-05.02: Flexible percutaneous approach in uretero-enteric stenosis

    Página :62

    P. Geavlete, R. Multescu, V. Mirciulescu, D. Georgescu, B. Geavlete

    Esquema Esquema
  • ·MP-05.03: HLA and ureteropelvic junction obstruction

    Página :62-63

    R. Farajidarkhaneh, S. Falahatkar, S. Aghazadeh, S. Tavasoli Yousefabad

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :63

    
  • ·MP-05.04: Valvular heart disorders in end stage renal disease patients

    Página :63

    F. Ataei, K. Pishehvar Esfahani, H. Shamsolkottabi, M. Shirazinejad, S. Yavari

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :63

    
  • ·MP-05.05: Possible cytoprotective roles of glyoxalase I and heat shock proteins in acute renal cell injury

    Página :63

    P. Pyo, M. Hoffman, R. Simon, H. Tazaki, M. Choudhury, S. Konno

    Esquema Esquema
  • ·MP-05.06: Results from an anatomic study of variations of renal vessels (240 cases)

    Página :63-64

    D.A. Lappas, A. Lekas, I. Gisakis, A. Karamanou, S. Vrakas, M. Chrisofos, C. Deliveliotis, P. Scandalakis

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :64

    
  • ·MP-05.08: Laparoscopic adrenalectomy for suspected metastasis of the adrenal glands: our experience

    Página :64

    O. Castillo, G. Vitagliano, M. Kerkebe, M. Díaz, R. Sánchez-Salas, A. Foneron

    Esquema Esquema
  • ·MP-05.09: Prevalence of incidental prostate cancer in radical cystectomy specimens

    Página :64

    C. Sweeney, D.S. Hendry

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :64

    
  • ·MP-05.10: Antegrade versus retrograde stenting in laparoscopic pyeloplasty: a two centre analysis

    Página :64-65

    N. Arumainayagam, A. Minervini, K. Davenport, V. Kumar, L. Masieri, S. Serni, M. Carini, A.G. Timoney, F. Keeley

    Esquema Esquema
  • ·MP-05.11: Percutaneous biopsy of indeterminate renal masses in patients with tuberous sclerosis complex (TSC)

    Página :65

    S.K. Misra, J.A. Cox, J.C. Kingswood, T. Doyle

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :65

    
  • ·MP-05.12: Determination of success by laparoscopic pyeloplasties based on strict renal scintigraphic criteria: no difference between primary and non-primary pyeloplasty success rates

    Página :65-66

    F. Pouliot, M.H. LeBel, J.F. Audet, T. Dujardin

    Esquema Esquema
  • ·MP-05.13: Urological aspects in retroperitoneal sarcomas

    Página :66

    M.C. Persoon, A. Hennipman, M.T.W.T. Lock

    Esquema Esquema
  • ·MP-05.14: Laparoscopic partial nephrectomy: what we have learned after 200 cases?

    Página :66

    T. Dujardin, W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, V. V. Molinié, H. Baumert

    Esquema Esquema
  • ·MP-06.01: Erectile nerve preservation during daVinci prostatectomy: a novel method using nerve action potential monitoring

    Página :66-67

    R. Fagin

    Esquema Esquema
  • ·MP-06.02: Robotic equipment malfunction during robotic prostatectomy: a multi-institutional study

    Página :67

    H.J. Lavery, T. Ahlering, A. Tewari, J.A. Smith, A. Shalhav, D. Albala, P. Wiklund, A.J. Costello, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :67

    
  • ·MP-06.04: Hem-o-lok polymer ligating clip for vascular control of the renal pedicle: points of controversy

    Página :67

    H. Izaki, M.G. El-Moula, T. Fukumori, M. Takahashi, R. Taue, T. Kishimoto, S. Kagawa, H. Kanayama

    Esquema Esquema
  • ·MP-06.05: Laparoscopic partial cystectomy for malignant and benign bladder conditions

    Página :67-68

    H. Kinoshita, G. Kawa, K. Yasuda, S. Kawakita, Y. Hiura, K. Muguruma, K. Yoshida, T. Masuda, T. Murota, T. Matsuda

    Esquema Esquema
  • ·MP-06.06: Ten years of experience with simple renal cyst sclerotherapy using acetic acid

    Página :68

    K. Yoo, J. Kim, S. Lee

    Esquema Esquema
  • ·MP-06.07: Nephron damages after partial nephrectomy with microwave tissue coagulator: three-year follow up study after surgery

    Página :68

    M. Kawasaki, Y. Satoh, C. Fujiyama, J. Uozumi

    Esquema Esquema
  • ·MP-06.08: Retroperitoneal laparoscopic nephrectomy for inflammatory renal diseases

    Página :68

    Y.S. Jeon, T.H. Oh, D.S. Kim, C.H. Lee, N.K. Lee

    Esquema Esquema
  • ·MP-06.09: Assessment of the durability of robotic-assisted laparoscopic sacrocolpopexy for the treatment of vaginal vault prolapse

    Página :68-69

    D.S. Elliott, I. Frank, G. Chow

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :69

    
  • ·Abstract Withdrawn

    Página :69

    
  • ·MP-06.10: Comparison between endoscopic minilaparotomy radical prostatectomy and conventional radical prostatectomy for prostate cancer

    Página :69

    Y. Kamiryo, Y. Urabe, N. Yamamoto, T. Moriwaka

    Esquema Esquema
  • ·MP-06.11: Preoperative erectile function and nerve-sparing are useful predictors for early recovery of urinary continence after laparoscopic radical prostatectomy

    Página :69-70

    A. Takenaka, H. Soga, T. Terakawa, A. Kumano, J. Furukawa, M. Muramaki, T. Kurahashi, H. Miyake, K. Tanaka, M. Fujisawa

    Esquema Esquema
  • ·MP-06.12: Laparoscopic simple prostatectomy with precise vascular control: going back to basics

    Página :70

    O. Castillo, D. Degiovanni, R. Saánchez-Salas, G. Vitagliano, A. Foneron, M. Diaz

    Esquema Esquema
  • ·MP-06.13: The impact of posterior sphincteropexy on early continence rates following laparoscopic radical prostatectomy

    Página :70

    C. Chabert, D. Merilees, C. Eden

    Esquema Esquema
  • ·MP-06.14: Usefulness of preoperative multidetector-row computed tomography with three-dimensional pelvic angiography in patients who undergo pelvic lymphadenectomy in robot-assisted radical prostatectomy: preliminary analysis of outcomes

    Página :70-71

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Esquema Esquema
  • ·MP-06.15: Robot-assisted laparoscopic radical prostatectomy in Korea: initial 160 cases

    Página :71

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Esquema Esquema
  • ·MP-06.16: Trans vesico-prostatic approach of laparoscopic simple prostatectomy (LSP): novel technique avoiding post operative bladder irrigation

    Página :71

    W. Massoud, N. Rebai, A. Ballaro, N. Saheb, J. Schlosser, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :71

    
  • ·MP-07.01: The natural history of hydronephrosis after hysterectomy: a prospective study

    Página :71-72

    M. Mansourghanai, S.A. Asgari

    Esquema Esquema
  • ·MP-07.02: Risk of gestational hypertension and pre-eclampsia in patients with polycystic ovarian syndrome (PCOS) in Iran

    Página :72

    M.R. Razaghi, S. Zadeh Modares, M. Karbalaeizadeh

    Esquema Esquema
  • ·MP-07.03: Intense inflammatory reaction with small intestine submucosa tensionless pubovaginal sling or tape for stress urinary incontinence

    Página :72

    T.T. John, N. Aggarwal, A.K. Singla, R.A. Santucci

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :72

    
  • ·MP-07.05: The usefulness of transurethral resection for the treatment of intravesical tape erosion with bladder stone following tension-free vaginal tape (TVT) procedure

    Página :72

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Esquema Esquema
  • ·MP-07.06: Factors influencing the outcome after mid-urethral sling procedures in female urinary incontinence

    Página :72

    S. Park, J. Ku, H. Son, S.J. Oh, S. Kim, J.S. Paick

    Esquema Esquema
  • ·MP-07.07: A novel visual analogue self-compiled sketch questionnaire as diagnostic tool for the prediction of disturbed urination in working women

    Página :73

    A. Lekas, I. Fokitis, V. Politis, G. Koritsiadis, S. Koritsiadis

    Esquema Esquema
  • ·MP-07.08: Endometriosis of the urogenital tract

    Página :73

    D. Papadopoulos, A. Lekas, A. Balangas, A. Schneider, S.O. Schattka, R. Homberg, A. Kollias

    Esquema Esquema
  • ·MP-07.09: Efficacy of tamsulosin in female patients with lower urinary tract symptoms

    Página :73

    H.S. Chang, C.H. Park, C.I. Kim, H.C. Jung, T.C. Park, H.S. Shin, T.G. Kwon, D.Y. Kim, T.H. Oh, D.S. Ryu

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :74

    
  • ·MP-07.11: Characteristics of voiding dysfunction in women with lower urinary tract disorders

    Página :74

    N. Seki, M. Takei, A. Yamaguchi, S. Naito

    Esquema Esquema
  • ·MP-07.12: Sexual dysfunction in women with newly diagnosed multiple sclerosis

    Página :74

    K. Skriapas, C. Konstantinidis, V. Tzortzis, G. Hadjigeorgiou, M. Samarinas, K. Aggelakis, V. Poulakis, M. Melekos

    Esquema Esquema
  • ·MP-07.13: Transobturator suburethral tape ARIS in the treatment of stress urinary incontinence: one year evaluation

    Página :74-75

    V. Delmas, P. Ballanger, P. Grise, C. Ortuno

    Esquema Esquema
  • ·MP-07.14: Anatomical basis of total vaginal mesh for rectocele and vaginal vault prolapse

    Página :75

    S. Ben Rhouma, A. Anghelus, V. Boublil, S. Dominique, V. Ravery, J.F. Hermieu, L. Boccon Gibod, V. Delmas

    Esquema Esquema
  • ·MP-07.15: Anatomical basis of total vaginal mesh for cystocele

    Página :75

    A. Anghelus, S. Ben Rhouma, V. Boublil, S. Dominique, V. Ravery, J.F. Hermieu, L. Boccon Gibod, V. Delmas

    Esquema Esquema
  • ·MP-07.16: Seven year follow-up of the tendinous vaginal support: a minimally invasive approach for stress urinary incontinence

    Página :75-76

    P. Palma, C. Riccetto, M. Martins, M. Dambros, R. Fraga, N. Netto

    Esquema Esquema  
  • ·MP-07.17 (podium): Female bladder outlet obstruction in community urology practice: is AUA symptom score helpful in prediction?

    Página :76

    P. Pandey, L. Hegde, C.D. Marsh, L.D. Monahan

    Esquema Esquema
  • ·MP-07.18 (podium): Reliability, validity and responsiveness of international prostate symptom score in females with lower urinary tract symptoms

    Página :76

    B.Y. Low, M.L. Liong, K.H. Yuen, C. Chee, W.S. Leong, W.L. Chong, N.K. Khan, P.Y. Cheah

    Esquema Esquema
  • ·MP-07.19 (podium): Women with type 2 diabetes: understanding bladder dysfunction

    Página :77

    J.L. Mehdizadeh, D.Y. Deng, W.C. Sweeting, P. Mallipeddi, J.M. Creasman, J.S. Brown

    Esquema Esquema
  • ·MP-08.01: Salvage therapy with bicalutamide 150 mg in patients with PSA failure under LHRH therapy or surgical castration for advanced prostate cancer

    Página :77

    Y. Fradet

    Esquema Esquema
  • ·MP-08.02: Metronomic chemotherapy for hormone refractory prostate cancer (HRPC)

    Página :77-78

    S. Hoshi, K. Hoshi, K. Ono, T. Kobayashi, M. Sasaki, K. Suzuki, M. Tukigi, K. Numahata, S. Ishidoya, S. Saito, Y. Arai

    Esquema Esquema
  • ·MP-08.03: Changes in the characteristics of patients and results of radical prostatectomy in the years 1990-2005

    Página :78

    G. Hidas, O.N. Gofrit, R. Katz, E.H. Landau, A. Shapiro, D. Pode

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :78

    
  • ·MP-08.05: Usefulness of prostate-specific antigen change as predictor of survival of patients with advanced prostate cancer after hormonal therapy

    Página :78

    H. Ehara, T. Katoh, K. Mizutani, K. Nakane, K. Seike, T. Sugawara, S. Katoh, T. Masue, T. Gotoh, T. Deguchi

    Esquema Esquema
  • ·MP-08.06: Amifostine administration during radiotherapy for prostate cancer: a prospective study

    Página :78-79

    E. Patris, C. Kalaitzis, S. Gianacopoulos, A. Bantis, N. Sofikitis, M. Koukourakis, S. Touloupidis

    Esquema Esquema
  • ·MP-08.07: Pathological correlation between prostatic needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer

    Página :79

    M.A. Bulbul, Y. El-Hout, A. Tawil, R.B. Khauli, K. Hemady, W. Wazzan, A. Hujeij, N. Bou Diab, M.C. Haddad

    Esquema Esquema
  • ·MP-08.08: Docetaxel-prednisolone combination therapy for japanese patients with hormone-refractory prostate cancer: a phase 2 study

    Página :79

    N. Miura, K. Numata, A. Shirato, K. Hashine, Y. Sumiyoshi

    Esquema Esquema
  • ·MP-08.09: Docetaxel, etoposide, and estramustine phosphate in the treatment of hormone-refractory prostate cancer

    Página :79-80

    K. Nagao, T. Misumi, M. Sasaki, Y. Kawai, S. Eguchi, T. Hara, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·MP-08.10: The relationship between Charlson score and clinical unilateral T3a prostate cancer

    Página :80

    C.Y. Hsu, S. Joniau, R. Oyen, T. Roskams, H. van Poppel

    Esquema Esquema
  • ·MP-08.11: Lymph node collection in radical prostatectomy

    Página :80

    N. Arumainayagam, S. McPhail, B. Ayres, J. MacGrath, S. Fowler, B. Cottier, J. Verne, D.A. Gillatt

    Esquema Esquema
  • ·MP-08.12: One single dose of zoledronic acid (Zometa) annually can prevent bone mineral density (BMD) in patients with prostate cancer treated with LHRH: early results of a randomized trial

    Página :80-81

    A. Lekas, M. Chrisofos, I. Fokitis, A. Balangas, A. Kollias, C. Deliveliotis

    Esquema Esquema
  • ·MP-08.13: Does saturation biopsy reliably predict unilateral prostate cancer in patients with low-risk tumours?

    Página :81

    D. Pushkar, A. Govorov, J. Kosko, M. Kovylina, M. Kurjiev, A. Bormotin

    Esquema Esquema
  • ·MP-08.14: Eradication of osteoblastic and osteolytic skeletal metastases of hormone refractory prostate cancer (mHRPC) after treatment with pegylated trispecific disulfide linked Fv (sdFv) targeting epitopes of EGFR, PTHrP and RANKL conjugated covalently with SATA to vinorelbine tartrate

    Página :81

    J. Giannios, N. Alexandropulos, E. Michailakis

    Esquema Esquema
  • ·MP-08.15: Low dose-rate brachytherapy with I125 in patients with local prostate cancer relapse after radical prostatectomy

    Página :81-82

    F.G. Veiga, J. Ponce, L.A. Castelo, E. Romero, A. Marinño, A. Candal, C. Veiras, J. Janeiro, D. Loópez, M. Gonzaález Martín

    Esquema Esquema
  • ·MP-08.16: Docetaxel and oral estramustine phosphate in patients with hormone refractory prostate cancer

    Página :82

    T. Segawa, N. Masuda, Y. Shiraishi, H. Negoro, H. Oka, H. Iwamura, S. Moroi, K. Okubo, T. Okada, M. Kawakita

    Esquema Esquema
  • ·MP-08.17: Correlation of clinical and pathological staging in patients undergoing radical prostatectomy

    Página :82

    N. Arumainayagam, S. McPhail, B. Ayres, J. MacGrath, S. Fowler, B. Cottier, J. Verne, D.A. Gillatt

    Esquema Esquema
  • ·MP-08.18: Robot-assisted laparoscopic radical prostatectomy in locally advanced prostate cancer: results of a single surgeon experience in Korea

    Página :82-83

    S.Y. Park, S.J. Park, Y.H. Lee, H.J. Kim, S.W. Lee, W.K. Han, J.H. Kim, Y.D. Choi, K.H. Rha, S.C. Yang

    Esquema Esquema
  • ·MP-08.19: Salvage HIFU effectively reduces PSA in patients with biochemical recurrence after attempted curative treatment for prostate cancer

    Página :83

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, R. Illing, G. Shaw, J. Calleary, C. Allen, M. Emberton

    Esquema Esquema
  • ·MP-08.20: Ablative salvage therapy following combination low dose rate brachytherapy and external beam radiation therapy is associated with higher levels of rectal toxicity

    Página :83

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, G. Shaw, R. Illing, J. Calleary, C. Allen, M. Emberton

    Esquema Esquema
  • ·MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients

    Página :83-84

    M. Gittelman, P.J. Pommerville, B.E. Persson, T. Kold Olesen

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :84

    
  • ·MP-08.23: Zoledronic acid produces benefits in patients with early malignant bone disease from hormone-refractory prostate cancer

    Página :84

    F. Saad, Y.M. Chen

    Esquema Esquema
  • ·MP-08.24: Zoledronic acid-mediated normalization of NTX levels correlates with increased clinical benefits in patients with bone metastases secondary to prostate cancer

    Página :84-85

    F. Saad, A. Lipton, R. Coleman

    Esquema Esquema
  • ·MP-08.25: Prevalence of symptoms and effectiveness of symptom relief for patients with advanced prostate cancer

    Página :85

    S. Wozniak, R. Zdrojowy, A. Kolodziej

    Esquema Esquema
  • ·MP-08.26: Staging saturation biopsy in patients with prostate cancer on an active surveillance protocol

    Página :85

    R. Abouassaly, J.S. Jones

    Esquema Esquema
  • ·MP-10.01: Treatment of post-operative male urinary incontinence by invance prosthesis: results and complications

    Página :85-86

    T.H. Arvanitakis, A. Rempelakos, A. Marketakis, S. Mpisias, A. Georgalis

    Esquema Esquema
  • ·MP-10.02: Activity of different phospholipids in hyperactivity in bladder irritation

    Página :86

    P. Tyagi, M.B. Chancellor, N. Yoshimura, J. Kaufmann

    Esquema Esquema
  • ·MP-10.03: Renal function and urodynamic evaluations in spina bifida patients managed with clean intermittent catheterization

    Página :86

    K. Inoue, H. Tsukino, H. Wakeda, M. Nagano, K. Nose, Y. Osada

    Esquema Esquema
  • ·MP-10.04: New male sling procedure in men with stress urinary incontinence

    Página :86-87

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Esquema Esquema
  • ·MP-10.05: Heart rates and cardiovascular co-morbidities in overactive bladder (OAB) patients

    Página :87

    K.E. Andersson, K. Kahler, U. Ebinger

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :87

    
  • ·MP-10.07: A cost-utility analysis of solifenacin 5 mg versus tolterodine ER 4 mg

    Página :87

    A. Thorpe, T. Terry, M. Fynes, M. Sidhu, J. Warner

    Esquema Esquema
  • ·MP-10.08: Effect of an antiepileptic - Levetiracetam (Keppra^™) - on neurogenic overactive bladder in chronic paraplegic rats

    Página :87-88

    E.A. Elzayat, L. Campeau, G. Karsenty, B. Blok, A.L. Padjen, J. Corcos

    Esquema Esquema
  • ·MP-10.09: The effect of darifenacin on health-related quality of life in patients with overactive bladder: results from the ABLE study

    Página :88

    M. Chancellor, W.S. Aronstein, M. Egermark, R. Ariely, U. Ebinger, F. Kianifard

    Esquema Esquema
  • ·MP-10.10: Experimental studies of influence of laser neuromodulation on detrusor function

    Página :88

    I.A. Makedonsky

    Esquema Esquema
  • ·MP-10.11: Collagen injection for incontinence after prior urethral or peri-urethral surgery

    Página :88-89

    P.E. Zimmern, G. Isom-Batz

    Esquema Esquema
  • ·MP-10.12: How does functional capacity and first sensation during cystometrogram relate to nocturia?

    Página :89

    S.S. Steele, J.B. Gajewski

    Esquema Esquema
  • ·MP-10.13: Use of the adjustable continence therapy for the treatment of recurrent female urodynamic stress urinary incontinence

    Página :89

    E. Kocjancic, S. Crivellaro, M. Favro, B. Frea

    Esquema Esquema
  • ·MP-10.14: Efficacy and tolerability of the OROS-based oxybutynin extended-release formulation (Lyrinel) in patients with neurogenic detrusor overactivity

    Página :89-90

    G. Riedasch, A. Reitz

    Esquema Esquema
  • ·MP-10.15: Responses to solifenacin in male and female patients with overactive bladder syndrome: post-hoc results from the randomised, double-blind STAR study

    Página :90

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Esquema Esquema
  • ·MP-10.16: Responses to solifenacin in overactive bladder patients with or without incontinence (‘OAB wet’ and ‘OAB dry’): post-hoc results from the randomised, double-blind STAR study

    Página :90-91

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Esquema Esquema
  • ·MP-10.17: Transrectal ultrasound-guided implantation of the ProACT system in patients with post-radical prostatectomy stress urinary incontinence: preliminary outcome data of a prospective study

    Página :91

    A. Gregori, S. Galli, S. Zaramella, M. Favro, S. Ranzoni, I.K. Goumas, F. Scieri, S. Stener, C. Terrone, F. Gaboardi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :91

    
  • ·MP-10.18: Adjustable male sling: combined pre and retropubic approaches

    Página :91-92

    P. Palma, C. Riccetto, R. Oliveira, C. D’Ancona, N. Netto

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :92

    
  • ·MP-10.19: Urodynamic evaluation after transobturator sling in patients with stress urinary incontinence

    Página :92

    P. Palma, C. Riccetto, R. Oliveira

    Esquema Esquema
  • ·MP-10.20: Receiver operator curves describing near infrared spectroscopy (NIRS) changes during pressure flow studies in men with obstruction

    Página :92

    A. McNab, L. Stothers

    Esquema Esquema
  • ·MP-10.21: The treatment of male urinary incontinence with AdVance^™: first European results

    Página :92-93

    P. Rehder, O. Dalpiaz, A. Kerschbaumer, C. Gozzi

    Esquema Esquema
  • ·MP-10.22: Intravesical instillation of human urine after oral administration of solifenacin, but not tolterodine or darifenacin, blocks carbachol-induced detrusor overactivity in a rat model

    Página :93

    M. Chancellor, C. Thomas, S. Tyagi, N. Yoshimura, P. Tyagi

    Esquema Esquema
  • ·MP-11.01: Clavien classification system-based report of short and long term complications of open retropubic radical prostatectomy

    Página :93

    C. Constantinides, S. Tyritzis, L. Evangelos, A. Skolarikos, C. Deliveliotis

    Esquema Esquema
  • ·MP-11.02: Motivating influences for patients seeking consultation for robotic prostatectomy

    Página :94

    K.J. Palmer, V. Patel, R. Thaly, K. Shah

    Esquema Esquema
  • ·MP-11.03: Prostate specific antigen adjusted for transition zone volume is useful for pre-biopsy prediction of clinically significant prostate cancer

    Página :94

    T. Ohigashi, R. Mizuno, K. Kanao, E. Kikuchi, A. Miyajima, K. Nakagawa, J. Nakashima, M. Murai

    Esquema Esquema
  • ·MP-11.04: Saturation biopsy does not improve concordance of Gleason grading between prostate needle biopsy and radical prostatectomy

    Página :94-95

    S. Hoshi, K. Suzuki, M. Tukigi, O. Sugano, K. Ono, G. Tamura, S. Saso, N. Yanagawa, T. Yamamoto

    Esquema Esquema
  • ·MP-11.05: Management of recurrent bladder neck contracture following radical prostatectomy using Ho:YAG laser and steroid injection

    Página :95

    E.A. Eltahawy, R. Virasoro, S. Schlossberg, G.H. Jordan

    Esquema Esquema
  • ·MP-11.06: Real-time balloon inflation elastography (RBIE) for prostate cancer detection: Clinicopathological analysis

    Página :95

    M. Tsutsumi, T. Matsumura, T. Miyagawa, S. Ishikawa, T. Shiina

    Esquema Esquema
  • ·MP-11.07: Results in patients who underwent prostate biopsy with PSA values 2,5 - 4 ng/ml

    Página :95-96

    E. Romero Selas, G. Veiga, D.R. Ponce, S. Pertega, A. Castelo, J. Janeiro, P. Casas, G. Martín

    Esquema Esquema
  • ·MP-11.08: Reduced infiltration of macrophage scavenger receptor is associated with poor prognosis of prostate cancer

    Página :96

    H. Takayama, N. Nonomura, A. Nagahara, D. Oka, Y. Nakai, M. Shiba, M. Nakayama, K. Nishimura, A. Okuyama

    Esquema Esquema
  • ·MP-11.09: Is there a role for digital rectal examination in the diagnosis of prostate cancer in symptomatic men with prostate specific antigen less than 3ng/ml?

    Página :96

    M. Nomikos, P. Mariappan, A. McNeil, P.R. Bollina

    Esquema Esquema
  • ·MP-11.10: DD3/PCA3 (differential display code 3) in prostate cancer diagnosis – first data from Czech Republic

    Página :96-97

    J. Klecka, M. Hora, M. Pesta, L. Holubec, O. Topolcan, V. Eret

    Esquema Esquema
  • ·MP-11.11: Can prostate biopsies be avoided in men above 75 years with a raised PSA?

    Página :97

    M. Nomikos, P. Mariappan, P.R. Bollina

    Esquema Esquema
  • ·MP-11.12: Japanese prospective cohort study of screening for prostate cancer (JPSPC): the study concept and the first analyses on compliance and contamination for the PSA test (gunma section)

    Página :97

    M. Kobayashi, Y. Takezawa, H. Takechi, K. Ito, T. Yamamoto, K. Suzuki, Y. Tomaru

    Esquema Esquema
  • ·MP-11.13: Examining the financial costs of robotic-assisted laparoscopic radical prostatectomy

    Página :97-98

    V. Patel, A. Gandevivala, R. Balkrishnan, K. Shah, K.J. Palmer

    Esquema Esquema
  • ·MP-11.14: Diagnosis of anterior prostate cancer by dynamic contrast-enhanced combined with T2W MR imaging

    Página :98

    A. Villers, L. Lemaitre, P. Puech, E. Poncelet, X. Leroy, J. Biserte

    Esquema Esquema
  • ·MP-11.15: Comparison study between ten core extended and saturation prostate biopsy in a repeat prostate biopsy population

    Página :98

    J. Ponce, F. Veiga, E. Romero, S. Pértega, J. Janeiro, P. Casas, S. Martínez, D. Lopez, I. Rodríguez, E. Fernández, M. González Martín

    Esquema Esquema
  • ·MP-11.16: Prostate cancer predictive model for patients candidates to first extended prostate biopsy with PSA 2.5 - 10 ng/ml

    Página :98-99

    J. Ponce, F.G. Veiga, E. Romero, S. Pértega, P. Casas, J. Janeiro, D. Loópez, S. Martínez, E.F. Rosado, I.R. Goómez, M. González Martín

    Esquema Esquema
  • ·MP-11.17: Pathological review of radical prostatectomy specimens identifies patients who benefit most from immediate post-operative irradiation (EORTC 22911)

    Página :99

    T. Van Der Kwast, M. Bolla, H. Van Poppel, K. Vekemans, P. Van Cangh, K.H. Kurth, F. Schroder, L. Dapozzo, J.F. Bosset, L. Collette

    Esquema Esquema
  • ·MP-11.18: Is there evidence of a continued stage migration in the PSA screening era in an Australian population?

    Página :99-100

    D. Golovsky, R. Thanigasalam, K. Rasiah, A.M. Haynes, S. Sutherland, P. Stricker, S. Henshall, L. Horvath

    Esquema Esquema
  • ·MP-11.19: Can dynamic contrast enhanced magnetic resonance imaging of the prostate reliably detect prostate cancer prior to TRUS biopsy?

    Página :100

    P. Rouse, G. Shaw, J.G. Calleary, H.U. Ahmed, E. Zacharakis, R. Illing, A. Kirkham, A. Freeman, C. Allen, M. Emberton

    Esquema Esquema
  • ·MP-11.20: The best decision-making nomogram for TRUS Bx

    Página :100

    L. Safarik, K. Novak, J. Stolz, M. Pesl, J. Dvoracek

    Esquema Esquema  
  • ·MP-11.21: Diagnostic accuracy of standard 6-core and extended 12-core transrectal prostate biopsy

    Página :100-101

    B.H. Eisner, B.C. Chapin, S.P. Psutkah, W.S. McDougal, S.T. Tabatabaei

    Esquema Esquema
  • ·MP-11.22 (podium): Laparoscopic radical prostatectomy: the impact of training on service provision

    Página :101

    C. Chabert, D. Merilees, C. Eden

    Esquema Esquema
  • ·MP-12.01: Analysis of spermatogenesis in nonobstructive azoospermia associated with unilateral testis pathology: does side matter?

    Página :101

    S. Shefi, P.J. Turek

    Esquema Esquema
  • ·MP-12.02: Male hypogonadism: clinical or lab reality?

    Página :102

    M. Grasso, F. Torelli, S. Blanco, S. Confalonieri, A. Grasso

    Esquema Esquema
  • ·MP-12.03: Conceiving a child after vasectomy

    Página :102

    R.P.J. Schroeder, M.L. Bots, V.F. de Kemp, P.M.M. Kastrop, M.T.W.T. Lock

    Esquema Esquema
  • ·MP-12.04: Validity of Spermcheck Vasectomy^® to predict post-vasectomy sperm concentrations

    Página :102-103

    M. Labrecque, M.A. Coppola, K. Ramsey, V.M. Brugh, K.L. Klotz, J.C. Herr

    Esquema Esquema
  • ·MP-12.05: Mechanisms of action of human growth hormone on isolated human penile erectile tissue

    Página :103

    S. Ückert, A.J. Becker, F. Scheller, U. Jonas, C.G. Stief

    Esquema Esquema
  • ·MP-12.06: Effect of hyperforin enriched extract on pro-ejaculatory effect of 8-OH-DPAT in anesthetized rats

    Página :103

    C.A. Thomas, S. Tyagi, N. Yoshimura, M.B. Chancellor, P. Tyagi

    Esquema Esquema
  • ·MP-12.07: Soluble guanylate cyclase b₁-subunit and pde-5 levels in peripheric mononuclear cells of E.D. patients treated with continuous or on demand treatment with sildenafil

    Página :103-104

    J.V. Garcia Cardoso, R. Vela Navarrete, A. Lopez Farre, P. Mateos Caceres, L. Lapuente, S. Zamorano

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :104

    
  • ·Abstract Withdrawn

    Página :104

    
  • ·Abstract Withdrawn

    Página :104

    
  • ·MP-12.08: Combination of alfuzosin and tadalafil exerts an additive relaxing effect on precontracted human corpus cavernosum

    Página :104

    S. Oger, D. Behr-Roussel, D. Gorny, J.C. Tremeaux, M. Combes, J. Bernabé, L. Alexandre, F. Giuliano

    Esquema Esquema
  • ·MP-12.09: Enhancement of the glans penis with partial disassembly technique

    Página :104

    J.S. Byun, J.M. Joo, S.C. Kang, Y.H. Jung, J.H. Jang, I.C. Park

    Esquema Esquema
  • ·MP-12.10: 6-month interim analysis of the longitudinal effects on penile oxygen saturation from a randomized study of the nightly use of intraurethral alprostadil vs sildenafil following nerve sparing radical prostatectomy (NSRRP)

    Página :104-105

    A. McCullough, D. Robbins, D. Fenig, D. Brassil, B. Goodwin

    Esquema Esquema  
  • ·MP-12.11: Pharmacological characterization of the novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum

    Página :105

    G. De Nucci, R. Lorenzetti, C.E. Okuyama, J.S. Baracat, J.L. Donato, E. Antunes, C.E. Teixeira

    Esquema Esquema
  • ·MP-13.01: Development and validation of the pelvic floor inventories leiden (PelFIs)

    Página :105-106

    P.J. Voorham–van der Zalm, A. Stiggelbout, I. Aardoom, S. Deckers, I. Greve, G.A.B. Lycklama à Nijeholt, R.C.M. Pelger

    Esquema Esquema
  • ·MP-13.02: Determination of the upper time limits of prolonged warm and cold ischemia in a solitary kidney rabbit model undergoing partial nephrectomy

    Página :106

    S. Tyritzis, A. Kyroudi, K. Pavlakis, T. Manousakas, M. Zachariades, A. Zervas, C. Constantinides

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :106

    
  • ·MP-13.03: Effect of cannabinoids on evoked CGRP release from bladder

    Página :106

    M. Hayn, B. Philips, C.A. Thomas, M.B. Chancellor, N. Yoshimura, P. Tyagi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :106

    
  • ·MP-13.04: Cardiovascular risk factors in chronic renal disease

    Página :106-107

    J. Wagner, V. Šerić, B. Babić-Ivančić, J. Milas-Ahić, H. Kuveždić

    Esquema Esquema
  • ·MP-13.05: Inhibitory effects of β-adrenoceptor agonists involve the urothelium and the β₃-adrenoceptor subtype in pig bladder dome

    Página :107

    K. Masunaga, C.R. Chapple, S. Murakami, M. Yoshida, D.J. Sellers

    Esquema Esquema
  • ·MP-13.06: Are age-related changes in the pelvic connective tissue related to function?

    Página :107

    C. Wallner, J. Bouma, N.F. Dabhoiwala, M.C. DeRuiter, W.H. Lamers

    Esquema Esquema
  • ·MP-13.07: The levator ani nerve and its clinical implications

    Página :107-108

    C. Wallner, C.P. Maas, N.F. Dabhoiwala, W.H. Lamers, M.C. DeRuiter

    Esquema Esquema
  • ·MP-13.08: Functional aspects of the pelvic floor in urinary continence

    Página :108

    C. Wallner, N.F. Dabhoiwala, M.C. DeRuiter, W.H. Lamers

    Esquema Esquema
  • ·MP-13.09: Proliferation and differentiation of renal urothelial transitional cells (RUTEC) after unilateral ureteral obstruction

    Página :108-109

    A. Girshovich, C. Vinsonneau, O. Traxer, S. Vandermersch, E. Letavernier, J. Perez, L. Baud, J.P. Haymann

    Esquema Esquema
  • ·MP-13.10: Combination of alfuzosin and tadalafil exerts additive relaxant effect on human prostate

    Página :109

    S. Oger, D. Behr-Roussel, O. Lecoz, T. Lebret, Y. Denoux, P. Denys, F. Giuliano

    Esquema Esquema
  • ·MP-13.11: The role of the cholinergic and purinergic interaction in the contraction of the cultured human and rat urinary bladder smooth muscle cells

    Página :109

    L. Lörincz, A. Varga, G.P. Szigeti, Á. Jenes, F. Ruzsnavszky, E.A. Széll, G.T. Somogyi, L. Csernoch

    Esquema Esquema
  • ·MP-13.12: Myths on polypropylene mesh structure: in vivo stereological study

    Página :109-110

    P. Palma, R. Siniscalchi, C. Riccetto, N. Netto, R. Miyaoka, L. Maciel

    Esquema Esquema
  • ·MP-13.13: Impact of helper orifices in monofilament meshes on the tensile strength at the interface: in vivo study

    Página :110

    P. Palma, C. Riccetto, R. Siniscalchi, R. Fraga, M. Suarez, N. Netto

    Esquema Esquema  
  • ·Abstract Withdrawn

    Página :110

    
  • ·MP-13.14: Stereological comparison of collagen and inflammatory reaction induced by four different synthetic slings

    Página :110

    P. Palma, M. Thiel, C. Riccetto, M. Dambros, N. Netto

    Esquema Esquema
  • ·MP-14.01: Dynamic functional MRI and multiple combined conventional modalities in different renal diseases

    Página :110-111

    N. Fouda, M. El-Rakhawy, A. Ashamalla, W. Abd-El-Baky

    Esquema Esquema
  • ·MP-14.02: Initial experience of functional imaging of upper urinary tract urotherial carcinoma by diffusion-weighted MRI

    Página :111

    S. Yoshida, H. Masuda, C. Ishii, Y. Matsuoka, N. Numao, K. Saito, F. Koga, T. Kobayashi, S. Kawakami, K. Kihara

    Esquema Esquema
  • ·MP-14.03: Comparison of conventional vs. current imaging modalities in the evaluation of hemato-chyluria

    Página :111

    P. Wadhwa, C.J. Das, V. Jain, R. Sharma, A.K. Hemal

    Esquema Esquema
  • ·MP-14.04: Evaluation of prostate cancer with real-time tissue elastography based on step-section pathologic analysis after radical prostatectomy

    Página :111-112

    M. Sumura, K. Shigeno, T. Hyuga, T. Yoneda, S. Shiina, M. Igawa

    Esquema Esquema
  • ·MP-14.05: A retrospective review of solid epididymal masses evaluated by scrotal sonography with pathologic and clinical correlation

    Página :112

    W. Alleman, B.F. King, D.L. Larson, J.C. Cheville, A. Nehra

    Esquema Esquema
  • ·MP-14.06: Evaluation of pelvic floor reconstructive surgery using tridimensional helical CT

    Página :112

    P. Palma, C. Riccetto, R. Fraga, R. Maia, N. Netto

    Esquema Esquema  
  • ·MP-14.07: The value of Doppler ureteral jets in patients with upper urinary tract pathology

    Página :113

    P. Geavlete, V. Cauni, C. Persu, S. Bancu, B. Geavlete

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :113

    
  • ·Abstract Withdrawn

    Página :113

    
  • ·MP-14.08: Diagnostic ureteroscopy for upper urinary tract tumours

    Página :113

    T. Oikawa, M. Endo, N. Sekido, S. Hinotsu, N. Miyanaga, K. Kawai, T. Shimazui, H. Akaza

    Esquema Esquema
  • ·MP-14.09: The development of urology in Zambia

    Página :113-114

    M. Labib

    
  • ·MP-14.10: Application of the Yang-Monti channel in adult continent cutaneous urinary diversion

    Página :114

    M. Wagner, D. Siamak

    Esquema Esquema
  • ·MP-14.11: Long term evaluation of the outlet after orthotopic urinary diversion: 15 years experience

    Página :114

    K. Fawaz, T. Osman, M. Shoeib, K. Taema, A. Abdelmaksoud, M.R. El-Halaby

    Esquema Esquema
  • ·MP-14.12: Long-term functional results of the implementation of the serous-lined extramural tunnel technique of ureterointestinal reimplantation in ileal neobladders and rectosigmoid urinary reservoirs

    Página :114-115

    A. Hinev, S. Paunov, D. Anakievski, P. Chankov, R. Raikov, S. Dyakov

    Esquema Esquema
  • ·MP-14.13: How to achieve urinary continence in neuropathic sphincters failure?

    Página :115

    L. Skobejko-Wlodarska, K. Felberg, P. Gastol, M. Baka-Ostrowska

    Esquema Esquema
  • ·MP-14.14: Surgical treatment for urethral recurrence of bladder cancer after ileal neobladder reconstruction

    Página :115

    K. Yoshida, H. Kinoshita, T. Matsuda

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :115

    
  • ·MP-14.15: Tuberculous bladder contracture treated by augmentation ileocystoplasty

    Página :115

    J. Hadzi-Djokic, T. Pejcic, M. Acimovic, Z. Dzamic

    Esquema Esquema
  • ·MP-14.16: Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection

    Página :116

    M. Rouprêt, O. Traxer, M. Tligui, P. Conort, S. Beley, V. Misraï, E. Chartier-Kastler, F. Haab, F. Richard, O. Cussenot

    Esquema Esquema
  • ·MP-14.17: Patient safety in the operating room

    Página :116

    B. Cilento, C. Estrada, M. Dierks

    Esquema Esquema
  • ·MP-14.18 (podium): Increasing urologic wait times in a universal health care system

    Página :116

    J. Kawakami, W.M. Hopman, R. Smith-Tryon, J.S. Lott, D.R. Siemens

    Esquema Esquema
  • ·MP-15.01: Tuberculosis in Iranian kidney transplant recipients: a single center experience

    Página :116-117

    A. Taghizade Afshari, A. Ghafari

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :117

    
  • ·MP-15.02: The bioflavonoids curcumin and quercetin improve early and late kidney transplant function: long term follow up of a randomized, placebo controlled study

    Página :117

    D.A. Shoskes, C. Lee, A. Wee

    Esquema Esquema
  • ·MP-15.03: Last resort for renal transplant recipients, diseased kidney from living donor/patients

    Página :117

    S. Fujita, R. Mannami, N. Mitsuhata, M. Nishi, K. Nanba, M. Mannami

    Esquema Esquema
  • ·MP-15.04: Nationality related living kidney donation as an extension of Iran model

    Página :117-118

    S.M. Kazemeyni, G. Naderi, D. Mehraban, A. Razi, M.A. Sedighi Gilani

    Esquema Esquema
  • ·MP-15.05: Comparison of outcome in renal transplant recipients with respect to arterial anastomosis: the internal versus the external iliac artery - a prospective randomized study

    Página :118

    A. Bahlooli, M. Amjadi, A. Zomorrodi, H. Barhaghi

    Esquema Esquema
  • ·MP-15.06: 10 years experience in renal transplantation challenged by renal graft vascular anomalies

    Página :118-119

    I. Sinescu, M. Hârza, B. Serbanescu, M. Manu, D. Tacu, E. Kerezsy, L. Domnisor, D. Daia

    Esquema Esquema
  • ·MP-15.07: Management of ureteral urologic complications: experience after 700 kidney transplantations

    Página :119

    A. Emamzadeh, A.R. Mehrsai, M.R. Nikoobakht, M. Maherimahmodi, G. Pourmand

    Esquema Esquema
  • ·MP-15.08: Early postoperative vascular complications following implantation of renal allografts with multiple renal arteries

    Página :119

    D. Basic, D. Milutinovic, J.H. Djokic, M. Djokic, Z. Boric, R. Blagojevic, D. Radivojevic, S. Micic

    Esquema Esquema
  • ·MP-15.10: A retrospective comparison in living-related renal transplantation in hand-assisted and full laparoscopic donor nephrectomy in Singapore general hospital

    Página :119-120

    C. Teo, S.K.H. Yip, W. Lau, Y.H. Tan, W.S. Cheng, A. Vathsala

    Esquema Esquema
  • ·MP-15.11: Retroperitoneoscopic hand-assisted surgery is ideal for live donor nephrectomy: Acceptable technical and functional outcomes in Jichi medical university hospital

    Página :120

    M. Yashi, T. Yagisawa, N. Ishikawa, A. Nukui, T. Fujiwara, Y. Sakuma, N. Miyamoto, F. Endo, O. Muraishi

    Esquema Esquema
  • ·MP-15.12: De novo malignancies after renal transplantation: a single center experience

    Página :120

    Z. Popov, O. Ivanovski, P. Kolevski, O. Stankov, D. Petrovski, N. Vanovski

    Esquema Esquema
  • ·MP-15.13: Power Doppler versus resistive index measurements for functional evaluation of early renal allograft complications

    Página :120-121

    M. Setten, T. El-Diasty, N. Fouda, H. Abd-El-Azez, H. Arif

    Esquema Esquema
  • ·MP-15.14 (Podium): Outcome after renal transplantation in pediatric patients: results of 15 years experience in a single center

    Página :121

    R. Taghavi, R. Mahdavi, M.R. Darabi, N. Naghibi, F. Nazemian, A. Zerati, S. Hashemi, M. Zolfaghari, G. Baghestani, M. Hossein Zadeh

    Esquema Esquema
  • ·MP-15.15 (Podium): Kidney transplantation before or after augmentation cystoplasty in children with high-pressure neurogenic bladder

    Página :121

    A. Basiri, H. Otookesh, R. Hoseini, N. Simforoosh, F. Farrokhi

    Esquema Esquema
  • ·MP-15.16 (Podium): Hand-assisted retro-peritoneoscopic live donor nephrectomy

    Página :121-122

    S. Kumar, S. Malek, S.G. Tullius

    Esquema Esquema
  • ·MP-16.01: Reduction of the cytosolic Cdk11 protein expression in clear cell renal cell carcinoma

    Página :122

    A. Kapoor, L. He, C. Fan, A. Rybak, J. Cutz, D. Tang

    Esquema Esquema
  • ·MP-16.02: The prognostic value of cyclooxygenase-2 expression and microvessel density in transitional cell carcinoma of the upper urinary tract

    Página :122

    S.J. Kim, H.S. Ahn, M.H. Cha, D.S. Cho, S. Kim, H. Yim, S.J. Hong, K.S. Cho, N.H. Cho

    Esquema Esquema
  • ·MP-16.03: Pathophysiological and clinical characterization of novel tumor suppressor kank gene in renal cell carcinoma

    Página :122-123

    T. Aoyagi, S. Kitsukawa, T. Samejima, B.C. Roy, R. Kiyama

    Esquema Esquema
  • ·MP-16.04: Prognostic factors for bladder recurrence after nephroureterectomy for upper tract urothelial carcinoma

    Página :123

    S. Chung, S. Chueh, H. Yu

    Esquema Esquema
  • ·MP-16.05: Chemotherapy of urothelial carcinomas of the upper urinary tract with Gemcitabine and Cis-/Carboplatin

    Página :123

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, H.M. Weber, G. Eschholz

    Esquema Esquema
  • ·MP-16.06: Promoter hypermethylation of the potential tumour suppressor genes in renal cell carcinoma and its clinical significance

    Página :123-124

    T. Kishida, T. Murakami, N. Nakaigawa, M. Baba, Y. Kubota, M. Yao, F. Latif

    Esquema Esquema
  • ·MP-16.07: Lymphovascular invasion is a useful prognostic factor for recurrence free survival in patients with upper urinary tract urothelial carcinoma

    Página :124

    R. Takazawa, Y. Kubo, T. Tujii

    Esquema Esquema
  • ·MP-16.09: Galectin-3 is overexpressed in renal cell carcinoma and it regulates immune suppression through the induction of apoptosis of cytotoxic T cells

    Página :124

    T. Fukumori, N. Oka, M.G. El-Moula, R. Nakanishi, R. Taue, T. Kishimoto, H. Izaki, M. Takahashi, S. Kagawa, H.O. Kanayama

    Esquema Esquema
  • ·MP-16.10: Nitrogen-containing bisphosphonates inhibit the growth of renal cell carcinoma cells

    Página :124-125

    N. Fujimoto, M. Nomura, H. Nishi, T. Matsumoto

    Esquema Esquema
  • ·MP-16.11: A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma treated with nephrectomy and immunotherapy

    Página :125

    S.J. Hong, S.J. Kim, B.H. Chung, Y.D. Choi, I.R. Cho, Y.S. Kim, K.S. Cho, W.S. Ham, H.S. Kim, J.S. Lee, C.I. Kim, D.H. Sung, D.H. Lee, J.S. Cho, Y.S. Song, W.J. Yang, S.I. Kim, S.H. Cheon, S.Y. Cho, D.J. Kim

    Esquema Esquema
  • ·MP-16.12: Surgical treatment of T3c Renal Cell Carcinoma with atrial tumor thrombus

    Página :125

    Z. Dobrowolski, W. Lipczynski, P. Trybek, J. J. Sadowski, B. Dobrowolska, J. Wojcik

    Esquema Esquema
  • ·MP-16.13: Acquisition of susceptibility in interferon-alpha (IFN) -resistant cell line by IFN response related gene in renal cell carcinoma cell line

    Página :126

    T. Shimazui, K. Yoshikawa, Y. Ami, T. Kojima, K. Uchida, Hinotsu Shiro, Saga Shinsuke, Akaza Hideyuki

    Esquema Esquema
  • ·MP-16.14: Rhabdoid phenotype renal cell carcinomas: clinicopathologic, immunohistochemical, and flow cytometry study

    Página :126

    J.P. Rioja, A. Panizo, J.E. Robles, J.J. Sola, A. Saiz, M.A. Idoate, D. Rosell, J.J. Zudaire, F.J. Pardo, J.M. Berian

    Esquema Esquema
  • ·MP-16.15: Endothelial fenestration of tumor microvasculature as a predictive factor of anti-VEGF therapy in clear cell renal cell carcinoma

    Página :126-127

    T. Kamba, T. Yamasaki, E. Nakamura, T. Kamoto, O. Ogawa

    Esquema Esquema
  • ·MP-16.16: Imbalance of PTEN, pAkt and p27 expression in acquired cystic disease of the kidney associated with renal cell carcinoma

    Página :127

    J. Sugimura, R. Konda, F. Soma, W. Obara, T. Fujioka

    Esquema Esquema
  • ·MP-16.17: A study of microsatellite instability of upper urinary tract transitional cell carcinoma

    Página :127

    S.B. Ryu, K. Park, D.D. Kwon, C. Choi, I.S. Hwang, T.W. Kang

    Esquema Esquema
  • ·MP-16.18: Expression of the apoptosis inhibitors survivin and XIAP in pulmonary metastases of renal cell carcinoma (RCC)

    Página :127-128

    P. Schneider, B. Baier, O. Holotiuk, M. Meinhardt, J. Stade, A. Meye, A. Rolle, M.P. Wirth

    Esquema Esquema
  • ·MP-16.19: FISH analysis of PTEN/mmca1 gene in patients with renal cell carcinoma treated exclusivelly with surgery

    Página :128

    S. Zequi, E. Campos, G. Guimarães, F. Fonseca, W. Bachega, I. Werneck, F. Soares, A. Lopes

    Esquema Esquema
  • ·MP-16.20: Thalidomide in combination with interleukin-2 for patients with metastatic renal cell carcinoma refractory to prior IL-2 and alpha-interferon treatment

    Página :128

    R. Shiroki, S. Mori, S. Miyakawa, M. Ichino, M. Hirano, M. Kusaka, K. Hayakawa, K. Ishikawa, K. Hoshinaga

    Esquema Esquema
  • ·MP-16.21: Aggressive variants of chromophobe renal cell carcinoma: a clinico-pathological study of prognostic factors

    Página :128-129

    L. Zini, X. Leroy, S. Aubert, L. Lemaitre, C. Fantoni, J. Biserte, A. Villers

    Esquema Esquema
  • ·MP-16.22: Contemporary open nephron sparing surgery offers excellent tumor control with significantly diminished perioperative morbidity

    Página :129

    B.R. Kava, R. De Los Santos, R. Ayyathurai, M. Manoharan, M.S. Soloway

    Esquema Esquema
  • ·MP-16.23: Efficacy of nephron sparing surgery for renal cell carcinoma > 4 cm

    Página :129

    E.G. Nemr, G. Azar, S. Merhej, E. Chalouhy, M. Moukarzel, P. Sarkis, R. Khoury, N. Ayoub

    Esquema Esquema
  • ·MP-16.24: Co-expression of CAIX and VEGF in clear cell renal cell carcinoma: implication for prognosis and immunotherapy

    Página :129-130

    N.B. Phuoc, H. Ehara, T. Gotoh, M. Nakano, S. Yokoi, T. Deguchi, Y. Hirose

    Esquema Esquema
  • ·MP-17.01: Identification of biomarker for androgen independence in prostate cancer

    Página :130

    Y. Ohno, M. Ohori, M. Tachibana, S. Akimoto, K. Yoshioka, T. Hatano, N. Sakamoto, T. Gondo, Y. Nakagami, Y. Horiguchi

    Esquema Esquema
  • ·MP-07.02: Bcl-2, bax expression in prostate carcinogenesis

    Página :130

    G. Mitropoulou, A. Georgalis, K. Tsakanika, A. Rempelakos, N. Apostolikas, A. Thanos, E. Panotopoulou

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :130

    
  • ·MP-17.04: Chemokine receptor CXCR4 expression and prognosis in patients with metastatic prostate cancer

    Página :130-131

    T. Akashi, K. Koizumi, K. Tsuneyama, I. Saiki, Y. Takano, H. Fuse

    Esquema Esquema
  • ·MP-17.05: A potent target for prevention: Increased cysteinylLT1 receptor expression and induction of apoptosis by its agonist in human prostate cancer

    Página :131

    M. Matsuyama, T. Hayama, K. Funao, T. Hase, K. Kuratsukuri, T. Tanaka, Y. Takemoto, T. Nakatani, R. Yoshimura

    Esquema Esquema
  • ·MP-17.06: Validation study for the diagnostic accuracy of complexed and total prostate specific antigen in Japanese men using discordance analysis characteristics (DAC)

    Página :131

    K. Okihara, O. Ukimura, T. Nakamura, S. Ushijima, Y. Mizutani, A. Kawauchi, Y. Naya, M. Kojima, Miki Tsuneharu

    Esquema Esquema
  • ·MP-17.07: Endogenously expressed sex hormone-binding globulin (SHBG) mediates the steroid response of prostate cancer cells

    Página :131-132

    S.M. Kahn, Y.H. Li, D.J. Hryb, A.M. Nahkla, W. Rosner, N.A. Romas

    Esquema Esquema
  • ·MP-17.08: Roles of vinexinβ in growth and paclitaxel resistance in androgen-independent human prostate cancer PC-3 cells

    Página :132

    K. Mizutani, K.I. Nagata, H. Ehara, Y. Nozawa, T. Deguchi

    Esquema Esquema  
  • ·MP-17.09: Serum chromogranin A in bone metastatic prostate cancer: comparison with prostatic specific antigen

    Página :132

    A. Bantis, A. Zissimopoulos, C. Kalaitzis, P. Sountoulides, S. Giannakopoulos, E. Patris, E. Aggelonidou, C. Voudalikakis, S. Touloupidis

    Esquema Esquema
  • ·MP-17.10: Peroxisome proliferator-activated receptor-gamma ligands inhibit cell growth of human prostate cancer

    Página :132-133

    Y. Hashimoto, Y. Naruyama, K. Tozawa, K. Kohri

    Esquema Esquema
  • ·MP-17.11: Detection of TMPRSS2: ERG fusion gene in the urine of men with prostate cancer

    Página :133

    E. Dimitriadis, T. Arvanitakis, A. Thanos, T. Kalogeropoulos, A. Pallantzas, A. Apostolaki, N. Pandis

    Esquema Esquema
  • ·MP-17.12: Bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient

    Página :133

    Y. Shimizu, T. Yoshida, T. Segawa, T. Inoue, T. Kobayashi, N. Terada, E. Nakamura, H. Kinoshita, T. Kamoto, O. Ogawa

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :133

    
  • ·Abstract Withdrawn

    Página :133

    
  • ·MP-17.13: Silencing of clusterin gene with siRNA accelerates doxazosin induced apoptosis in PC-3 human prostate cancer cell lines

    Página :133-134

    G.S. Cha, T.K. Yoo, Y.H. Youm, M.K. Jo, C. Lee

    Esquema Esquema
  • ·MP-17.14: Survivin shRNA constructed in adenovirus vector and apoptosis induction of prostate cancer PC-3 cells

    Página :134

    Y.X. Shan, P. Gao, D.R. Yang

    Esquema Esquema
  • ·MP-17.15: Expression of DD3PCA3 is androgen dependent

    Página :134

    G. Shaw, P. Purkis, T. Oliver, D. Prowse

    Esquema Esquema
  • ·MP-17.16: Distinct role of DNA methyltransferases and methyl-CpG binding proteins on apoptosis, invasion, proliferation and migration of prostate cancer cell – an in-vitro study

    Página :134-135

    A. Yaqinuddin, F. Abbas, S. Qureshi

    Esquema Esquema
  • ·MP-17.17: FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome

    Página :135

    M. Yoshimoto, I.W. Cunha, R.A. Coudry, F.P. Fonseca, C.H. Torres, F.A. Soares, J.A. Squire

    Esquema Esquema
  • ·MP-18.01: PSA kinetics and PSA bounce following permanent seed prostate brachytherapy

    Página :135

    J. Crook, C. Gillan, I. Yeung, M. McLean, G. Lockwood

    Esquema Esquema
  • ·MP-18.02: Evaluation of the continuous vesicourethral anastomosis after robotic-assisted laparoscopic radical prostatectomy

    Página :135

    A. Mues, K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Esquema Esquema
  • ·MP-18.03: High resolution imaging of the radical prostatectomy specimen: feasibility to predict positive margin status

    Página :136

    K. Shah, K.J. Palmer, R. Thaly, V.R. Patel

    Esquema Esquema
  • ·MP-18.04: Robotic-assisted laparoscopic radical prostatectomy: perioperative outcomes of 1500 consecutive cases

    Página :136

    K.J. Palmer, K. Shah, R. Thaly, V. Patel

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :136

    
  • ·MP-18.06: Immediate adjuvant radiation and hormonal therapy for positive surgical margins following radical prostatectomy: selection criteria and outcome

    Página :136

    M.A. Bulbul, N. Bou Diab, Y. Hout, A. Hujeij, O. Darwish, A. Tawil, F. Geara

    Esquema Esquema
  • ·MP-18.07: The association of prostatitis and prostate cancer in patient undergoing radical prostatectomy for localized disease and its effect on tumor parameters

    Página :136-137

    M.A. Bulbul, A. Hujeij, Y. El-Hout, S. Saab, A. Tawil

    Esquema Esquema
  • ·MP-18.08: Incidental prostatic neoplasia in patients undergoing radical cystoprostatectomy: does it affect the overall prognosis?

    Página :137

    R. Ayyathurai, S. Vyas, M. Manoharan, T. Luongo, M.S. Soloway

    Esquema Esquema
  • ·MP-18.09: Treatment results of patients with seminal vesicle invasion (pT3b) undergoing radical prostatectomy with wide resection

    Página :137

    I. Fukui, J. Yonese, S. Kawakami, Y. Fujii, S. Yamamoto, Y. Ohkubo

    Esquema Esquema
  • ·MP-18.10: The effect of risedronate for prostate cancer patients under androgen deprivation therapy

    Página :137-138

    K. Ishizaka, T. Machida, M. Tanaka, N. Kawamura, K. Nakamura, Y. Mizuno, K. Maekawa, T. Kamai, M. Honda, K.I. Yoshida

    Esquema Esquema
  • ·MP-18.11: Venous thromboembolism in radical prostatectomy: Is postoperative heparinoid prophylaxis recommended?

    Página :138

    M. Grasso, F. Torelli, S. Blanco, S. Confalonieri, A. Grasso

    Esquema Esquema
  • ·MP-18.12: Urologic factors associated with post-permanent prostate brachytherapy urinary retention

    Página :138

    T. Wilson, D. Hillman, L. Mynderse, B. Davis

    Esquema Esquema
  • ·MP-18.13: Quality of life after radical prostatectomy: a comparison of operative methods

    Página :138-139

    A. Kaipia, E. Johansson, M. Häggman, H. Ageheim, S. Brändstedt

    Esquema Esquema
  • ·MP-18.14: Seed migration rate to the chest following permanent prostate brachytherapy is markedly reduced with the use of seeds in vicryl suture material

    Página :139

    B. Davis, C. Goulet, K. Furutani, L. Mynderse, T. Wilson

    Esquema Esquema
  • ·MP-18.15: Visually-directed primary HIFU for treating localised prostate cancer: determinants of PSA kinetics

    Página :139-140

    E. Zacharakis, H.U. Ahmed, A. Ishaq, R. Scott, R. Illing, G. Shaw, J. Calleary, C. Allen, M. Emberton

    Esquema Esquema
  • ·MP-18.16: Modified transverse Pfannenstiel and vertical minilaparotomy incisions provide excellent exposure, minimal perioperative pain, and excellent cosmesis in patients undergoing radical retropubic prostatectomy

    Página :140

    B.R. Kava, C. Soloway, M. Manoharan, M.S. Soloway

    Esquema Esquema
  • ·MP-18.17: Retrospective analysis of the distance between neurovascular bundle and prostate cancer foci in radical prostatectomy specimen - clinical implication of nerve-sparing surgery

    Página :140-141

    H. Shiina, S. Urakami, S. Inoue, T. Hiraoka, M. Sumura, M. Igawa

    Esquema Esquema
  • ·MP-18.18: Thermoablation of localized prostate cancer: clinical results and complications

    Página :141

    R. Sanseverino, O. Intilla, A. Campitelli, G. Napodano, A. Barela, U. Di Mauro

    Esquema Esquema
  • ·MP-18.19: First surgical series of 100 radical retropubic prostatectomies from Pakistan

    Página :141

    F. Abbas, N. Faruqui, A. Razzak Nasir

    Esquema Esquema
  • ·MP-18.20: Comparison of prospective and longitudinal assessment of health- and disease-related QOL between radical perineal and retropubic prostatectomy in men with localized prostate carcinoma

    Página :141-142

    R. Shiroki, S. Mori, S. Miyakawa, M. Kusaka, K. Hayakawa, K. Ishikawa, K. Hoshinaga

    Esquema Esquema
  • ·MP-18.21: Comparative study of health-related quality of life in patients underwent brachytherapy, external beam radiation therapy combined with brachytherapy and radical prostatectomy for localized prostate cancer

    Página :142

    M. Kosugi, Y. Hanawa, T. Takeda, Y. Kono, H. Nagata, T. Momma, T. Ohashi, K. Toya, A. Yorozu, S. Saito

    Esquema Esquema
  • ·MP-18.22: Urinary continence evatuation in patients submitted to radical prostatectomy

    Página :142

    F.P. Fonseca, S. Carlos, S.C. Zequi, G.C. Guimarães, J. Francisco, I.N. Nishimoto, A. Lopes

    Esquema Esquema
  • ·MP-18.23: Primary cryoablation for Gleason 8, 9 or 10 localized prostate cancer: results from the COLD registry

    Página :142-143

    J.S. Jones

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :143

    
  • ·MP-18.24: Primary prostate cryoablation: 5-year outcomes from a single center

    Página :143

    J. Vestal, J. Rewcastle, T. Manny, D. Ellis

    Esquema Esquema
  • ·MP-18.25: Repeat vascular targeted phototherapy with Tookad after EBRT failure

    Página :143

    J. Trachtenberg, M. Elhilali

    Esquema Esquema
  • ·MP-18.26: Focal and nerve sparing cryoablation: results from the COLD registry

    Página :143-144

    J.C. Rewcastle, A.E. Katz, B.J. Donnelly, L.L. Pisters, F.M. Lugnani, J.S. Jones

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :144

    
  • ·MP-19.01: The use of KTP laser tumor ablation for treatment of bladder transitional cell carcinoma (initial results)

    Página :144

    B.F. Chapin, B.H. Eisner, S. Lahey, S. Tabatabaei

    Esquema Esquema
  • ·MP-19.02: The correlation of urine and serum P53 protein and protein overexpression in tumor of patient with transitional cell carcinoma of urinary bladder

    Página :144

    M.R. Darabi, N.T. Meibodi, R. Mahdavi, D. Arab, M. Zolfaghari, Z. Maleki

    Esquema Esquema
  • ·MP-19.03: Prognosis of primary and non-primary T1G3 bladder cancer: is there any difference?

    Página :145

    F. Ouaki, O. Celhay, B. Merlet, R. Briffaux, C. Pirès, B. Doré, J. Irani

    Esquema Esquema
  • ·MP-19.04: High incidence of independent non-urothelial tumours in the follow up of superficial bladder cancer

    Página :145

    D.S. Engeler, H. Zecha, H.P. Schmid

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :145

    
  • ·MP-19.06: Metronomic-maintenance outpatient-based chemotherapy with daily oral 5 ′-DFUR and biweekly low-dose CDDP infusion in advanced urothelial cancer

    Página :145

    T. Hara, S. Yoshihiro, H. Ito, K. Nagao, C. Ohmi, S. Sakano, H. Matsuyama, K. Naito

    Esquema Esquema
  • ·MP-19.07: Low efficacy of intravesical BCG immunotherapy in elderly patients with intermediate-high risk Ta-T1 transitional cell carcinoma (TCC) of the bladder: long term experience of a single institution

    Página :145-146

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Esquema Esquema
  • ·MP-19.08: Reduced dose BCG is effective in carcinoma in situ (CIS) of the bladder: long term results of a phase ii study

    Página :146

    M. Brausi, G. Verrini, M. Gavioli, G.C. Peracchia, G. De Luca, G. Giliberto, M. Viola, G.L. Simonini

    Esquema Esquema
  • ·MP-19.09: Mast cell variations with histopathological grading in bladder transitional cell carcinoma

    Página :146

    D.S. Kim, J.H. Yun, S.W. Doo, J.E. Koh, C.H. Lee, Y.S. Jeon, N.K. Lee

    Esquema Esquema
  • ·MP-19.11: Does delay in radical cystectomy effect survival in invasive bladder cancer?

    Página :146-147

    B. Ayres, S. McPhail, N. Arumainayagam, J. McGrath, B. Khoubehi, B. Cottier, J. Verne, R. Persad, D. Gillatt

    Esquema Esquema
  • ·MP-19.10: Nomograms for prediction of disease recurrence and progression in patients with superficial bladder cancer

    Página :147

    S.J. Hong, K.S. Cho, W.S. Ham

    Esquema Esquema
  • ·MP-19.12: Oncological and functional outcome of radical cystectomy in patients with bladder cancer and obstructive uropathy

    Página :147

    A. Seth, S.B. Kolla, N.P. Gupta, A.K. Hemal, P.N. Dogra, R. Kumar

    Esquema Esquema
  • ·MP-19.13: CYP3A mediated dapsone recovery ratio may predict tumour progression in superficial bladder cancer

    Página :147-148

    B. Ayres, B. Buch, V. Kondragunta, D. Gillatt, M. Romkes, R. Branch, R. Persad

    Esquema Esquema
  • ·MP-19.14: Three year follow-up of a multicenter trial comparing mitomycin C (MMC) long term with short-term treatment with MMC or Bacillus Calmette-Guerin (BCG) in non muscle-invasive bladder cancer (NMIBC)

    Página :148

    M.G. Friedrich, U. Pichlmeier, H. Schwaibold, H. Huland, S. Conrad

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :148

    
  • ·MP-19.15: Urinary fluorescence in situ hybridization predicts long-term disease status after bacillus Calmette-Guerin therapy

    Página :148

    J.R. Karnes, B.C. Leibovich, S. Boorjian, M.L. Blute

    Esquema Esquema
  • ·MP-19.16: Resection of small bladder tumors using a flexible cystoscopy on an out patient basis

    Página :148-149

    F. Endo, M. Ikeda, T. Oguchi, Y. Shiga, M. Yashi, O. Muraishi

    Esquema Esquema
  • ·MP-19.17: Prognostic factors for patients with lymph node metastases following radical cystectomy

    Página :149

    T. Osawa, T. Abe, N. Shinohara, T. Harabayashi, A. Sazawa, T. Shibata, S. Kamota, A. Kumagai, T. Mori, K. Nonomura

    Esquema Esquema
  • ·MP-20.01: Prediction of prostate volume in community dwelling men

    Página :149

    S.J. Jacobsen, D.J. Jacobson, J.L. St. Sauver, M.E. McGree, A.V. Sarma, C.J. Girman, M.M. Lieber

    Esquema Esquema
  • ·MP-20.02: The efficacy, duration of efficacy and safety of Ozarelix, a novel GnRH antagonist, in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH)

    Página :149-150

    B. Denes, A.V. Bantchev, S.S. Karanikolov, M. Nikolovski, P. Pantchev, L.D. Petkova, F. Debruyne

    Esquema Esquema
  • ·MP-20.03: Associations of obesity with lower urinary tract symptoms in Korean elderly men

    Página :150

    J.H. Kim, S. Lee, H.J. Lee, H.S. Jo

    Esquema Esquema
  • ·MP-20.04: Photoselective vaporization of the prostate (PVP) for treatment of large benign prostatic hyperplasia (BPH)

    Página :150-151

    J. Heo, G.W. Jung

    Esquema Esquema
  • ·MP-20.05: Alpha tocopherol inhibition of human prostatic stromal cell proliferation, correlates with inhibition of protein kinase C (PKC)-alpha activity

    Página :151

    B.B. Purnomo, D.M. Soebadi

    Esquema Esquema
  • ·MP-20.06: KTP laser vaporization of the prostate for the treatment of benign prostatic hyperplasia: preliminary results of a single surgeon experience

    Página :151

    R.O. Fourcade, A. Ammani, B. Faraj, B. Makhoul

    Esquema Esquema
  • ·MP-20.07: Endoscopic ablation of canine prostatic tissue using the diode laser

    Página :151-152

    P. Pyo, R. Simon, A. Chen, C. Dixon, M. Grasso

    Esquema Esquema
  • ·MP-20.08: The effect of the transition zone resection rate for transurethral resection of the prostate (TURP)

    Página :152

    H. Lee, H. Chung, J. Song

    Esquema Esquema
  • ·MP-20.09: Effects of preoperative methoxamine on blood loss and haemodynamic variables during transurethral prostatic resection under spinal anaesthesia

    Página :152

    S. Soleymani, R. Maghsoudi

    Esquema Esquema
  • ·MP-20.10: Hormonal characteristics of patients with benign prostate hyperplasia (BPH)

    Página :152-153

    S.Z. Bak, Z. Dobrowolski, W. Lipczynski, K. Sztefko, A. Malek, P. Trybek

    Esquema Esquema
  • ·MP-20.11: Holmium laser enucleation of prostate for post TURP symptomatic residual/recurrent prostatic adenomas

    Página :153

    A. Varshney, A. Agarwal, B.S. Bansal, P. Joshi, S. Yadu

    Esquema Esquema
  • ·MP-20.12: Alfuzosin, but not tamsulosin, relieves bladder hypertrophy in rats despite a persistent bladder outlet obstruction

    Página :153-154

    P. Lluel, M. Méen, A. Maurel, D. Heudes, P. Bruneval, S. Palea

    Esquema Esquema
  • ·MP-20.13: Prostate volume doubling time: long-term longitudinal study

    Página :154

    M.M. Lieber, T. Rhodes, D.J. Jacobson, M.E. McGree, C.J. Girman, S.J. Jacobsen, J.L. St. Sauver

    Esquema Esquema
  • ·MP-20.14: Combination of alfuzosin and tadalafil exerts an additive enhancing effect on norepinephrine-induced relaxation of pre-contracted human detrusor smooth muscle

    Página :154

    S. Oger, D. Behr-Roussel, D. Gorny, T. Lebret, P. Denys, J. Bernabé, F. Giuliano

    Esquema Esquema
  • ·MP-20.15: Transurethral resection of the prostate in the warfarinised patient

    Página :154-155

    D. MacDonald, K. Alo, A. Golash, S. Liu, C. Luscombe, M. Saxby

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :155

    
  • ·MP-20.16: Safety and tolerability of dutasteride, tamsulosin and a combination of dutasteride and tamsulosin: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Página :155

    R. Roehrborn, P. Siami, J. Barkin, R. Damião, F. Montorsi, CombAT Study Group

    Esquema Esquema
  • ·MP-20.17: Trends in LUTS BPH management: is real life a mirror of PLESS and MTOPS? Are older men disadvantaged?

    Página :155-156

    J. Graham, M. Hehir, K. Riddle, V. Crispin, M.A. Paterson

    Esquema Esquema
  • ·MP-20.18: Three-year review of 170 patients treated for BPH with RevoLix 2 micron continuous wave laser

    Página :156

    S. Mattioli

    Esquema Esquema
  • ·MP-20.19: Effects of dutasteride on the microvessel density of the prostate in BPH patients

    Página :156

    G.S. Cha, T.K. Yoo, M.K. Jo, H.S. Kim

    Esquema Esquema
  • ·MP-20.20: BPH surgical treatment trends in the U.S. – the dramatic increase in the application of minimally invasive technologies

    Página :156-157

    X. Yu, S.P. Elliott, T. Wilt, M. McBean

    Esquema Esquema  
  • ·MP-20.21: Rotoresection versus transurethral resection of the prostate: 2-years evaluation of a prospective randomized study

    Página :157

    S.A. Soliman, B.S. Wadie, E.H. Ibrahim, A. Shehab El-Dein

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :157

    
  • ·MP-20.23: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of serum prostate-specific antigen (PSA) level

    Página :157-158

    C.G. Roehrborn, S.A. Kaplan, S.R. Kraus, J.T. Wang, T. Bavendam, Z. Guan

    Esquema Esquema
  • ·MP-20.24: Tolterodine extended release (TER) and/or Tamsulosin (TAM) in men with lower urinary tract symptoms (LUTS) including overactive bladder (OAB): effects of prostate size

    Página :158-159

    C.G. Roehrborn, S.A. Kaplan, J.S. Jones, W. Steers, J.T. Wang, T. Bavendam, Z. Guan

    Esquema Esquema
  • ·MP-20.25: Lessons learnt from first 200 procedures of holmium laser enucleation of prostate (HoLEP)

    Página :159

    A. Bhandarkar

    Esquema Esquema
  • ·MP-20.26: A prospective study of long-term outcome following transurethral incision of the prostate (TUIP)

    Página :159

    D.J. Argirovic

    Esquema Esquema
  • ·MP-20.27: PV prostatectomy (KTP laser) as an office-based surgical procedure replacing the “gold standard” TURP

    Página :159-160

    A.C. Gellman, D. Dershewitz, M.A. Greenstein, S.C. Gillis

    Esquema Esquema
  • ·MP-20.28: Dutasteride provides greater improvement in symptoms and Qmax than tamsulosin in men with moderate-to-severe symptoms of BPH and prostate enlargement: Two-year results from the Combination of Avodart^® and Tamsulosin (CombAT) study

    Página :160

    C. Roehrborn, P. Siami, J. Barkin, R. Damião, F. Montorsi, CombAT Study Group

    Esquema Esquema
  • ·MP-21.01: Report on the early and late complications of 169 penile fractures

    Página :160-161

    S.A. Asgari, A. Roshani, S. Falahatkar, G. Mokhtari, F. Pourreza

    Esquema Esquema
  • ·MP-21.02: Comparative assessment of three different surgical modalities for urethroplasty in long strictures of the anterior urethra

    Página :161

    C.H. Slavov, E. Popov, M. Tzvetkov

    Esquema Esquema
  • ·MP-21.03: Penile brachytherapy: results for 60 patients

    Página :161

    J. Crook, L. Grimard, B. Esche, G. Pond

    Esquema Esquema
  • ·MP-21.04: Adult orchidopexy: is intraoperative testicular biopsy necessary?

    Página :161

    M. Moradi, A. Moradi, B. Karimian

    Esquema Esquema
  • ·MP-21.05: A pilot study to investigate the effect of pulsed radiofrequency in chronic testicular pain

    Página :161-162

    S.K. Misra, S. Ward, C. Coker

    Esquema Esquema
  • ·MP-21.06: Prognosis of advanced testicular cancer patients

    Página :162

    T. Miura, J. Oota, S. Sugiura

    Esquema Esquema
  • ·MP-21.07: Testicular cancer: its effect on fertility and changing practice?

    Página :162

    E. Mazaris, M. Chrisofos, I. Varkarakis, E. Chatzidarelis, A. Skolarikos, G. Alivizatos, C. Deliveliotis

    Esquema Esquema
  • ·MP-21.08: Salvage chemotherapy with paclitaxel, gemcitabine and nedaplatin (TGN) for cisplatin refractory germ cell tumors

    Página :162-163

    T. Nakamura, K. Mikami, N. Takaha, T. Shiraishi, A. Kawauchi, Y. Mizutani, T. Miki

    Esquema Esquema
  • ·MP-21.09: Laparoscopic resection of post-chemotherapy residual mass in nonseminomatous germ cell tumor: is it feasible?

    Página :163

    O. Castillo, J.M. Campero, R. Sanchez-Salas, F. Secin, G. Vitagliano, M. Diaz, J.C. Aranguibe, A. Foneron

    Esquema Esquema
  • ·MP-21.10: The value of repeat chest x-ray in the follow-up of stage one testicular germ cell tumours

    Página :163

    R. Richardson, A.E. Boeken Kruger, G. Stapper, M.T.W. Lock, J.L.H. Bosch

    Esquema Esquema
  • ·MP-21.11: Laparoscopic post chemotherapy retro peritoneal lymph node dissection for residual mass: initial results

    Página :163-164

    H. Baumert, W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, V. Molinié, K. Fizazi

    Esquema Esquema
  • ·MP-21.12: Late relapses (LR) in 1503 patients (pts) with germ cell testicular tumors (GCTT)

    Página :164

    D.J. Argirovic, A. Argirovic

    Esquema Esquema
  • ·MP-21.13: High risk (HR) clinical stage A (CS-A) nonseminomatous testicular tumors (NSTT): patterns of recurrence and outcome of treatment

    Página :164

    D.J. Argirovic, A. Argirovic

    Esquema Esquema
  • ·MP-21.14: Dorsal onlay urethroplasty: our experience in 73 patients

    Página :164-165

    S. Bapat, P. Yadav, A. Padhye, P. Mahajan, A. Bhave

    Esquema Esquema
  • ·MP-21.15 (Podium): The protective effect of erythropoietin on seminiferous tubules damage in rat testicular torsion model

    Página :165

    B.B. Purnomo, A. Setiadi

    Esquema Esquema
  • ·MP-21.16 (Podium): Primary laparoscopic retroperitoneal lymph-node dissection for clinical stage I nonseminomatous germ-cell testis tumor: long term results

    Página :165

    O. Castillo, J.M. Campero, R. Sanchez-Salas, F. Secin, G. Vitagliano, M. Diaz, J.C. Aranguibe, A. Foneron

    Esquema Esquema
  • ·MP-21.17 (Podium): Paratesticular masses: the Mayo Clinic experience

    Página :165-166

    A.K. Tsao, R.J. Karnes, T.J. Sebo, A. Nehra

    Esquema Esquema
  • ·MP-21.18 (Podium): Testosterone deficiency and bone metabolism damage in testicular cancer survivors

    Página :166

    D. Ondrus, B. Spanikova, M. Ondrusova, J. Mardiak

    Esquema Esquema
  • ·MP-22.01: Buccal mucosa graft combined with genital flaps for urethral lengthening in female transsexuals

    Página :166

    M. Djordjevic, S. Perovic, G. Korac, M. Bizic, M. Majstorovic

    Esquema Esquema
  • ·MP-22.02: Evaluation and management of blunt renal trauma in adults with solitary kidney or impaired renal function

    Página :166-167

    R. Santucci, E. Serafetinides, I. Mitsogiannis, K. Stravodimos, I. Anastasiou, M. Giannopoulou, A. Giannopoulos

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :167

    
  • ·MP-22.03: First stage urethroplasty as a permanent solution in patients with complex anterior urethral stricture

    Página :167

    S.P. Elliott, J.W. McAninch

    Esquema Esquema
  • ·MP-22.04: Perineopenile degloving (PPD) in complex anterior urethral srictures

    Página :167

    A. Elkassaby, E. Eltahawy

    Esquema Esquema
  • ·MP-22.05: Perineal urethrostomy stenosis repair with buccal mucosa: Description of the technique and report of three cases

    Página :167

    N. Kamat

    Esquema Esquema
  • ·MP-22.06: Outcomes and special techniques for treatment of severe penile injuries

    Página :167-168

    S. Perovic, M. Djordjevic, R. Santucci, M. Bumbasirevic

    Esquema Esquema
  • ·MP-22.07: The main causes of surgical failure in the treatment of the posterior urethral stricture

    Página :168

    X. Hong, Y. Xu, Y. Qiao

    Esquema Esquema
  • ·MP-22.08: Is there any association among grade of renal injury and beta-2 microglobulin concentration in incidental urinary sample?

    Página :168

    A. Lekas, I. Fokitis, V. Politis, K. Filis, G. Lefakis, V. Maniotis, G. Koritsiadis, S. Koritsiadis

    Esquema Esquema
  • ·MP-22.09: Penetrating bladder injuries in abdominal trauma: Iraqi experience of Alyarmouk Teaching Hospital

    Página :168-169

    N.K.N. Alsaigh, F.G. Petros

    Esquema Esquema
  • ·MP-22.10: Management of urinary fistula: experience in a tertiary care hospital in Dhaka city

    Página :169

    Z.H. Bhuiyan, K.M.H. Tawhid, S.A. Khan, M. Fakhrul Islam

    Esquema Esquema
  • ·MP-22.11: Penile invagination technique in full length buccal mucosa urethroplasty

    Página :169

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·MP-22.12: A new technique to repair urethro perineal fistula after abdominoperineal resection of rectum

    Página :169-170

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·MP-22.13: Spectrum and challenges of elective reconstructive urologic operations in Sokoto, Nigeria

    Página :170

    I.A. Mungadi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :170

    
  • ·MP-22.14: Urethroplasty for bulbar urethral necrosis

    Página :170

    S.B. Kulkarni, S. Lambe, A. Bapat, D.T. Kama, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :170

    

• Video Poster Sessions

  • ·VID-01.01: Beneficial effects of photoselective vaporization of the prostate-vaporization excision technique (PVP-VET)

    Página :171

    J.S. Byun, J.M. Joo, S.C. Kang, H.Y. Jung, J.H. Jang, I.C. Park

    Esquema Esquema
  • ·VID-01.02: Can holmium laser visual internal urethrotomy (VIU) replace cold knife VIU in the management of stricture urethra?

    Página :171

    A. Bhandarkar

    Esquema Esquema
  • ·VID-01.03: Thulium laser vapo-resection of the prostate

    Página :171

    W. Massoud, N. Rebai, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-01.04: Robotic-assisted laparoscopic radical prostatectomy in patients with previous inguinal meshplasty: technique and perioperative outcome

    Página :171-172

    K.J. Palmer, R. Thaly, K. Shah, V.R. Patel

    Esquema Esquema
  • ·VID-01.05: Transperitoneal laparoscopic prostatectomy: tips and tricks

    Página :172

    G. Fournier, A. Rammal, V. Joulin, C. Deruelle, B. Rousseau, A. Erauso, A. Valeri

    Esquema Esquema
  • ·VID-01.06: Early retrograde release of the neurovascular bundle during robotic-assisted laparoscopic radical prostatectomy

    Página :172

    K.J. Palmer, K. Shah, R. R. Thaly, V. Patel

    Esquema Esquema
  • ·VID-01.07: Transrectal pulsed focused ultrasound (3 MHz) as local prostate cancer treatment

    Página :172

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·VID-01.08: Nerve sparing robotic prostatectomy – preserving the accessory obturator artery

    Página :172-173

    N.A. Bin Mohd Zam, K.O. Lau, K.H. Yip, W.S. Cheng

    Esquema Esquema
  • ·VID-01.09: Laparoscopic radical prostatectomy in a renal allograft recipient: surgical technique

    Página :173

    G. Fournier, A. Erauso, M. Moal, A. Rammal, V. Joulin, B. Rousseau, A. Valeri

    Esquema Esquema
  • ·VID-01.10: Different techniques for prostatic dissection according to individualised oncological and functional requirements

    Página :173

    N. Rebai, W. Massoud, N. Saheb, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-01.11: Technique of laparoscopic extended lymphadenectomy for prostate cancer

    Página :173

    G. Fournier, C. Deruelle, J. Vincent, N. Kerfant, C. Fedorenko, R. El Atat, A. Valeri

    Esquema Esquema
  • ·VID-01.12: Tips and tricks of Ablatherm^® treatment

    Página :174

    S. Thueroff, C. Chaussy

    Esquema Esquema
  • ·VID-02.01: Video-urodynamic testing in the upper urinary tract

    Página :174

    R. Vela Navarrete, C. Gonzalez Enguita, L. Lopez Martin

    Esquema Esquema
  • ·VID-02.02: First stage incisionless placement of Implantable Pulse Generator (IPG) in children: video description of technique and results

    Página :174

    J.C. Routh, S.M. McGee, T.J. Roth, P. Hollatz, D.R. Vandersteen, Y. Reinberg

    Esquema Esquema
  • ·VID-02.03: Xenograft interposition in female urethral diverticulum surgery

    Página :175

    J.E. Robles, J.P. Rioja, A. Saiz, X. Brugarolas, A. Rincón, E. Tolosa, D. Rosell, J.J. Zudaire, J.M. Berian

    Esquema Esquema
  • ·VID-02.04: Uterus sparing procedure in total urogenital prolapse

    Página :175

    P. Palma, C. Riccetto, R. Fraga, V. Herrmann, N. Netto

    Esquema Esquema
  • ·VID-02.05: 46-XY complete gonadal dysgenesis

    Página :175

    D. Mehraban, M.A. Sedighi-Gilani

    Esquema Esquema
  • ·VID-02.06: Bolstering up the urethra in male urinary ıncontinence with folded polypropylene mesh

    Página :175-176

    M. Kilinc

    Esquema Esquema
  • ·VID-02.07: Miniperc sling for stress urinary incontinence: rationale & technique

    Página :176

    P. Palma, C. Riccetto, R. Fraga, R. Oliveira, L. Ikari, R. Miyaoka, A. Prudente, R. Aidar, N. Netto

    Esquema Esquema
  • ·VID-03.01: Laparoscopic dismembered pyeloplasty: an innovative technique for intracorporeal ureteral stenting

    Página :176

    A. El-Feel, H. Abouel-Fettouh, A. Abdel-Hakim

    Esquema Esquema
  • ·VID-03.02: Technique of robotic management of congenital primary obstructed megaureter with secondary stones in adults

    Página :176-177

    R. Rao, R. Nayyar, A.K. Hemal

    Esquema Esquema
  • ·VID-03.03: Laparoscopic pieloplasty in pelvic kidney

    Página :177

    M. Featherston, J. Rozanec, C. Vallote, J. Ares, A. Hernandez, R. Fabiano, M. Rumian, D. Hernandez, A. Nolazco

    Esquema Esquema
  • ·VID-03.04: Technique allowing the warm ischemia time to be reduced by half during laparoscopic partial nephrectomy

    Página :177

    N. Rebai, W. Massoud, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-03.05: Robotic extended pyelolithotomy – open surgery revisited

    Página :177-178

    R. Nayyar, A.K. Hemal

    Esquema Esquema
  • ·VID-03.06: Laparoscopic ureterolithotomy: a transition from transperitoneal to retroperitoneal approach

    Página :178

    B.K. Poh, S.H. Ho

    Esquema Esquema
  • ·VID-03.07: Laparoscopic assisted percutaneous nephrolithotomy in ectopic pelvic kidneys: what is best access point?

    Página :178

    S.H. Mousavi-Bahar, M.A. Amir-Zargar, H.R. Gholamrezaei, S. Amir-Hassani

    Esquema Esquema
  • ·VID-03.08: Indications and limits of diagnostic flexible ureteroscopy

    Página :178-179

    P. Geavlete, R. Multescu, D. Georgescu, B. Geavlete

    Esquema Esquema
  • ·VID-03.09: Mini-incisional nephrectomy in living donor kidney transplant (LDKT)

    Página :179

    R. Vela Navarrete, J.L. Rodriguez-Miñon, F. Calahorra Fernández, C. Gonzalez Enguita, J. Cabrera

    Esquema Esquema
  • ·VID-03.10: Novel technique for percutaneous nephrolithotomy in lateral decubitus flank position

    Página :179

    H. Karami, A.H.M.M. Arbab

    Esquema Esquema
  • ·VID-03.11: Particularities of flexible ureteroscopic approach in treatment of upper urinary tract lithiasis

    Página :179

    P. Geavlete, R. Multescu, V. Cauni, D. Georgescu, B. Geavlete

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :179

    
  • ·VID-04.01: Reconstructive laparoscopy for ureteral lesions: a single institute experience

    Página :180

    A. El-Feel, H. Abouel-Fettouh, A. Abdel-Hakim

    Esquema Esquema
  • ·VID-04.02: The limits of nephron-sparing surgery in von hippel lindau disease

    Página :180

    R. Vela Navarrete, C. Gonzalez Enguita, J.V. Garcia Cardoso, F. Manzarbeitia, J. Gomez, C. Martin

    Esquema Esquema
  • ·VID-04.03: Laparoscopic adrenalectomy is feasible even for large tumors

    Página :180

    H.R. Gholamrezaie, A. Shadab, A. Akbarzadeh Pasha

    Esquema Esquema
  • ·VID-04.04: Supine position urethrectomy in conjunction with radical cystectomy for bladder cancer

    Página :180-181

    G. Glück, I. Sinescu

    Esquema Esquema
  • ·VID-04.05: Laparoscopic Boari bladder flap ureteroneocystostomy for distal uretral tumor: a case report

    Página :181

    A. Basiri, H. Karami, S. Mehrabi, A. Javaherforooshzadeh

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :181

    
  • ·Abstract Withdrawn

    Página :181

    
  • ·VID-04.06: The Brazilian Urological Society’s “PTU Programa de Tele-Urologia”: an option for interactive telemedicine to a developing country

    Página :181

    S.C. Zequi, A.C. Nardi, C.A.R. Sacomani, C. Mendes Gomes, C.A.L. d’Ancona, E.R. Wroclawski, S. Glina

    Esquema Esquema
  • ·VID-04.07: Retroperitoneoscopic drainage of a psoas abscess

    Página :181

    R. Rabii, S. El Mhef, B. Querfani, A. Joual, F. Meziane

    Esquema Esquema
  • ·VID-05.01: Laparoscopic treatment for bilateral varicocel

    Página :181-182

    R. Rabii, S. Elmhef, B. Querfani, F. Meziane

    Esquema Esquema
  • ·VID-05.02: Three piece penile prosthesis implant (Titan^® with Resist^®) in complex cases

    Página :182

    S. Pecoraro, A. Fienga, B. Giammusso

    Esquema Esquema
  • ·VID-05.03: Original space maintainer device in penile lengthening: a new technique

    Página :182

    G. Alei, P. Letizia, F. Ricottilli

    Esquema Esquema
  • ·VID-05.04: “Double breasted” corporoplasty in congenital penile recurvatum: ten years’ experience

    Página :182-183

    G. Alei, P. Letizia, F. Ricottilli

    Esquema Esquema
  • ·VID-05.05: Laparoscopic cystectomy and neo-bladder formation in woman

    Página :183

    W. Massoud, N. Rebai, L. Peyrat, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-05.06: Laparoscopic management of an ureteral injury during laparoscopic procedures

    Página :183

    N. Rebai, W. Massoud, N. Saheb, M. Fennouri, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-05.07: Combined buccal mucosa graft and penile flap for urethral reconstruction in failed hypospadias repair

    Página :183

    M. Djordjevic, R. Santucci, S. Perovic

    Esquema Esquema
  • ·VID-05.08: Asopa’s technique for penile urethral reconstruction

    Página :183-184

    E. Palminteri, E. Berdondini

    Esquema Esquema
  • ·VID-05.09: Resurfacing of the glans penis

    Página :184

    E. Palminteri, E. Berdondini

    Esquema Esquema
  • ·VID-05.10: Management of iatrogenic urinary tract injuries

    Página :184

    M. Yazdani, K. Nouri-Mahdavi, M.R. Gheraati

    Esquema Esquema
  • ·VID-05.11: Radical cystectomy and orthotopic ileal neobladder with preservation of the prostate capsule and the seminal vesicles

    Página :184-185

    D. Delakas, I. Karyotis, C. Konstantinidis, G. Barbaras

    Esquema Esquema
  • ·VID-06.01: Glansectomy and circumcision for penile carcinoma with skin graft on the corporal heads

    Página :185

    C. Gingu, M. Harza, S. Patrascoiu, B. Serbanescu, B. Stefan, V. Zogas, R. Stoica, D. Tica, V. Cerempei, I. Sinescu

    Esquema Esquema
  • ·VID-06.02: Retroperitoneal lymph node dissection for testicular teratoma in a patient with horseshoe kidney

    Página :185

    C. Gîngu, M. Hârza, S. Pǎtrǎşcoiu, C. Chibelean, D. Tica, B. Ştefan, C. Bǎlşanu, C. Surcel, R. Stoica, C. Baston, I. Sinescu

    Esquema Esquema
  • ·VID-06.03: Multimodal salvage therapy for a patient with penile carcinoma and bulky inguinal lymph nodes metastases

    Página :185-186

    C. Gingu, S. Patrascoiu, M. Harza, C. Chibelean, B. Stefan, C. Balsanu, D. Tica, C. Surcel, I. Sinescu

    Esquema Esquema
  • ·VID-06.04: Ventral bulbar augmentation [VBA]: a technique to enhance support of buccal mucosal graft placed ventrally for proximal bulbar urethral strictures

    Página :186

    D. Dalela, R.J. Sinha, S. Sankhwar, V. Singh

    Esquema Esquema
  • ·VID-06.05: Substituiton urethroplasty for bulber-urethral stricture: modified Barbagli procedure: experience in 10 cases

    Página :186

    Z.H. Bhuiyan, K.M.H. Tawhid, S.A. Khan, M. Fakhrul Islam

    Esquema Esquema
  • ·VID-06.06: Induratio penis plastica: preliminary experience with extracorporeal shock-wave treatment (ESWT)

    Página :186-187

    R. Giulianelli, S. Brunori, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, Bc. Gentile, T. Shestani

    Esquema Esquema
  • ·VID-06.07: Introduction of the 2μM CW laser for several applications in urology

    Página :187

    T. De Boorder, M. Grimbergen, R. Bosch, J. Klaessens, R. Verdaasdonk, T. Lock

    Esquema Esquema
  • ·VID-06.08: Laparoscopic extra peritoneal post chemo retroperitoneal lymph node dissection (RPLND)

    Página :187

    W. Massoud, N. Rebai, N. Saheb, O. Dumonceau, H. Baumert

    Esquema Esquema
  • ·VID-06.09: Transperitoneal approach for laparoscopic retro peritoneal lymph node dissection (RPLND) for large residual mass

    Página :187-188

    H. Baumert, W. Massoud, N. Rebai, J. Schlosser, O. Dumonceau, K. Fizazi

    Esquema Esquema
  • ·VID-06.10: Bipolar endoscopic procedures in complicated urethral strictures

    Página :188

    P. Geavlete, D. Georgescu, V. Cauni, V. Mirciulescu, B. Geavlete

    Esquema Esquema

• Unmoderated Poster Sessions

  • ·POS-01.01: O’Connor technique and its effects on bladder function in previously failed vesicovaginal fistulas

    Página :189

    F. Sharifiaghdas, H. Akhavizadegan

    Esquema Esquema
  • ·POS-01.02: Efficacy analysis of trans-obturator tension-free vaginal tape (TVT-O) versus tension-free vaginal tape in the treatment of mixed urinary incontinence: a randomized study

    Página :189

    C. Moon, H.Y. Moon, D.H. Lim, C.S. Kim, J. Rho, H.S. Park, S.J. Chun

    Esquema Esquema
  • ·POS-01.03: Tension-free vaginal tape (TVT), suprapubic ARC (SPARC) sling and transobturator tape (TOT) in the treatment of mixed urinary incontinence in women

    Página :189

    S. Choi, J. Ku, H. Son, S.J. Oh, S. Kim, J.S. Paick

    Esquema Esquema
  • ·POS-01.04: Omentoplasty in the treatment of complex vesico-vaginal fistulas: A forgotten method?

    Página :189-190

    D.S. Popescu, V. Popescu, A. Irimie, S. Nicoara

    Esquema Esquema
  • ·POS-01.05: Anatomic and functional comparison of pelvic floor in women with voiding difficulty and normal women

    Página :190

    S. Hajebrahimi, Z. Miabi, A. Azaripour, A. Mahdkhah

    Esquema Esquema
  • ·POS-01.06: Novel technique for the treatment of stress urinary incontinence: early outcomes

    Página :190

    M. Mustafa, H. Abol-Enein

    Esquema Esquema
  • ·POS-01.07: Anatomical basis for effective placement of adjustable continence therapy (ACT®) balloons for treatment of female stress urinary incontinence

    Página :190-191

    E. Kocjancic, B. Frea, P. Robertson, H. O’Connell

    Esquema Esquema
  • ·POS-01.08: Periodic outcomes of tension-free vaginal tape procedure for women with stress urinary incontinence

    Página :191

    W.Y. Cho, T.H. Kim, K.S. Lee, Y.K. Seong, J.S. Hwang

    Esquema Esquema
  • ·POS-01.09: Female urethral tear resulting in urinary incontinence following spontaneous vaginal delivery

    Página :191

    A. Bolukbasi

    Esquema Esquema  
  • ·POS-01.10: Comparison of cystometric, uroflowmetric and voiding diary volumes to determine the correct maximum bladder capacity in women with urinary incontinence

    Página :191-192

    I. Sen, A. Çamtosun, M. Onaran, M. Kiraç, M.Ö. Tan, I. Bozkirli

    Esquema Esquema
  • ·POS-01.11: Comparison of uroflowmetry parameters in women with urge, stress and mixed type urinary incontinence

    Página :192

    I. Sen, A. Çamtosun, M. Onaran, M. Kiraç, M.Ö. Tan, I. Bozkirli

    Esquema Esquema
  • ·POS-01.12: The effects of estrogen on nNOS, eNOS expression and histologic composition in the rat bladder and urethra

    Página :192

    S.W. Park, C.Y. Lee, J.Z. Lee

    Esquema Esquema  
  • ·POS-01.13: Why do pre-pubic slings fail?

    Página :192-193

    P. Palma, A. Silveira, C. Riccetto, A. Prudente, M. Dambros, N. Netto

    Esquema Esquema
  • ·POS-01.14: Vaginal wall prolapse repair with and withot meshes: A global analysis of impact on symptons, quality of life and sexuality

    Página :193

    P. Palma, C. Riccetto, R. Thiel, L. Perchon, M. Dambros, V. Muller, N. Netto

    Esquema Esquema  
  • ·POS-01.15: Nazca: a monoprosthesis for the simultaneous correction of cystocele and urinary stress incontinence - a multicentric trial

    Página :193-194

    P. Palma, C. Riccetto, V. Muller, R. Fraga, O. Contreras, C. Sarsotti, M. Paladini, A. Cianci, P. Barthos

    Esquema Esquema
  • ·POS-01.16: Level specific correction of apical and posterior prolapses: why transcoccigeal fixation makes a difference

    Página :194

    P. Palma, C. Riccetto, R. Fraga, V. Pagotto, E. Castro, V. Herrmann, J. Tejerizo, S. Metrebien

    Esquema Esquema  
  • ·POS-01.17: The percutaneous sling for stress urinary incontinence: Towards the in-office procedure

    Página :194

    P. Palma, C. Riccetto, V. Herrmann, R. Miyaoka, R. Fraga

    Esquema Esquema  
  • ·POS-01.18: Can short-term administration of anticholinergics predict improvement of overactive bladder symptoms after sling surgery in patient with both stress urinary incontinence and overactive bladder?

    Página :194-195

    W.Y. Cho, T.H. Kim, D.W. Choi, D.W. Kim

    Esquema Esquema
  • ·POS-01.19: Managing vascular complications during transobturator sling

    Página :195

    P. Palma, R. Fraga, C. Riccetto, N. Netto

    Esquema Esquema
  • ·POS-01.20: Obstruction following sling procedures is more frequent in autologous than synthetics: urethrolysis effectiveness is similar

    Página :195-196

    P. Palma, C. Riccetto, R. Fraga, R. Oliveira, N. Netto

    Esquema Esquema
  • ·POS-01.21: Endoscopic treatment in vesicovaginal fistulas

    Página :196

    P. Geavlete, D. Georgescu, V. Mirciulescu, B. Geavlete

    Esquema Esquema
  • ·POS-01.22: Male infertility: sperm disorders and stytic dysfunction in Byzantine times (330-1453 AD)

    Página :196

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris, A. Rempelakos

    Esquema Esquema
  • ·POS-01.23: Consequences of the sexual behaviour of Byzantine emperors (330-1453 AD)

    Página :196-197

    A. Rempelakos, E. Koutsiaris, C. Tsiamis, E. Poulakou-Rebelakou

    Esquema Esquema
  • ·POS-01.24: The reasons of orchectomy from Hippocrates to the 20^th century

    Página :197

    E. Koutsiaris, A. Rempelakos

    Esquema Esquema
  • ·POS-01.25: French influence on the establishment and development of Greek urology

    Página :197

    E. Poulakou-Rebelakou, C. Tsiamis, E. Koutsiaris, A. Rempelakos

    Esquema Esquema
  • ·POS-01.26: The first urological department in Russia

    Página :197

    A. Novikov

    
  • ·POS-01.27: Prevalence of microorganisms colonizing in the bladder catheters in 204 patients

    Página :197-198

    T. Arvanitakis, A. Rempelakos, A. Palantzas, A. Marketakis, S. Mpisias, E. Chinou

    Esquema Esquema
  • ·POS-01.28: Changes in causative organisms and antimicrobial sensitivity of the urinary tract infection

    Página :198

    S.J. Oh, D.Y. Han, S.H. Baek, S.C. Park, J.S. Hwa, I.Y. Seo, H.J. Jeong, J.S. Rim

    Esquema Esquema
  • ·POS-01.29: Treatment of symptomatic simple renal cysts by percutaneous aspiration and ethanol sclerotherapy

    Página :198

    M. Labib

    Esquema Esquema
  • ·POS-01.30: Influence of E. coli genomic pathogenecity islands on the clinical course of urinary tract infections

    Página :198-199

    L.A. Khodyreva, A.E. Verschinin, V.M. Bondarenko, T.S. Perepanova, V.N. Sinyukhin

    Esquema Esquema  
  • ·POS-01.31: Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients

    Página :199

    T. Ito

    Esquema Esquema
  • ·POS-01.32: Emphysematous pyelonephritis – our experience

    Página :199-200

    P.V.L.N. Murthy, J. Srikanth, C. Ramreddy, R. Devraj, B. Suresh, N. Prasad, H. Kumar

    Esquema Esquema
  • ·POS-01.33: Positive results of the URISCREEN^™ test for UTI may indicate bladder cancer

    Página :200

    D. Pode, I. Golan, A. Shapiro, R. Katz, O. Gofrit

    Esquema Esquema
  • ·POS-01.34: pCREB immunohistochemical staining of dorsal root ganglia after repeated UPEC infection into rat bladder

    Página :200

    W. Sung, H. Rho, S.J. Lee, S.G. Chang, J. Kim

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :200

    
  • ·POS-01.36: Safety and pathological findings of prostate biopsy in male interstitial cystitis patients with an elevated PAS level: What dose an elevated PSA level mean?

    Página :200-201

    M. Kajiwara, K. Mutaguchi, M. Oki, H. Moriyama

    Esquema Esquema
  • ·POS-01.37: Novel quantification method using voided stain on paper technique for voiding analysis in the mouse

    Página :201

    Y. Sugino, A. Kanematsu, K. Yoshimura, Y. Hayashi, N. Yoshimura, O. Ogawa

    Esquema Esquema
  • ·POS-01.38: Isolated retrovesical cystic mass (hydatid cyst)

    Página :201

    D. Nourizadeh, M. Amjadi

    Esquema Esquema
  • ·POS-01.39: Septic shock after transrectal biopsy of prostate due to extended-spectrum beta-lactamase producing Escherichia coli

    Página :201-202

    K. Hikita, T. Watanabe, T. Isyama, M. Honda, N. Kobayashi, S. Morizane, S. Toji, M. Matsumoto, T. Masago, I. Miyagawa

    Esquema Esquema
  • ·POS-01.40: Filarial hydrocelectomy: the West African experience

    Página :202

    S. Mante, S. Anders

    Esquema Esquema
  • ·POS-01.41: Chlamydia trachomatis infection in male partners of infertile couples

    Página :202-203

    I. Ouzounova, V. Raykova, I. Mitov

    Esquema Esquema
  • ·POS-01.42: A comparative study of two methods of perineal and genital skin antiseptic preparation prior to urological procedures in adult male patients

    Página :203

    E.O. Kehinde, Y. Ali, F. Khodakhast, W. Jamal, M. Seshah, V.O. Rotimi

    Esquema Esquema
  • ·POS-01.43: Dorsal free buccal mucosal graft urethroplasty for recurrent anterior urethral strictures via ventral sagittal urethrotomy approach

    Página :203

    P. VLN Murthy, P. Sriman, C. Ramreddy, R. Devraj, V. Sagar, N. Prasad, J. Srikanth, B. Suresh

    Esquema Esquema
  • ·POS-01.44: Clinical study of male urethritis in Nagano Matsushiro General Hospital

    Página :203-204

    T. Nakagawa

    Esquema Esquema
  • ·POS-01.45: Alpha blockers versus phytotherapy for the treatment of chronic non-bacterial prostatitis

    Página :204

    M.H. Sherief, A. Elnashar, G. Alatrash, M. Motawe

    Esquema Esquema
  • ·POS-01.46: Levofloxacin for antibiotic prophylaxis in cases of prostate biopsy

    Página :204

    D. Pushkar, A. Zaitcev, A. Govorov, P. Rasner

    Esquema Esquema
  • ·POS-01.47: Male genital tuberculosis

    Página :204-205

    A. Bolukbasi, F. Þengül, C. Öztürk, O. Bayýr

    Esquema Esquema
  • ·POS-01.48: Sexual dysfunctions in infertile women

    Página :205

    S.M. Yassini Ardekani, M.R. Moein, N. Tayybi

    Esquema Esquema
  • ·POS-01.49: Bilateral but not unilateral testis hypotrophy predicts severe impairment of semen quality

    Página :205

    A. Wu, T.J. Walsh, P.J. Turek

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :205

    
  • ·POS-01.51: Intratesticular blood flow in patients with azoospermia

    Página :205-206

    M.K. Alchinbaev, A.S.H. Ibraeva, T.E. Husainov, Y.S.H. Ismoldayev, A. Eralieva

    Esquema Esquema
  • ·POS-01.52: Semen profiles and body mass indices of African males seeking treatment for infertility in Ghana

    Página :206

    K.E.K. Aboah

    Esquema Esquema
  • ·POS-01.53: Interest of varicocele repair in azoospermic men

    Página :206

    H. Ketata, H. Jallouli, M. Bouacida, A. Sahnoun, S. Ben Amar, A. Kertiti, M.N. Mhiri

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :206

    
  • ·POS-01.55: Investigation of tubular loop: New modified technique of microsurgical vasoepididymostomy

    Página :206-207

    R.K. Shimpi

    Esquema Esquema
  • ·POS-01.56: Does reactive oxygen species (ROS) production in seminal fluid correlate with the severity of varicocele in infertile men?

    Página :207

    M.R. Moein, M. Soleimani, N. Tabibnejad

    Esquema Esquema
  • ·POS-01.57: Sperm chromosomal abnormalities and DNA damage in infertile mustard gas casualties’ men detected by fluorescence in-situ hybridization, inverse restriction site mutation assay, sperm chromatin structure assay and the comet assay

    Página :207

    M.R. Safarinejad

    Esquema Esquema
  • ·POS-01.58: Participation of apoptosis in the mechanism of dysfunction of spermatogenesis after vasectomy

    Página :207-208

    Y. Umemoto, S. Sasaki, M. Hayase, Y. Kojima, Y. Kubota, K. Kohri

    Esquema Esquema
  • ·POS-01.59: Isolation and characterization of HANP1/H1T2, a novel histone H1-like protein involved in nuclear formation and sperm fertility

    Página :208

    Y. Matsuoka, A. Tsujimura, T. Takao, Y. Miyagawa, S. Takada, H. Tanaka, Y. Nishimune, A. Okuyama

    Esquema Esquema
  • ·POS-01.60: Comparision of semen profile and frequency of chromosome aneuploidy in sperm nuclei of patients with varicocele before and after surgical treatment

    Página :208

    H. Acar, M. Kilinc, T. Yurdakul, R. Celik, S. Guven

    Esquema Esquema
  • ·POS-01.61: Kartagener syndrome: An unusual presentation of the rare condition

    Página :208

    A. Jha, H. Yahiya, J. Flynn, A. Busutill

    Esquema Esquema
  • ·POS-01.62: Comparison of prevalence of varicocele in first-degree relatives of patients with varicocele and male kidney donors

    Página :208-209

    G.H. Mokhtari, A. Noshad, M. Jamali

    Esquema Esquema
  • ·POS-01.63: A prospective study comparing fluoxetine versus clomipramine in management of premature ejaculation

    Página :209

    R. Taghavi Razavizadeh, R. Mahdavi, M.R. Darabi, K. Tavakoli

    Esquema Esquema
  • ·POS-01.64: Surgical sperm retrieval: MESA continues to play a role for ICSI

    Página :209

    H. Hibi, T. Ohori, Y. Yamada, N. Honda, Y. Hashibi, Y. Asada

    Esquema Esquema
  • ·POS-01.65: Role of nitric oxide concentrations in the patients with oligozoospermia on spermatogenesis: using L-arginine loading test and supplementation therapy

    Página :209

    H. Terada, M. Harada, S. Ozono, M. Kanayama, T. Terao

    Esquema Esquema
  • ·POS-01.66: Varicocelectomy can improve natural and assisted procreation

    Página :209-210

    M.N. Mhiri, H. Jallouli, H. Ketata, M. Hadj Slimen, M. Bouacida, S. Ben Amar, H. Fakhfekh

    Esquema Esquema
  • ·POS-01.67: Results of vasoepididymostomy for non-vasectomy patients: comparative analysis of the side-to-side technique and the two-suture invagination technique

    Página :210

    T.N. Nguyen, D.T.B. Mai, V.L. Chuyen, Q.T. Duong, V.S. Tran

    Esquema Esquema
  • ·POS-01.68: Antegrade scrotal sclerotherapy for the treatment of varicocele: prospective study of 180 cases

    Página :210

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, Y. Kalel, N. Ben Sorba, A.F. Mosbah

    Esquema Esquema
  • ·POS-01.69: Testicular sperm extraction in oncological patents: our results

    Página :210-211

    L. Rolle, C. Ceruti, A. Tamagnone, M. Timpano, C. Negro, D. Fontana

    Esquema Esquema
  • ·POS-01.70: Identification of the mineralocorticoid receptor (MR) in human corpus cavernosum penis

    Página :211

    T. Kishimoto, Y. Kawanishi, M. Sakaki, H. Muguruma, R. Taue, H. Izaki, T. Fukumori, M. Takahashi, S. Kagawa, H. Kanayama

    Esquema Esquema
  • ·POS-01.71: Effect of aldosterone on isolated human penile corpus cavernous tissue

    Página :211

    H. Muguruma, Y. Kawanishi, H. Sugiyama, S. Tanimoto, M. Yamanaka, K. Kojima, H. Anzai, A. Numata, T. Kishimoto, H. Kanayama

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :211

    
  • ·POS-01.72: Relationship between lower urinary tract symptoms and erectile dysfunction in men above 50 years old

    Página :211-212

    F. Tadayyon, A. Pourreza, M. Yazdani

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :212

    
  • ·POS-01.74: The real-life safety and efficacy of vardenafil (REALISE) study: results from the pooled European and overseas study

    Página :212

    H. van Ahlen, J. Zumbé, H. Landen, Vardenafil REALISE Study Group

    Esquema Esquema
  • ·POS-01.75: The real–life safety and efficacy of vardenafil (REALISE) study – six months’ follow-up data from Germany

    Página :212

    H. van Ahlen, J. Zumbé, K. Stauch, H. Landen

    Esquema Esquema
  • ·POS-01.76: A prevalence survey on sexual dissatisfaction in Rasht (North Iran-2006)

    Página :212-213

    S.A. Asgari, M. Mansour Ghanai

    Esquema Esquema
  • ·POS-01.77: Sexual dysfunction related to metabolic syndrome

    Página :213

    H. Lee, B.S. Shim, Y.Y. Park, Y.S. Hong

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :213

    
  • ·POS-01.78: Study on correlation between metabolic syndrome and diabetes-related erectile dysfunction

    Página :213

    Y.J. Seo, K.S. Sim, J.M. Heo, J.O. Lee, J.Y. Park

    Esquema Esquema
  • ·POS-01.79: Sexual dysfunction in epileptic patients

    Página :213-214

    M.R. Nikoobakht, M. Motamedi, A.H. Orandi, S. Ebrahimi Nasrabady, A.A. Orandi, A. Afshin, F. Tale Khatibi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :214

    
  • ·POS-01.80: Relationship between polysomnographic indexes and erectile function in men who complain of sleep apnea

    Página :214

    D.Y. Yang, S.Y. Kim, H. Kim, S.W. Lee, J.H. Lee

    Esquema Esquema
  • ·POS-01.81: The effect of smoking on penile hemodynamics in erectile dysfunction

    Página :214

    H.J. Park, N.C. Park, S.K. Chung, W.H. Chon, C.Y. Lee

    Esquema Esquema
  • ·POS-01.82: A comparison of penile oximetry between low dose intraurethral alprostadil 125 and 250 Mcg and intracorporal prostaglandin E-1

    Página :214-215

    P. Padmanabhan, A. Kanofsky, D. Brassil, B. Goodwin, S. Telegrafi, A. McCullough

    Esquema Esquema
  • ·POS-01.83: Six-month interim analysis return of erectile function from a randomized study of nightly intraurethral alprostadil vs sildenafil as penile rehabilitation in post bilateral nerve sparing radical prostatectomy (BNSRRP)

    Página :215

    D. Fenig, D. Brassil, B. Goodwin, H. Lepor, S. Taneja, A. McCullough

    Esquema Esquema
  • ·POS-01.84: The differences of AMS score and testosterone level between rural and urban areas

    Página :215

    D. Rahardjo, A. Taher, C. A Mochtar, S. Hudaya, R. Hamid, A. Wahyudi, M. Palinrungi, G. Sutanto, E. Manuputty

    Esquema Esquema
  • ·POS-01.85: Penile strangulation: presentation of two unusual cases

    Página :215-216

    O. Ivanovski, O. Stankov, M. Kuzmanoski, S. Banev, L. Lekovski, Z. Popov

    Esquema Esquema  
  • ·Abstract Withdrawn

    Página :216

    
  • ·POS-01.86: Severity of erectile dysfunction at presentation: association of premature ejaculation and low desire

    Página :216

    A.I. El-Sakka

    Esquema Esquema
  • ·POS-01.87: Hypercium perforatum extract improves both intravaginal ejaculatory latency time and sexual satisfaction

    Página :216

    T.W. Cannon-Smith, J.H. Kaufman

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :216

    
  • ·POS-01.88: Study of efficacy and safety of oral tramadol in the treatment of premature ejaculation

    Página :217

    A. Mohammadi-Jazi, K. Nori Mahdavi, S. Salehi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :217

    
  • ·Abstract Withdrawn

    Página :217

    
  • ·POS-01.89: Comparison of vitamin E and propionyl-l-carnitine, separately or in combination in patients with early chronic Peyronie’s disease: a double blind, placebo-controlled, randomized study

    Página :217

    M.R. Safarinejad

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :217

    
  • ·Abstract Withdrawn

    Página :217

    
  • ·POS-01.90: The modified Nesbitt’s operation for penile curvature: our results in la Peyronie’s disease

    Página :217

    L. Rolle, C. Ceruti, A. Tamagnone, M. Timpano, C. Negro, D. Fontana

    Esquema Esquema
  • ·POS-01.91: Y-V preputioplasty for phimosis: an audit of 90 cases

    Página :217-218

    H. Khan, N.P. Munro, N.A. Shaikh, I. Appleyard, P. Koenig

    Esquema Esquema
  • ·POS-01.92: Penile augmentation in dysmorphopenophobic patients using a matrix collagen graft

    Página :218

    S. Pecoraro, A. Fienga, R. Giannella, G. Sepe

    Esquema Esquema
  • ·POS-01.93: The long term results of modified plication of the tunica albuginea in the congenital penile curvature

    Página :218

    J. Heo, G.W. Jung

    Esquema Esquema
  • ·POS-01.94: AMS 700 series inflatable penile prosthesis with the Momentary Squeeze pump: a review of the device modifications, intraoperative localization of the pump, and patient satisfaction results

    Página :218-219

    A. Nehra, D. Nienow

    Esquema Esquema
  • ·POS-01.95: Safety and efficacy of tubeless percutaneous nephrolithotomy

    Página :219

    S. Falahatkar, S. Tavasoli Yousefabad, I. Khosropanah, H. Niroumand, S. Nikpour

    Esquema Esquema
  • ·POS-01.96: Comparison of three less invasive procedures for large upper ureteral stones

    Página :219

    A. Basiri, N. Simforoosh, S.A.M. Ziaee, H. Shayaninasab, S. Hosseini, S.M.M. Moghaddam

    Esquema Esquema
  • ·POS-01.97: Comparison of balloon and Amplatz fascial dilation systems for percutaneous tract dilation in percutaneous nephrolithotomy

    Página :219-220

    Y.B. Jeong, S.B. Jeon, H.J. Kim, Y.G. Kim, Y.K. Park

    Esquema Esquema
  • ·POS-01.98: Efficiency of combined pneumatic and ultrasonic lithotripsy with transluminal suction in percutaneous nephrolithotripsy

    Página :220

    M. Etemadian, P. Shadpour, A. Saidi, M.J. Solemani

    Esquema Esquema
  • ·POS-01.99: Percutaneous nephrolithotomy (PCNL) in pediatric patients

    Página :220

    M. Hosseini, S. Shakeri, A. Khezri, A. Basiri, R. Inaloo, A. Yousefi, A. Hasanpour

    Esquema Esquema
  • ·POS-01.100: Management of 10-15 mm proximal ureteral stones: ureteroscopy or ESWL, a prospective patient preference trial

    Página :220

    S.A.M. Ziaee, M.R. Halimi, A. Aminsharifi, H. Shafi, A. Basiri

    Esquema Esquema
  • ·POS-01.101: One stage tract dilation for percutaneous nephrolithotomy: is it justified?

    Página :220

    S.A.M. Ziaee, H. Karami, A. Aminsharifi, S. Mehrabi, S. Zand, A. Javaherforooshzadeh

    Esquema Esquema
  • ·POS-01.102: Does sealing of the tract with absorbable gelatin (Spongostan^™) facilitate ‘tubeless percutaneous nephrolithotomy’? A pilot study

    Página :221

    I. Singh, G. Mehrotra, R. Saran, A. Singh, M. Jain

    Esquema Esquema
  • ·POS-01.103: The use of ureteroscopy (URS) in ureteral stone treatment

    Página :221

    D. Papadopoulos, A. Lekas, A. Balangas, A. Schneider, S.O. Schattka, R. Homberg, A. Kollias

    Esquema Esquema
  • ·POS-01.104: ESWL for treatment of large ureteral stones

    Página :221

    N. Rexha, I.A. Jusuj, A. Hoxha, A. Hazrolli, S. Rexha, R. Kasumaj

    Esquema Esquema
  • ·POS-01.105: Ureteroscopy without fluoroscopy for distal ureteral stones

    Página :221-222

    M. Wishahi, M. Roushdy, H. El-Ganzoury, S. Ghobashy, A. El-Baz, T. El-Leithy, I. Mahmoud, M. Ali, T. El.kalsh

    Esquema Esquema
  • ·POS-01.106: Treatment of intravesical ureterocele with transurethral resection in adults

    Página :222

    L. Lõrincz, A. Varga, A. Farkas, C. Berczi, C. Tóth, T. Flaskó

    Esquema Esquema
  • ·POS-01.107: Asymptomatic microscopic hematuria and urinary lithiasis

    Página :222

    S. Falahatkar, S. Tavasoli Yousefabad, H. Farhadabadi, S. Nikpour

    Esquema Esquema
  • ·POS-01.108: Survey of relative frequency of microbial agents in urine culture and their sensitivity to antibiotics in patients with renal stone

    Página :222-223

    S. Tavasoli Yousefabad, S. Falahatkar

    Esquema Esquema
  • ·POS-01.109: The local factor is more important than systemic factor in the formation of bladder uric acid stone

    Página :223

    C.C. Li, W.M. Li, Y.H. Chou, C.C. Liu, W.J. Wu, C.H. Huang

    Esquema Esquema
  • ·POS-01.110: Contralateral ureterolithotomy

    Página :223

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni, D. Kirpekar

    Esquema Esquema
  • ·POS-01.111: TUL or ESWL is the approach of choice for upper ureter stones management: a comparative study

    Página :223-224

    M. Nikoobakht, A. Emamzadeh, A. Abedi, A. Mehrsai, M. Taherimahmoudi, G. Pourmand

    Esquema Esquema
  • ·POS-01.112: Electrostimulation in the therapy of post-prostatectomy incontinence

    Página :224

    W. Hoffman, S. Hoffman, U. Otto

    Esquema Esquema
  • ·POS-01.113: Effects of clomipramine, imipramine, doxepine and duloxetine on acetic acid-induced bladder irritation in rabbits

    Página :224

    F.J. Perez Martínez, R. Vela Navarrete, C. Castilla Reparaz, C. González Enguita

    Esquema Esquema
  • ·POS-01.114: Treatment of post prostatectomy incontinence using the SAFYRE male sling

    Página :224-225

    M.R. El Halaby, A. Abdelmaksoud, T. Osman, K. Fawaz

    Esquema Esquema
  • ·POS-01.115: Correlation of self-assessment instruments with pad count in patients after laparoscopic radical prostatectomy

    Página :225

    J.M. Fialkov

    Esquema Esquema
  • ·POS-01.116: The 1-year outcome and prognostic factor of suprapubic arch sling (SPARC) operation in female stress urinary incontinence in multicenter study

    Página :225

    H.K. Park, H.W. Lee, K.S. Lee, B.C. Jung, H. Son, S.S. Byun, S.E. Lee

    Esquema Esquema
  • ·POS-01.117: Comparison of transobturator suburethral sling (MONARC) vs suprapubic arc (SPARC) sling procedures for female stress incontinence in multicenter study

    Página :225-226

    H.K. Park, H.W. Lee, K.S. Lee, B.C. Jung, H. Son, S.S. Byun, S.E. Lee

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :226

    
  • ·POS-01.118: Transobturator IVS used in failed stress urinary incontinence cases

    Página :226

    C. Chibelean, C. Surcel, M. Harza, C. Gingu, V. Cerempei, D. Avram, S. Patrascoiu, C. Moldovan, I. Sinescu

    Esquema Esquema
  • ·POS-01.119: Risk factors for postprostatectomy incontinence in a country with low incidence of prostate cancer

    Página :226-227

    A.Y. Lai, Y. Kuo, S. Lu, M. Lai, S.F. Hung

    Esquema Esquema
  • ·POS-01.120: Transrectal linear array ultrasonography complements urodynamics and eliminates cine’ radiation exposure

    Página :227

    I. Perkash, V. Wolfe, G. Friedland

    Esquema Esquema
  • ·POS-01.121: Improving voiding efficiency in the diabetic rat by a 5-HT1A serotonin receptor agonist

    Página :227-228

    B. Gu, J. Si, F. Liu, Y. Xu, K.E. Andersson

    Esquema Esquema
  • ·POS-01.122: Variation between clinical and urodynamic responses in patients receiving intradetrusor botulinum A for refractory neurogenic detrusor overactivity

    Página :228

    K.L. Toh, A. Tow

    Esquema Esquema
  • ·POS-01.123: Treatment of voiding dysfunction in patients with multiple sclerosis by injection of botulinum-A toxin (BTX-A) in external sphincter

    Página :228

    M.A. Mohamadzadeh Rezaei, M. Foroghipoor

    Esquema Esquema
  • ·POS-01.124: The application of solifenacin in myelodysplasic and other patients with ineffective pharmacological and/or surgical treatment

    Página :228-229

    L. Skobejko-Wlodarska, K. Felberg, P. Gastol, M. Baka-Ostrowska

    Esquema Esquema
  • ·POS-01.125: Two cases of intraperitoneal bladder rupture following vaginal delivery

    Página :229

    K.S. Png, Y.L. Chong, C.K. Ng

    Esquema Esquema
  • ·POS-01.126: Initial experience of transurethral bulking agent (deflux injection) in patients presenting with incontinence after radical prostatectomy or in advanced ca prostate involving posterior urethra/sphincter and unresponsive to conservative measures

    Página :229

    R. Sood, S. Kathuria

    Esquema Esquema
  • ·POS-01.127: Urodynamic and erectile dysfunction outcomes of tamsulosin oral controlled absorption system in BPH

    Página :229-230

    C. Persu, S. Bancu, V. Cauni, P. Geavlete

    Esquema Esquema
  • ·POS-01.128: Why is a male transobturator sling retro-urethral and non-obstructive?

    Página :230

    P. Rehder, C. Gozzi

    Esquema Esquema
  • ·POS-01.129: X-linked recessive transmitted diabetes insipidus – an interdisciplinary urological challenge

    Página :230

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, G. Eschholz

    Esquema Esquema
  • ·POS-01.130: The effect of amitryptline in female overactive bladder patients with nocturia

    Página :230

    H.J. Jeong, D.Y. Han, S.H. Baek, S.C. Park, S.J. Oh, J.S. Rim, S.O. Kim, D.D. Kwon, J.H. Roh, J. Roh, Y.B. Jeong

    Esquema Esquema
  • ·POS-01.131: Besipirdine: a new and powerful drug for urinary incontinence

    Página :231

    F.C. Perez-Martinez, R. Vela-Navarrete, C. Castilla-Reparaz, F. Haab, J. Ferté, H. Bienaymé, P. Attali

    Esquema Esquema
  • ·POS-01.132: Diary and patient-reported outcomes with solifenacin in patients with overactive bladder reporting high symptom bother and residual urgency on tolterodine

    Página :231

    N. Zinner, M.B. Chancellor, S. Forero-Schwanhaeuser

    Esquema Esquema
  • ·POS-01.133: Clinical trial of tension-free transobturator suburethral tape (inside-out TVT-O) procedure for the treatment of stress urinary incontinence

    Página :231-232

    Y.J. Kim, J. Lee, J.S. Huh

    Esquema Esquema
  • ·POS-01.134: Responses to solifenacin in patients >65 years and ≤65 years with overactive bladder syndrome: post-hoc results from the randomised, double-blind STAR study

    Página :232

    C.R. Chapple, T. Drogendijk, D.M. Wright, J. Bolodeoku

    Esquema Esquema
  • ·POS-01.135: On integrative genito-urology and interdisciplinarity

    Página :232-233

    M.C.H. Michailov, E. Neu, J. Stiglmayr, G. Schulz, U. Welscher

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :233

    
  • ·Abstract Withdrawn

    Página :233

    
  • ·POS-02.01: An experimental model of hydatidosis in rabbit testis

    Página :233

    H. Ahmadnia, M. Darabi, M. Movarekh, S. Ghanbarizadeh, M. Molaee, M. Shokohian

    Esquema Esquema
  • ·POS-02.03: Does Denonvilliers’ fascia consist of anterior and posterior layers? An anatomic study of cadaveric dissections and robotic prostatectomy findings

    Página :233

    A. Takenaka, H. Soga, A. Tewari, R. Leung, H. Miyake, K. Tanaka, M. Fujisawa

    Esquema Esquema
  • ·POS-02.04: Laparoscopic vesical autoaugmentation: An animal model in rabbits (Oryctolagus Cunilicus)

    Página :233-234

    R. Sanchez-Salas, K. Palmer-Román, H. Davila-Barrios, A. Sanchez-Ismayel, R. Miquilarena

    Esquema Esquema
  • ·POS-02.05: Prevention of renal fibrosis by angiotensin receptor blocker (ARB) in mice with pyelonephritis

    Página :234

    H. Miyakita, M. Tokunaga, T. Terachi

    Esquema Esquema
  • ·POS-02.06: Neoadjuvant chemotherapy with gemcitabine and carboplatin followed by concurrent chemoradiotherapy in locally advanced carcinoma of urinary bladder

    Página :234

    T.N. Ansari

    Esquema Esquema
  • ·POS-02.07: Alteration of the p53 expression in bladder transitional cell carcinoma

    Página :234-235

    M. Kalantari, H. Ahmadnia

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :235

    
  • ·POS-02.09: Triptolide (PG490)-mediated sensitization of urothelial cancer cells to cisplatin via the interaction between glycogen synthase kinase-3β and p53

    Página :235

    H. Nishiyama, Y. Matsui, J. Watanabe, T. Kamoto, O. Ogawa

    Esquema Esquema
  • ·POS-02.10: Lymphatic vessel architecture in normal tissue and carcinoma of the urinary bladder

    Página :235

    K. Matsushita, K. Matsumoto, S. Soh, T. Fujita, T. Satoh, E. Satoh, M. Iwamura, T. Ishii, S. Baba

    Esquema Esquema
  • ·POS-02.11: Prognostic significance of Her2/neu overexpression in patients of muscle invasive urinary bladder carcinoma treated with radical cystectomy

    Página :235-236

    A. Seth, S.B. Kolla, M.K. Singh, N.P. Gupta, A.K. Hemal, P.N. Dogra, R. Kumar

    Esquema Esquema
  • ·POS-02.12: Analysis of genome-wide copy number changes in bladder cancers using array-based comparative genomic hybridization

    Página :236

    S. Eguchi, Y. Yamamoto, Y. Chochi, T. Furuya, A. Oga, S. Kawauchi, S. Sakano, H. Matsuyama, K. Sasaki, N. Naito

    Esquema Esquema
  • ·POS-02.13: siRNA-mediated multitarget inhibition of antiapoptotic BCL2, BCLX_L and XIAP in bladder cancer cells

    Página :236

    D. Kunze, D. Wuttig, J. Stade, S. Fuessel, O.W. Hakenberg, A. Meye

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :236

    
  • ·POS-02.15: The expression of claudin-7 in transitional cell carcinoma of the urinary bladder: a quantitative reverse transcriptase-polymerase chain reaction analysis

    Página :236-237

    H. Kanayama, M. Gad El-Moula, T. Fukumori, E. Elsamman, R. Taue, T. Kishimoto, H. Izaki, N. Oka, M. Takahashi, S. Kagawa

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :237

    
  • ·POS-02.17: Potent effects of two distinct mushroom extracts on growth of bladder cancer cells

    Página :237

    P. Pyo, M. Hoffman, P. Grewall, H. Tazaki, M. Choudhury, S. Konno

    Esquema Esquema
  • ·POS-02.18: BTA, UBC, TPS tumor markers, urinary cytology and cystoscopy in recurrent bladder tumors

    Página :237

    G. Glück, I. Sinescu, R. Stoica, O. Drăgoescu, Stanciu Adina, N. Stafidov, Bogdan Mariana, M. Stanciu

    Esquema Esquema
  • ·POS-02.19: C-reactive protein predicts prognosis of muscle-invasive bladder cancer patients treated with chemoradiotherapy

    Página :237-238

    S. Yoshida, K. Saito, F. Koga, Y. Kageyama, M. Yokoyama, Y. Matsuoka, H. Masuda, R. Kobayashi, S. Kawakami, K. Kihara

    Esquema Esquema
  • ·POS-02.20: FISH (Fluorescense hybridisation in situ) in the diagnosis of superficial bladder cancer

    Página :238

    B. Dobrowolska, W. Lipczynski, K. Juszczak, Z. Dobrowolski, R. Tomaszewska, A. Sinczak

    Esquema Esquema
  • ·POS-02.21: Upstaging in T1G3 urothelial urinary bladder cancer – an evaluation of data from Nordic cystectomy trial 1

    Página :238

    A. Sherif, E. Rintala, O. Mestad, S. Nilsson, P.U. Malmström, M. Duchek

    Esquema Esquema
  • ·POS-02.22: Neoadjuvant low-dose chemoradiotherapy against muscle-invasive bladder cancer: Possible improvement of survival and favorable local control for bladder-preserved patients

    Página :238-239

    F. Koga, S. Yoshida, Y. Kageyama, S. Kawakami, Y. Fujii, K. Saito, H. Masuda, T. Kobayashi, K. Kihara

    Esquema Esquema
  • ·POS-02.23: The association between prostatic involvement in transitional cell carcinoma of the bladder and pathologic characteristics of the bladder tumor

    Página :239

    A. Tabibi, N. Simforoosh, M. Parvin, H. Abdi, A. Javaherforooshzadeh, Z. Razzaghi

    Esquema Esquema
  • ·POS-02.24: Laparoscopic radical cystectomy in the treatment of invasive bladder cancer

    Página :239

    V.N. Dubrovin, A.V. Tabakov, G.A. Melnic, K.A. Kudriashov

    Esquema Esquema
  • ·POS-02.25: Combined intra-arterial chemotherapy and radiotherapy for treatment of invasive bladder cancer

    Página :239-240

    H. Mochizuki, K. Gotoh, K. Hieda, Y. Kobukata, N. Hiromoto, H. Kiriu

    Esquema Esquema
  • ·POS-02.26: Combined intra-arterial chemotherapy and radiotherapy for invasive bladder carcinoma

    Página :240

    H. Wakeda, Y. Hasui, H. Tshukino, K. Yakushiji, T. Kamimura, M. Nagano, K. Inoue, K. Nose, R. Hamasuna, Y. Osada

    Esquema Esquema
  • ·POS-02.27: Chemotherapy or radical cystectomy as first therapeutic option for young patients with locally invasive TCC (T2-3NxMo)

    Página :240

    J. Djozic, J. Bogdanovic, D. Donat, A. Zivanovic, M. Djozic, S. Djozic, N. Dejanovic, M. Dukic, I. Levakov, S. Vojnov, R. Herin

    Esquema Esquema
  • ·POS-02.28: Preoperative radiotherapy (rt) + cystectomy(c) vs cystectomy alone in pt3- t4 bladder cancer: long term results

    Página :240-241

    M. Brausi, M. Gavioli, G. Verrini, G. Simonini De Luca, M. Viola, G. Peracchia, G.L. Giliberto

    Esquema Esquema
  • ·POS-02.29: Gemcitabine plus cisplatin therapy, a safety regimen in advanced bladder tumor

    Página :241

    H. Lee, H. Chung, J. Song

    Esquema Esquema
  • ·POS-02.30: Review of latent prostatic adenocarcinoma in patients who underwent radical cystoprostatectomy for TCC of bladder

    Página :241

    A. Daneshdezfuli, S.Y. Hosseini, A. Nahabidian

    Esquema Esquema
  • ·POS-02.31: Squamous cell carcinoma of the bladder unrelated to schistosomiasis: A series of 51 cases

    Página :241-242

    W. Chaaben, A. Sahnoun, M. Bouacida, T. Bahcine, H. Fakhfekh, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POS-02.32: Long term follow up of ileal neo bladder hautmann following radical cystectomy

    Página :242

    H. Elganzoury

    Esquema Esquema
  • ·POS-02.33: Primary lymphoepithelioma-like carcinoma of the urinary bladder (LELCB): report of a case and review of the literature

    Página :242

    N. Ferakis, K. Bouropoulos, T. Granitsas, C. Perivoliotis, D. Giannopoulos, A. Bamias, I. Poulias

    Esquema Esquema
  • ·POS-02.34: Clinical trial of metastatic bladder carcinoma treated by S-1/CDDP combination chemotherapy

    Página :242-243

    R. Ando, S. Okada, Y. Kojima, Y. Hashimoto, K. Tozawa, K. Hohri

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :243

    
  • ·POS-02.36: Clinical experience with a novel transurethral resection protocol: TUR in saline (TURis)

    Página :243

    H. Hibi, T. Ohori, K. Naruse, Y. Yamada, N. Honda

    Esquema Esquema
  • ·POS-02.37: Value of three-dimensional echography in superficial bladder tumors diagnosis

    Página :243

    V. Cauni, D. Georgescu, P. Geavlete

    Esquema Esquema
  • ·POS-02.38: Impact of dose, follow-up period, age, and pretreatment episodes on bacillus calmette-guerin for eradication of superficial bladder cancers

    Página :243

    T. Okamura, M. Imura, T. Kaneko, Y. Yada, K. Mizuno, K. Tozawa, K. Kohri

    Esquema Esquema
  • ·POS-02.39: Chromocystoscopic assisted trans-urethral resection of superficial bladder tumors

    Página :243-244

    A.A. Mehena, M. Wishahi, H. Abdel Magid

    Esquema Esquema
  • ·POS-02.40: Local anesthesia (LA) with N-Do injector (PHYSION) for TUR of small bladder tumors (BT) and bladder mapping (BM): preliminary results and cost-effectiveness analysis

    Página :244

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Esquema Esquema
  • ·POS-02.41: Urinary tract infections are uncommon after instalation of intravesical mitomycin C

    Página :244

    S. Wozniak, N. Kuppurajan, C. Kouriefs, D. Ilo, N. Sarangi

    Esquema Esquema
  • ·POS-02.42: Superficial bladder tumors and metachronous upper urinary tract tumors

    Página :244-245

    P. Geavlete, D. Georgescu, S. Bancu, B. Geavlete

    Esquema Esquema
  • ·POS-02.43: Laser treatment of superficial bladder tumors

    Página :245

    P. Geavlete, G.H. Nita, S. Bancu, D. Soroiu, B. Geavlete

    Esquema Esquema
  • ·POS-02.44: Further evidence for a significance of the nitric oxide (NO) cyclic gmp signalling in the control of the human prostate

    Página :245

    S. Ückert, K. Richter, G. Bartsch, U. Jonas, G. Wolf

    Esquema Esquema
  • ·POS-02.45: Bag-1 and bax expression in benign prostatic hyperplasia and prostate cancer

    Página :245-246

    G. Mitropoulou, A. Georgalis, K. Tsakanika, A. Rempelakos, N. Apostolikas, A. Thanos, E. Panotopoulou

    Esquema Esquema
  • ·POS-02.46: Downregulation of nitric oxide synthase expression in lower urinary tracts from spontaneously diabetic goto-kakizaki rats: correlation with superoxide dismutase

    Página :246

    S.M. Yoon, T. Lee, Y.H. Kwon, C.S. Park, L.H. Jin, H.Y. Choi

    Esquema Esquema  
  • ·POS-02.47: Effect of 5 alpha reductase inhibitor in expression of cyclooxygenase-2 in benign prostatic hyperplasia

    Página :246

    H. Lee, H. Chung, J. Song

    Esquema Esquema
  • ·POS-02.48: Expression of nitric oxide synthase (NOS) in the rat bladder subjected to partial bladder outlet obstruction

    Página :246-247

    H. Lee, H. Chung, J. Song

    Esquema Esquema
  • ·POS-02.49: Immunohistochemical estimation of hypoxia in obstructed human bladders and correlations with clinical parameters

    Página :247

    G. Koritsiadis, K. Stravodimos, C. Constantinides, I. IAnastasiou, A. Lazaris, A. Lekas, S. Koritsiadis, A. Zervas

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :247

    
  • ·Abstract Withdrawn

    Página :247

    
  • ·POS-02.52: Epidemiological study of patients having undergone surgery for benign prostatic hyperplasia

    Página :247

    S. Falahatkar, S. Tavasoli Yousefabad, G. Mokhtari

    Esquema Esquema
  • ·POS-02.53: Voiding dysfunction of men with metabolic syndrome

    Página :247-248

    B.S. Shim, H. Lee, Y.Y. Park, Y.S. Hong

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :248

    
  • ·POS-02.55: BPH: a nosologic perspective, from F. Legueu (Paris 1921) to A. Randall (N.Y.1937)

    Página :248

    R. Vela Navarrete, R.O. Fourcade

    Esquema Esquema
  • ·POS-02.56: The risk factors of progression in patients with BPH in real practice

    Página :248

    S.C. Park, S.H. You, S.J. Oh, I.Y. Seo, H.J. Jeong, J.S. Rim

    Esquema Esquema
  • ·POS-02.57: Follow up survey of a prostate assessment clinic cohort

    Página :248

    K. Riddle, M. Hehir, J. Graham, V. Crispin, M.A. Paterson

    Esquema Esquema
  • ·POS-02.58: Etiology and management of urinary retention in men admitted to a tertiary level teaching hospital in South Africa

    Página :248-249

    S. Van Vuuren, S. Van Deventer, C. Heyns

    Esquema Esquema
  • ·POS-02.59: IPSS as a prognostic predictor of BPH development and treatment in men of different age

    Página :249

    D. Mladenov, I. Donkov, M. Tzvetkov

    Esquema Esquema
  • ·POS-02.60: Independent predictors of bladder outlet obstruction associated with benign prostatic hyperplasia

    Página :249

    D. Volanis, I. Karyotis, I. Boulalas, E. Serafetinidis, D. Delakas

    Esquema Esquema
  • ·POS-02.61: Vascular risk factors and post void residual: a new tool for an old problem?

    Página :249-250

    K. Stravodimos, G. Koritsiadis, B. Loymos, A. Lekas, C. Alamanis, D. Mitropoylos, C. Constantinides, I. Anastasioy

    Esquema Esquema
  • ·POS-02.62: Impact of different bladder volumes on uroflowmetry parameters in benign prostatic hyperplasia

    Página :250

    I. Sen, M. Onaran, C. Guneri, A. Camtosun, M. Celik, M. Tan, I. Bozkirli

    Esquema Esquema
  • ·POS-02.63: Correlation between subjective symptoms and bladder outlet obstruction parameters in men with lower urinary tract symptoms

    Página :250

    J.Y. Chung, H.M. Kim, L.H. Sung, W.J. Yang

    Esquema Esquema
  • ·POS-02.64: Suprapubic transvesical prostatectomy (Freyers) without suprapubic and urethral catheter only 4 days postoperatively

    Página :250-251

    B. El-Wkhi, N. Mandour

    Esquema Esquema
  • ·POS-02.65: Acute urinary retention due to primary retrovesical hydatid cyst

    Página :251

    G. Glück, N. Pietrareanu, N. Toma, I. Sinescu

    Esquema Esquema
  • ·POS-02.66: Secondary significant bleeding in the first month following TURP

    Página :251

    G. Normand, O. Celhay, R. Briffaux, C. Pirès, B. Doré, J. Irani

    Esquema Esquema
  • ·POS-02.67: The efficacy of transurethral resection of the prostate in patients with large prostate (over 80 g)

    Página :251

    Y.S. Lho, S.H. Paick, M. Baek, W.H. Park, H.G. Kim

    Esquema Esquema
  • ·POS-02.68: Our experience with 150 patients, treated by photoselective vaporization of the prostate (PVP) in the Czech Republic

    Página :252

    J. Klecka, M. Hora, P. Behounek, M. Hajzman

    Esquema Esquema
  • ·POS-02.69: Our experience with HoLEP-improvement in BPH treatment

    Página :252

    W. Lipczynski, S. Bak, B. Dobrowolska, J. Kusionowicz, Z. Dobrowolski, L. Michalski

    Esquema Esquema
  • ·POS-02.70: Bipolar electroresection - latest technological achievement in BPH TURP

    Página :252-253

    W. Lipczynski, S. Bak, B. Dobrowolska, J. Kusionowicz, Z. Dobrowolski, L. Michalski

    Esquema Esquema
  • ·POS-02.71: Comparative randomized study on the efficaciousness of treatment of BOO due to BPH in patients having till 100 gr prostate using endoscopic gyrus prostate resection versus opsu. Preliminary data

    Página :253

    R. Giulianelli, S. Brunori, G. Vincenti, F. Pisanti, L. Mavilla, L. Albanesi, B.C. Gentile, T. Shestani

    Esquema Esquema
  • ·POS-02.72: Clinical evaluation on sexual function of BPH patients after photoselective vaporization of the prostate

    Página :253

    Y.X. Shan, T. Wei, D.R. Yang

    Esquema Esquema
  • ·POS-02.73: Combination of alfuzosin and tamsulosin in BPH patients with acute urinary retention

    Página :254

    D. Pushkar, A. Zaitsev, P. Rasner, J.W. Kosko

    Esquema Esquema
  • ·POS-02.74: Detrusor overactivity after prostate resection: preventing postoperative incontinence with darifenacin

    Página :254

    S. Laschke, S. Carl

    Esquema Esquema
  • ·POS-02.75: A randomized clinical trial of an ethanol extract of Ganoderma lucidum (edible and medicinal mushroom) in men with lower urinary tract symptoms

    Página :254

    M. Noguchi, T. Kakuma, K. Tomiyasu, K. Itoh, F. Konishi, S. Kumamoto, K. Shimizu, R. Kondo, K. Matsuoka

    Esquema Esquema
  • ·POS-02.76: The effect of a₁-blocker in hypoxia in human obstructed detrusor

    Página :254-255

    K. Stravodimos, G. Koritsiadis, D. Mitropoylos, G. Koytalellis, I. Adamakis, A. Lazaris, A. Zervas

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :255

    
  • ·POS-02.78: Intra operative tranrectal ultrasonography guide during TURP: Description of the technique

    Página :255

    N. Kamat

    Esquema Esquema
  • ·POS-02.79: Simple intratesticular cyst – is there a need for follow up?

    Página :255

    S.K. Misra, P. Thompson, C. Coker

    Esquema Esquema
  • ·POS-02.80: Diuresis renography for differentiation of upper urinary tract dilatation from obstruction: F+20 and F-15 methods

    Página :255-256

    R. Taghavi Razavizadeh, K. Ariana, R. Mahdavi Zafarghandi, M.R. Darabi Mahboub

    Esquema Esquema
  • ·POS-02.81: CT urography using the 64 multidetector CT scanner: correlation with cystoscopic and cytology findings

    Página :256

    T. Vriska, A. Nehra, B. King, T. Aadland, D. Nienow

    Esquema Esquema
  • ·POS-02.82: Laminin-5 immunochemistry identifies bellini ducts and bellini duct carcinoma

    Página :256

    X. Krah, B. Henkel, E. Hauschild, G. Eschholz, H. Kosmehl

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :256

    
  • ·POS-02.84: Vasculogenic mimicry in renal cell carcinoma

    Página :256

    R. Barod, M.G.B. Tran, T.S. O’Brien, P.H. Maxwell

    Esquema Esquema
  • ·POS-02.85: Overexpression of metastin receptor in renal cell carcinoma: metastin and its receptor are probable targets for the suppression of renal cell carcinoma metastasis

    Página :257

    S. Shoji, T. Uchida, Y. Nagata, M. Shima, Y. Usui, T. Terachi, S. Umemura, X. Tang, N. Egashira, R.Y. Osamura

    Esquema Esquema
  • ·POS-02.86: Expression of voltage-gated potassium ion channels in human renal cell cancer

    Página :257

    P. Wadhwa, S. Wadhwa, S. Chaudhury, A.K. Dinda, T.C. Nag, N.P. Gupta

    Esquema Esquema
  • ·POS-02.87: Is the correct diagnosis being assigned to adult chromophobe renal cell carcinoma: An immunocytochemical verification?

    Página :257

    H.U. Ahmed, A. Tsiouris, M. Arya, A.V. Kaisary, R.J. Morgan, M.P.A. Young

    Esquema Esquema
  • ·POS-02.88: Gamma-delta T lymphocytes are of no prognostic value in clear cell renal cell carcinoma

    Página :257-258

    B.A. Inman, X. Frigola, K. Harris, S. Kuntz, C. Lohse, J. Cheville, B. Leibovich, E.D. Kwon

    Esquema Esquema
  • ·POS-02.89: Experimental study for percutaneous electro-vaporization of renal cell carcinoma using a new shape memory alloy probe

    Página :258

    A. Kawauchi, Y. Naitoh, J. Soh, K. Okihara, O. Ukimura, Y. Mizutani, T. Miki

    Esquema Esquema
  • ·POS-02.90: Preoperative prediction by imaging and prognostic significance of ostium renal vein invasion in renal cell carcinoma with inferior vena cava tumor thrombus

    Página :258

    L. Zini, L. Garnier-Destrieux, X. Leroy, J. Fantoni, L. Lemaitre, J. Biserte, A. Villers

    Esquema Esquema
  • ·POS-02.91: Role of upper tract imaging in patients with atypical urine cytology

    Página :258-259

    S.K. Misra, P.A. Berresford, C. Coker

    Esquema Esquema
  • ·POS-02.92: Can the ASA-American Society of Anesthesiology physical status classification predict the oncological outcomes in renal cell carcinoma?

    Página :259

    S.C. Zequi, G.C. Guimaraes, F.P. Fonseca, I. Werneck da Cunha, F.A. Soares, E.C. Ribeiro-Campos, W. Bachega, A. Lopes

    Esquema Esquema
  • ·POS-02.93: Partial nephrectomy for renal tumors

    Página :259

    M. Yazdani, D. Moshtaghi

    Esquema Esquema
  • ·POS-02.94: A new flexible video cystoscope with bullet-tip: is this more comfortable than the conventional type in females?

    Página :259-260

    S. Kitsukawa, T. Aoyagi, T. Samejima, T. Matsumoto, K. Noda

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :260

    
  • ·POS-02.96: New convenient device for circumcision

    Página :260

    D. Ihm, S. Lee, J. Song

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :260

    
  • ·POS-02.98: The effect of ophthalmic thermal cautery application to prevent neonatal circumcision bleeding complication with utilization of plastible ring

    Página :260

    M. Rezaeinasab, M. Jamali, S.T. Tabatabaei, A. Mosavat

    Esquema Esquema
  • ·POS-02.99: Early effect of non-surgical treatment using betamethasone valerate ointment for phimosis in Japanese childhood

    Página :260

    S. Kitsukawa, T. Aoyagi, K. Noda, S. Hosoda, N. Otsuru, Y. Yamamoto, T. Ito, T. Matsumoto

    Esquema Esquema
  • ·POS-02.100: A study of patients with cured nocturnal enuresis

    Página :260-261

    M. Tsugaya, T. Ito, S. Endo, T. Hamakawa, S. Okada, Y. Ito

    Esquema Esquema
  • ·POS-02.101: Is VCUG necessary for all patients that undergo pyeloplasty?

    Página :261

    S.A. Asgari, S. Falahatkar, G. Mokhtari, F. Pourreza

    Esquema Esquema
  • ·POS-02.102: Impalpable testis: Laparoscopy or inguinal canal exploration?

    Página :261

    F. Sharifiaghdas, F. MA Beigi

    Esquema Esquema
  • ·POS-02.103: Use of oxidized cellulose surgicel for corporal body grafting for sutureless correction of severe penile chordee: An experimental study in rabbits

    Página :261

    A. El-Assmy, W. Eassa, M. Abdl Hamid, E. Nour, A. Hafez

    Esquema Esquema
  • ·POS-02.104: Sleep stage and functional bladder capacity in children with refractory nocturnal enuresis

    Página :261-262

    T. Hirayama, S. Soh, M. Iwamura, T. Endo, T. Iwasaki, S. Baba

    Esquema Esquema
  • ·POS-02.105: Neonatal hypospadias

    Página :262

    G.Q. Liu, H.J. Tang, J.F. Wang, H. Li, D.J. Zhu, W. Zhen, Y.W. Zhao

    Esquema Esquema
  • ·POS-02.106: Yoke technique for severe proximal hypospadias

    Página :262

    T. Yamaguchi, Y. Koikawa, T. Konomoto, Y. Akita

    Esquema Esquema
  • ·POS-02.107: Open pyeloplasty with a minimally invasive incision in children: comparison of skin incision size

    Página :262

    A. Nakane, Y. Hayashi, K. Mizuno, K. Kojima, T. Maruyama, K. Kohri

    Esquema Esquema
  • ·POS-02.108: Dismembered pyeloplasty in infants: A review of 5 years single center experience

    Página :262-263

    F. Kazemi Rashed, S. Aslanabadi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :263

    
  • ·POS-02.110: Surgical management of late complications in a boy with prune-belly syndrome

    Página :263

    A. Lekas, A. Balangas, R. Homberg, S. Schattka, A. Kollias

    Esquema Esquema
  • ·POS-02.111: Indications for nephrectomy in children: A changing profile

    Página :263

    H. Jallouli, A. Sahnoun, I. Ben Abdallah, M. Gassara, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POS-02.112: Paediatric bladder stones, a disappearing disease

    Página :263

    M. Mhiri, H. Ketata, M. Gassara, I. Benabdallah, M. HadjSlimen, A. Bahloul

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :263

    
  • ·POS-02.114: Tubularized incised plate as first choice of therapy for hypospadias

    Página :264

    M. Mustafa, H. Abol-Enein

    Esquema Esquema
  • ·POS-02.115: Avagard^™ in pediatric urological surgery: safe, effective and time efficient

    Página :264

    J.S. Palmer

    Esquema Esquema
  • ·POS-02.116: A simple and reliable formula for determining the proper JJ stent length in the pediatric patient: Age + 10

    Página :264

    J.S. Palmer, L.S. Palmer

    Esquema Esquema
  • ·POS-02.117: Clinical evaluation of 47 boys with nonpalpable testis

    Página :264-265

    T. Kamimura, M. Nagano, H. Waketa, H. Tsukino, C. Onizuka, M. Yamauchi, S. Sugie, Y. Hasui, Y. Osada

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :265

    
  • ·POS-02.119: Intravesical oxybutynin for children with poorly compliant neurogenic bladders: a Systematic Review

    Página :265

    L.A. Guerra, D. Moher, N. Barrowman, M. Sampson, J. Pike, M. Leonard

    Esquema Esquema
  • ·POS-02.120: Status quo of repeated botulinum-toxin injections in spina bifida children with detrusor hyperreflexia: long term follow up

    Página :265

    S. Laschke, S. Carl

    Esquema Esquema
  • ·POS-02.121: Results of continent vesicostomy as a newer alternative to appendicovesicostomy for Mitrofanoff procedure

    Página :265-266

    D. Irani

    Esquema Esquema
  • ·POS-02.122: Development of a multi-specialty robotic surgery program

    Página :266

    K.J. Palmer, V. Patel, K. Shah, R. Thaly

    Esquema Esquema
  • ·POS-02.123: Assessment of pain in patients undergoing office-based urological procedures as a function of staff surgeon versus resident

    Página :266

    J.S. Jones, C. Nguyen

    Esquema Esquema
  • ·POS-02.124: Successful microsurgical reimplantation of traumatic amputated testicle

    Página :266-267

    M. Salehi, S. Falahatkar, A. Noshad, S. Nikpour, M. Fouladimehr

    Esquema Esquema
  • ·POS-02.125: Office dilation of the female urethra: still a commonly performed procedure

    Página :267

    R. Santucci, Urologic Diseases in American Project

    Esquema Esquema
  • ·POS-02.126: Iatrogenic ureteric injury

    Página :267

    G. Glück, I. Sinescu

    Esquema Esquema
  • ·POS-02.127: Genitourinary trauma: The military hospital experience

    Página :267

    S.D. Mante

    Esquema Esquema
  • ·POS-02.128: Stenson’s duct stenosis - a rare complication of buccal mucosal harvest

    Página :267-268

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·POS-02.129: Penile fracture co-existing or not with urethral injury

    Página :268

    A. Lekas, I. Fokitis, K. Filis, G. Doumanis, V. Politis, V. Charalampidis, S. Koritsiadis

    Esquema Esquema
  • ·POS-02.130: Renal injuries: from surgical intervention to conservative management

    Página :268-269

    A. Lekas, I. Fokitis, G. Lefakis, V. Politis, A. Balangas, D. Xenis, K. Filis, A. Kollias, S. Koritsiadis

    Esquema Esquema
  • ·POS-02.131: Efficacy of retrograde balloon dilation for the treatment of benign ureteral strictures

    Página :269

    H.S. Ahn, S.J. Kim, S.H. Lee, S. Kim, Y.S. Kim

    Esquema Esquema
  • ·POS-02.132: Dorsal onlay buccal mucosal urethroplasty for post TURP urethral strictures

    Página :269

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·POS-02.133: Robotic-assisted laparoscopic ureteral reimplantation with psoas hitch: A multi-institutional multinational evaluation of 13 cases

    Página :269-270

    K.J. Palmer, V. Patel, K. Shah, M. Chammas, A. Mottrie, B. Sundaram

    Esquema Esquema
  • ·POS-02.134: Ureteral substitution by an isolated ileal segment via novel antireflux technique

    Página :270

    A. Hinev, S. Paunov, R. Raikov, P. Chankov, D. Anakievski, S. Dyakov, B. Balev

    Esquema Esquema
  • ·POS-02.135: Penile fractures: immediate surgical approach with a midline dorsal incision

    Página :270

    K. Livadas, E. Mazaris, D. Chalikopoulos, A. Skolarikos, A. Bisas, I. Kastriotis

    Esquema Esquema
  • ·POS-02.136: Dorsal onlay small intestinal submucosa urethroplasty : our experience

    Página :270

    S.B. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema
  • ·POS-02.137: The role of cotton padding and elastic bandage in imobilizing the extremity after closure of bladder exstrophy

    Página :270-271

    S. Watya, S. Kaggwa, I. Kajja, S. Muwazi

    Esquema Esquema
  • ·POS-02.138: Surgical treatment of penoscrotal lymph edema

    Página :271

    A. Bolukbasi, F. Þengül, M. Ayhan, E. Aksungur, M. Görgü

    Esquema Esquema  
  • ·POS-02.139: Penile fracture. Differential diagnosis, Management and outcome

    Página :271

    J. Cabral Ribeiro, V. Hugo Nogueira, A. Carvalho, A. Ribeiro Santos

    Esquema Esquema
  • ·POS-02.140: Spontaneous rupture of the urinary bladder as a cause of death

    Página :271-272

    K. Albrecht, M. Tsokos, F. Schulz, S. Ückert, D. Breitmeier, U. Jonas

    Esquema Esquema
  • ·POS-02.141: The use of isolated cecal bowl segment in the complicated vaginal reconstruction

    Página :272

    D. Irani

    Esquema Esquema
  • ·POS-02.142: Results of buccal mucosal graft onlay patch urethroplasty in the repair of adult bulbar urethral stricture

    Página :272

    D. Irani, M.M. Hosseini

    Esquema Esquema
  • ·POS-02.143: Dorsal buccal mucosal onlay grafts in complex pendulous urethral reconstruction: extended indications and intermediate results

    Página :272-273

    D. Rosenstein

    Esquema Esquema
  • ·POS-02.144: Is ultrasound renal tract appropriate in screening for upper tract TCC?

    Página :273

    R. Gujadhur, P. Shah, R. Marsh, P. Menezes

    Esquema Esquema
  • ·POS-02.145: Adjuvant and neoadjuvant chemotherapy for urothelial cancer of the upper urinary tract with lymph node metastasis

    Página :273

    T. Isoyama, T. Watanabe, S. Morizane, K. Hikita, I. Miyagawa

    Esquema Esquema
  • ·POS-02.146: Transitional cell carcinoma of bladder in young adults

    Página :273

    M.H. Jalbani

    Esquema Esquema
  • ·POS-03.01: Retroperitoneal laparoscopic marsupialization of symptomatic renal cyst: comparison with transperitoneal approach

    Página :273-274

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Esquema Esquema
  • ·POS-03.02: Transmesocolic pyeloplasty: experience of a single center

    Página :274

    O. Castillo, G. Vitagliano, M. Díaz, R. Sánchez-Salas, A. Foneron

    Esquema Esquema
  • ·POS-03.03: Risk factors for recurrence after radiofrequency ablation of renal tumors

    Página :274

    N. Ferakis, K. Bouropoulos, T. Granitsas, A. Pilitsis, S. Mylona, I. Poulias

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :274

    
  • ·POS-03.04: Robotic pyeloplasty using a 4 arm technique

    Página :274-275

    R. Kooner, D. Golovsky, R. Thanigasalam, K. Rasiah

    Esquema Esquema
  • ·POS-03.05: Bleeding incidence following transrectal ultrasound-guided prostate biopsy in patients taking low dose aspirin

    Página :275

    D. Volanis, I. Karyotis, I. Boulalas, C. Konstadinidis, D. Delakas

    Esquema Esquema
  • ·POS-03.06: Retroperitoneal laparoscopic nephrouretectomy for urothelial carcinoma of the renal pelvis and ureter

    Página :275

    M. Nagano, T. Kamimura, H. Tsukino, H. Wakeda, K. Inoue, T. Kobayashi, Y. Yamashita, R. Hamasuna, Y. Hasui, Y. Osada

    Esquema Esquema
  • ·POS-03.07: Clinical experience of laparoscopic management for retroperitoneal masses

    Página :275-276

    T. Seki, S. Ishikawa, H. Higashiyama, M. Miura, M. Togashi, H. Harada, T. Hirano

    Esquema Esquema
  • ·POS-03.08: Transperitoneal laparoscopic nephrectomy for giant hydronephrosis

    Página :276

    S. Moudouni, Z. Dahami, A. El Haous, I. Sarf

    Esquema Esquema
  • ·POS-03.09: Assessment of incidence and interventional treatment in patients with post renal transplant lymphocele in Ghaem Hospital: from the first days of renal transplantation in Ghaem Hospital to 2006

    Página :276

    A. Yarmohamadi

    Esquema Esquema
  • ·POS-03.10: Evaluation of a new radiofrequency-based resection device (Habib^™ 4X) for ischemia-free partial nephrectomy in a porcine kidney model

    Página :276

    D.S. Engeler, T. Leippold, C. Hobi, A. Zerz, H. Marlovits, M. Hell, P.A. Diener, H.P. Schmid

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :276

    
  • ·Abstract Withdrawn

    Página :276

    
  • ·POS-03.12: Simple ureteroscopy and ureteroscopic procedures in kidney transplanted and other patients underwent ureteral reimplantation

    Página :276-277

    F. Dadkhah, M. Aliaskary, S. Tara, N. Shakhsesalim

    Esquema Esquema
  • ·POS-03.13: Parathyroid hormone and valvular disorders in end stage renal disease patients

    Página :277

    F. Ataei, K. Pishehvar Esfahani, H. Shamsolkottabi, M. Shirazinejad, S. Yavari

    Esquema Esquema
  • ·POS-03.14: Effect of simple renal cysts on renal function with ^99mtc-dtpa scyntigraphy

    Página :277

    M. Kilinc, S. Guven, N. Cevat, M. Arslan, M.M. Piskin, M. Kaynar

    Esquema Esquema
  • ·POS-03.15: Preservation versus non-preservation of the gonadal vein while dissecting the ureter in donor nephrectomies

    Página :277-278

    M. Aliasgari, N. Shakhssalim, F. Dadkhah, A. Ghadian, S.M. Hosseini Moghadam

    Esquema Esquema
  • ·POS-03.16: Preservation versus non-preservation of the gonadal vein while dissecting the ureter in donor nephrectomies

    Página :278

    M. Aliasgari, N. Shakhssalim, F. Dadkhah, A. Ghadian, S.M.M. Hosseini Moghadam, Z. Razzaghi

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :278

    
  • ·Abstract Withdrawn

    Página :278

    
  • ·POS-03.19: Age does matter in relation to survival in renal cell carcinoma

    Página :278

    D. Mehraban, M. Moosavi, A. Razi, G.H. Naderi

    Esquema Esquema
  • ·POS-03.20: Evaluation of the renal changes in patients with unilateral renal stone using ^99mtc-MAG₃

    Página :279

    M. Kilinc, S. Guven, N. Cevat, M. Arslan, M.M. Piskin, M. Kaynar

    Esquema Esquema
  • ·POS-03.21: Ca19-9 tumor marker in benign hydronephrosis and the correlation with lewis status blood group

    Página :279

    K. Stravodimos, G. Koritsiadis, A. Michalakis, V. Migdalis, N. Panagis, B. Loumos, A. Tsoukala, A. Karafoylidoy, A. Zervas

    Esquema Esquema
  • ·POS-03.22: The frequency of perirenal fat invasion according to size and protrusion shape of renal cell carcinomas

    Página :279-280

    H.N. Lee, H.S. Moon, Y.T. Kim, H.Y. Choi, H.Y. Park, Y.N. Woo, T.Y. Lee

    Esquema Esquema
  • ·POS-03.23: Buccal mucosal flap substitution urethroplasty for the long post-traumatic posterior urethral stricture

    Página :280

    D. Sharma, L. Goetz, M. Rampaul, G. Bajrangee, P. Ayoungchee, K. Ramsoobhag

    Esquema Esquema
  • ·POS-03.24: Results of the organ conserving therapy in the case of urothelial carcinoma of the upper urinary tract – a retrospective consideration of 4 cases

    Página :280

    X. Krah, E. Hauschild, G. Atanassov, C. Güttner, G. Eschholz, H.M. Weber

    Esquema Esquema
  • ·POS-03.25: Mini-incision muscle-sparing lumbotomy

    Página :280

    A. Hinev, S. Paunov, D. Anakievski, P. Chankov, R. Raikov, S. Dyakov

    Esquema Esquema
  • ·POS-03.26: Cautery wire balloon incision (Acucise) as treatment option for ureteral strictures lower than the UPJ

    Página :280-281

    V.F. de Kemp, A. Beganović, M.T.W.T. Lock

    Esquema Esquema
  • ·POS-03.27: Spontaneous rupture of renal tumors

    Página :281

    M. Grasso, S. Blanco, A. Vianchi, C. Di Bella, A. Grasso, A. Pappini

    Esquema Esquema
  • ·POS-03.28: Partial laparoscopic adrenalectomy in Conn’s syndrome

    Página :281

    O. Castillo, M. Díaz, R. Sánchez-Salas, G. Vitagliano, A. Foneron

    Esquema Esquema
  • ·POS-03.29: Treatment of the hydatid cyst of the kidney: a retrospective study about a series of 43 cases

    Página :281-282

    M. Bouacida, H. Ketata, I. Benabdallah, H. Jallouli, S. Kchaou, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POS-03.30: Is pre-op stenting routinely required prior to retrograde intrarenal surgery (RIRS)?

    Página :282

    S. Bapat, A. Padhye, P. Yadav, A. Bhave, P. Mahajan, S. Purnapatre, K. Pai

    Esquema Esquema
  • ·POS-03.31: Needleoscopic percutaneous high ligation of inguinal hernia in children

    Página :282

    W.Y. Wong, Y.C. Tsai

    Esquema Esquema
  • ·POS-03.32: Laparoscopic partial cystectomy for adenocarcinoma of bladder

    Página :282-283

    J.H. Kim, J.O. Kwon, D.S. Ryu, T.H. Oh

    Esquema Esquema
  • ·POS-03.33: Transperitoneal versus retroperitoneal laparoscopic radical nephrectomy: patient selection and perioperative outcomes: a single-center experience

    Página :283

    R. Taue, H. Izaki, M. Gad El-Moul, T. Kishimoto, T. Fukumori, M. Takahashi, S. Kagawa, H. Kanayama

    Esquema Esquema
  • ·POS-03.34: Comfort and tolerability of SCD response compression system in patients undergoing radical retropubic prostatectomy

    Página :283

    L. Cindolo, E. de Fortuna, V. Tripodi, A. Quaranta, F. Attanasi, F. Del Vecchio, L. Schips, L. Salzano

    Esquema Esquema
  • ·POS-03.35: Transurethral resection of the ureteral orifice with antegrade stripping of the ureter (pluck-off technique) during hand-assisted laparoscopic nephroureterectomy: a safe procedure

    Página :283-284

    J. Tornero, P. López, P. Lopez-Cubillana, A. Prieto, A. Lopez, A. Maluff, F. Escudero, M. Pérez

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :284

    
  • ·POS-03.37: Laparoscopic treatment for renal hydatid cyst using a retroperitoneal approach (an initial experience)

    Página :284

    R. Rabii, S. Elmhef, B. Querfani, F. Meziane

    Esquema Esquema
  • ·POS-03.38: Resection of renal hydatid cyst using a retroperitoneal approach

    Página :284

    R. Rabii, B. Querfani, S. Elmhef, F. Meziane

    Esquema Esquema
  • ·POS-03.39: Balloon dilation in stenotic pathology of the caliceal system

    Página :284

    P. Geavlete, V. Mirciulescu, R. Multescu, B. Geavlete

    Esquema Esquema
  • ·POS-03.40: Comparative study of the premeatal based flap and the tubularized incised plate urethroplasty in repairing distal penile hypospadias

    Página :284-285

    R. Mahdavi, K. Shafipoor, M. Mahdavi, M. Zolfaghari

    Esquema Esquema
  • ·POS-03.41: Penile fracture: a retrospective study of 102 cases

    Página :285

    A. Hidoussi, M. Jaidane, A. Slama, A. Youssef, N. Ben Sorba, A.F. Mosbah

    Esquema Esquema
  • ·POS-03.42: Assessment of outcomes of a new closed surgical technique for hydrocele operation and comparison with standard excisional techniques in patients referred to the educational hospitals of Mashhad University

    Página :285

    M.R. Darabi, A. Ahanian, M. Zolfaghari, L. Darabi

    Esquema Esquema
  • ·POS-03.43: Penile amputation and replantation: aetiology, diagnosis, management and outcome

    Página :285-286

    D.D. Odan, N.H. Ajuyah, A.O. Akingbala

    Esquema Esquema
  • ·POS-03.44: Urethroplasty with combined free tissue grafts

    Página :286

    C. Slavov, G. Venkov, E. Popov, M. Tzvetkov

    Esquema Esquema
  • ·POS-03.45: Primary mucinous tumor of the testis

    Página :286

    P. Kartsaklis, A. Gekas, C. Konstantinidis, I. Palaiodimos, S. Andreadakis, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis

    Esquema Esquema
  • ·POS-03.46: A familial case of Peyronie’s disease

    Página :286

    A. Gekas, P. Kartsaklis, C. Konstantinidis, S. Andreadakis, I. Palaiodimos, N. Kalogeropoulos, D. Baltogiannis, N. Sofikitis

    Esquema Esquema
  • ·POS-03.47: Foley balloon assisted scrotal pouch orchiopexy

    Página :286-287

    D. Dalela, R.J. Sinha, S. Sankhwar, V. Singh

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :287

    
  • ·POS-03.49: Urethral injury associated with penile fracture: report of five cases

    Página :287

    H. Ketata, A. Bouhlel, M. Gassara, A. Sahnoun, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POS-03.50: Urethral erosion after long-term urethral catheterization

    Página :287

    C. Konstantinidis, K. Kalokerinou, A. Siatelis, P. Kartsaklis, A. Nikolia, I. Karyotis, A. Gekas, D. Delakas

    Esquema Esquema
  • ·POS-03.51: The profile of testicular germ cell tumours in the south of Tunisia

    Página :287-288

    M. Bouacida, A. Bahloul, M.N. Mhiri, A. Sahnoun, W. Chaabene, M. Gassara

    Esquema Esquema
  • ·POS-03.52: Organ-sparing surgery for invasive penile cancer with using buccal mucosal graft for resurfacing after excision of tumors on the glans penis: early follow-up data

    Página :288

    G. Venkov

    Esquema Esquema
  • ·POS-03.53: Complications and survival in patients with retroperitoneal lymph node dissection (RPLND) after chemotherapy for testicular cancer in a medium volume referral centre

    Página :288

    A. Boeken Kruger, R. Richardson, T. Lock, G. Groenewegen, R. Bosch

    Esquema Esquema
  • ·POS-03.54: Penile fracture: no difference in treatment in two European centres

    Página :288-289

    S. Wozniak, R. Zdrojowy, P. Debinski, N. Kuppurajan, A. Kolodziej, P. Kowal, D. Ilo

    Esquema Esquema
  • ·POS-03.55: Adult para-testicular tumours: report of two cases

    Página :289

    M.A. Omar, A. Rao, H. Motiwala, O. Karim

    Esquema Esquema
  • ·POS-03.56: Quality of life in patients with prostate carcinoma treated with LH-RH agonists

    Página :289

    K. Jagodic, I. Bizjak, M. Erklavec, S. Poteko, H. Korosec-jagodic

    Esquema Esquema
  • ·POS-03.57: Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate caner

    Página :290

    Y. Fujii, J. Yonese, S. Kawakami, S. Yamamoto, Y. Okubo, D. Suyama, Y. Komai, T. Kijima, I. Fukui

    Esquema Esquema  
  • ·POS-03.58: Prevalence and distress due to hot flushes in patients receiving endocrine therapy for prostate cancer and therapeutic efficacy of Japanese herbal medicine

    Página :290

    M. Kajiwara, M. Oki, K. Mutaguchi, H. Moriyama

    Esquema Esquema
  • ·POS-03.59: Prospective randomized trial comparing transverse (pfannenstiel) and vertical incisions for patients undergoing radical retropubic prostatectomy

    Página :290-291

    M. Manoharan, T. Luongo, S. Vyas, R. Ayyathurai, M.S. Soloway

    Esquema Esquema
  • ·POS-03.60: A comparative head on efficacy study of 3 monthly goserelin 10.8 mg, 3 monthly leuprolide 11.25 mg with 3 montly leuprolide 22.5 mg preparations for treatment in patients with prostate cancer

    Página :291

    R. Sood, S. Kathuria

    Esquema Esquema
  • ·POS-03.61: Impact of hot flashes on quality of life during treatment with maximum androgen blockade for prostate cancer

    Página :291-292

    H. Sakai, T. Igawa, H. Kanetake, M. Hayashi, S. Iwasaki, Y. Kusaba, H. Hakariya, T. Hara

    Esquema Esquema
  • ·POS-03.62: Characterization of novel candidate biomarkers for prostate cancer using quantitative proteomic profiling

    Página :292

    S. Tyritzis, S. Garbis, K. Pavlakis, S. Vourekas, T. Roumeliotis, P. Zerefos, A. Vlahou, S. Kossida, J. Diaz, C. Constantinides

    Esquema Esquema
  • ·POS-03.63: Is neuroendocrine cell differentiation detected immunohistochemically using chromogranin A in diagnostic needle biopsy specimens from patients with bone metastatic prostate cancer a prognostic factor for outcome?

    Página :292

    Y. Yamada, K. Nakamura, S. Aoki, T. Taki, K. Naruse, M. Tobiume, K. Zennami, R. Katsuda, N. Honda

    Esquema Esquema
  • ·POS-03.64: Receptor activator of nuclear factor-κb ligand (RANKL) as a novel prognostic marker in prostate carcinoma

    Página :292-293

    F.C. Perez Martinez, V. Alonso, F.J. Calahorra, J.l. Sarasa, F. Manzarbeitia, P. Esbrit, R. Vela Navarrete

    Esquema Esquema
  • ·POS-03.65: Expression of HAI-1 in prostate cancer

    Página :293

    K. Yasuda, T. Akashi, Y. Fujiuchi, H... Fuse

    Esquema Esquema
  • ·POS-03.66: Adjuvant radiotherapy for pt3 prostate cancer after radical prostatectomy

    Página :293

    K. Kimura, O. Kamihira, S. Hagikura, Y. Funahashi, S. Kasugai, A. Fukatu, O. Matuura

    Esquema Esquema
  • ·POS-03.67: Pathomorphological changes of erythrocytes during prostate benign hyperplasia

    Página :293-294

    M. Alibegashvili, N. Kotrikadze, I. Bochorishvili, L. Managadze, T. Chigogidze, N. Gabunia

    Esquema Esquema
  • ·POS-03.68: Using of fluorescent method in the diagnosis of prostate tumors

    Página :294

    I. Bochorishvili, K. Arcivadze, L. Ramishvili, L. Managadze, T. Chigogidze

    Esquema Esquema
  • ·POS-03.69: Transrectal non invasive prostate cancer treatment by pulsed high intensity focused ultrasound (HIFU) devices: is current technology comparable?

    Página :294

    S. Thueroff, C. Chaussy

    Esquema Esquema
  • ·POS-03.70: Immunohistochemical localization of elongation factor 1a in human prostate adenocarcinomas

    Página :294

    V.V. Lyzogubov, I.A. Makedonsky, A.P. Pogribna, B.S. Negrutskii, A.V. El’skaya, A.M. Fridberg, S.I. Zabashny, V.S. Usenko

    Esquema Esquema
  • ·POS-03.71: Transcript signatures of tumor-related marker genes for the prediction of prostate cancer on paired prostate tissue samples and artificial biopsies

    Página :295

    S. Unversucht, A. Lohse, M. Zenker, S. Fuessel, A. Meye, M. Haase, M. Toma, R. Koch, G.B. Baretton, M.P. Wirth

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :295

    
  • ·POS-03.73: Antibodies against the testis cancer antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical recurrence after surgery

    Página :295

    R.B. Parmigiani, F. Bettoni, A. Lopes, A.L. Carvalho, F. Fonseca, A.A. Camargo

    Esquema Esquema
  • ·POS-03.74: The role of inducible nitric oxide synthase (iNOS) at the biochemical failure after radical prostatectomy

    Página :295

    F.P. Fonseca, I.N. Nishimoto, S.C. Zequi, R.A. Coudry, F.A. Soares, A. Lopes

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :296

    
  • ·POS-03.76: Bone mineral density in men undergoing prostate biopsy

    Página :296

    D.E. Leocádio, S. Mandalapu, B.S. Stein

    Esquema Esquema
  • ·POS-03.77: Correlation between the international prostate symptom score, prostate specific antigen, and quality of life findings in a screening population

    Página :296

    D.E. Leocádio, B.S. Stein, M. Schwartz

    Esquema Esquema
  • ·POS-03.78: Usefulness of magnetic resonance imaging (MRI) screening for the patients with gray-zone prostate-specific antigen levels

    Página :296

    O. Ishizuka, T. Ogawa, T. Tanabe, Y. Kinebuchi, M. Kawakami, Y. Igawa, O. Nishizawa

    Esquema Esquema
  • ·POS-03.79: Survey of relative frequency of incidental carcinoma of the prostate in patients undergone prostatectomy in Razi hospital in Rasht city, Iran

    Página :296-297

    I. Khosropanah, A. Roshani, M. Salehi, S. Askari, G. Mokhtari, S. Falahatkar, Z. Hydari Bateni, S. Khosropanah

    Esquema Esquema
  • ·POS-03.80: Large and sphere-shaped prostate affects the periprostatic nerve block anesthesia

    Página :297

    S. Voinea, M. Harza, C. Gingu, A. Iordache, C. Dudu, I. Manea, C. Pavel, B. Haineala, I. Sinescu

    Esquema Esquema
  • ·POS-03.81: Effect of transrectal color Doppler ultrasonography monitoring prostate nerve block on pain during prostate biopsy: a prospective randomized study

    Página :297

    Y. Nasu, N. Ono, T. Kurashige, E. Andou

    Esquema Esquema
  • ·POS-03.82: Malignant phyllodes tumor of the prostate (report of 2 cases and review of literature)

    Página :298

    R. Chen, Y. Xu, X. Zhang

    Esquema Esquema
  • ·POS-03.83: Using the Vienna nomogram to determine the number of prostate biopsy cores to be taken, does not seem to have statistical advantage: an ongoing, prospective, randomised study

    Página :298

    A.T. Lecuona, A. Naidoo, C.F. Heyns

    Esquema Esquema
  • ·POS-03.84: Robotic assisted transperineal saturation prostate biopsy in men with previous negative biopsy: comparison with transrectal approach

    Página :298-299

    H. Ho, P. Mohan, D.L. Li, J. Yuen, W.S. Ng, W. Lau, C. Cheng

    Esquema Esquema
  • ·POS-03.85: Serum PSA levels and prostate cancer in Iranian men

    Página :299

    D. Mehraban, G.H. Naderi, H. Arshadi, A. Tahvildar, A. Razi, S.M. Kazemeyni, M. Moosavi

    Esquema Esquema
  • ·POS-03.86: The meaning of anaesthesia by periprostatic injection in TR prostate biopsy

    Página :299

    G. Passavanti, V. Pizzuti, F.M. Costantini, A. Bragaglia, M. Carlucci, A.M. Aloisi, R. Paolini

    Esquema Esquema
  • ·POS-03.87: Significance of magnetic resonance image prior to prostate biopsies for the consideration of unnecessary biopsies

    Página :299-300

    A. Joraku, M. Yamaguchi, T. Oikawa, N. Sekido, S. Hinotsu, N. Miyanaga, K. Kawai, T. Shimazui, H. Akaza

    Esquema Esquema
  • ·POS-03.88: Prostate cancer detection using combined morphological MR imaging and MR 3D proton spectroscopy

    Página :300

    W. Lipczynski, Z. Dobrowolski, S.z. Bak, P. Trybek, A. Urbanik, R. Chrzan

    Esquema Esquema
  • ·POS-03.89: Blood supply in peripheral and transitional zone of the prostate gland in patients with adenoma and adenocarcinoma in 3D power Doppler imaging

    Página :300

    L. Wolinski, W. Lipczynski, K. Juszczak, Z. Dobrowolski, M. Dobrowolska-Bak

    Esquema Esquema
  • ·POS-03.90: Anti-tumor effect of telmisartan (angiotensin II receptor blocker) in prostate cancer

    Página :300

    K. Funao, M. Matsuyama, T. Naganuma, Y. Takemoto, T. Nakatani, R. Yoshimura

    Esquema Esquema
  • ·POS-03.91: Can the prostate cancer detection rate be improved with a saturation technique of prostate biopsy?

    Página :300-301

    S. Mallick, F. Comoz, S. Le Toquin, Y. Fouques, C. Jeanne-Pasquier, P. Rousselot, H. Bensadoun

    Esquema Esquema
  • ·POS-03.92: Early detection of prostata carcinoma: comparison of the diagnostical accuracy of complexed psa and ratio c/tpsa versus total psa and ratio F/TPSA

    Página :301

    W. Berg, U. Wolf, C.D. Haas, U.T. Becker, T. Deufel, J. Schubert

    Esquema Esquema
  • ·POS-03.93: Microbiological assessment of patients undergoing transrectal prostate needle biopsy with and without enema application before the procedure

    Página :301

    I. Sen, A. Camtosun, B. Sipahioglu, N. Sultan, S. Sozen, M. Onaran, I. Bozkirli

    Esquema Esquema
  • ·POS-03.94: An analysis of effective biopsy selection for men with serum PSA levels of less than 4.0 ng/ml

    Página :301-302

    H. Aoki, S. Kawamura, T. Tochigi, M. Kuwahara

    Esquema Esquema
  • ·POS-03.95: Long-term urinary sequellae following iodine 125 prostate brachytherapy

    Página :302

    J. Crook, N. Fleshner, C. Roberts, G. Pond

    Esquema Esquema
  • ·POS-03.96: The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry

    Página :302

    J. Crook, M. Neill, G. Studer, L. Le, M. McLean, I. Yeung, G. Pond

    Esquema Esquema
  • ·POS-03.97: Decision analyses for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era

    Página :302-303

    F. Shimizu, A. Igarashi, T. Fukuda, Y. Kawachi, S. Minowada, Y. Ohashi, M. Fujime

    Esquema Esquema
  • ·POS-03.98: Operative complications of robotic assisted laparoscopic radical prostatectomy: the learning curve and beyond - a single surgeon series

    Página :303

    A. Patel, K. Shah, R. Thaly, K.J. Palmer, V. Patel

    Esquema Esquema
  • ·POS-03.99: Robotic radical prostatectomy: Technical refinements essential for success

    Página :303

    V. Patel, K.J. Palmer, K. Shah, R. Thaly

    Esquema Esquema
  • ·POS-03.100: Successful implementation of a robotic prostatectomy programme: a no-complication learning curve

    Página :303-304

    D. Golovsky, R. Kooner, R. Thanigasalam, K. Krishan Rasiah

    Esquema Esquema
  • ·POS-03.101: Nerve sparing radical prostatectomy: role in early prostate cancer patients

    Página :304

    T. Hussain, M. Al-Sudani

    Esquema Esquema
  • ·POS-03.102: Prostatectomy in the low PSA range (1-3.9 ng/ml) - is there a difference in histopatholgical reports depending on type of surgery?

    Página :304

    A. Nilsson, L. Hjertzell, L. Egevad, S. Brändstedt, M. Hellström

    Esquema Esquema
  • ·POS-03.103: Can preoperative clinicopathological parameters predict postoperative biochemical recurrence in the patients who received radical prostatectomy?

    Página :304-305

    N. Tanaka, Y. Matsumura, A. Tomioka, S. Anai, K. Fujimoto, Y. Hirao

    Esquema Esquema
  • ·POS-03.104: A prospective study of quality of life following high-intensity focused ultrasound therapy in the treatment of localized prostate cancer

    Página :305

    S. Shoji, T. Uchida, Y. Nagata, N. Mayumi, M. Nitta, M. Shima, Y. Usui, T. Terachi

    Esquema Esquema
  • ·POS-03.105: Are post operative CT scans necessary when performing true real time brachytherapy?

    Página :305

    S. Cornish, A. Van Rensburg, W. Van Niekerk

    Esquema Esquema
  • ·POS-03.106: Real time brachytherapy in patients having undergone prior TURP

    Página :305-306

    S. Cornish, A. Van Rensburg, W. Van Niekerk

    Esquema Esquema
  • ·POS-03.107: Iridium-192 high-dose-rate brachytherapy for T1c-T3bN0M0 prostate cancer

    Página :306

    Y. Jo, R. Hara, N. Kondo, T. Fujii, T. Yokoyama, Y. Miyaji, A. Nagai

    Esquema Esquema
  • ·POS-03.108: Impacts of intermittent androgen suppression on bone mineral density, fat metabolism and anemia in patients with locally advanced prostate cancer

    Página :306

    Y. Takezawa, M. Kobayashi, K. Ito, K. Suzuki, H. Yamanaka

    Esquema Esquema
  • ·POS-03.109: Simple and easy technique to prevent post-radical retropubic ptostatectomy inguinal hernia

    Página :306-307

    Y. Fujii, S. Yamamoto, J. Yonese, S. Kawakami, Y. Okubo, D. Suyama, Y. Komai, T. Kijima, I. Fukui

    Esquema Esquema
  • ·POS-03.110: Complete apical dissection at radical prostatectomy

    Página :307

    K. Kiyotaka, H. Ichikawa

    Esquema Esquema
  • ·POS-03.111: Continence rates and stricture formation following radical prostatectomy

    Página :307

    J. Bhatt, B. Little, H. Begg, S. McPhee, L. Cameron, A. Bell, E. Crombie, N. Al Saffar, G. Hollins

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :307

    
  • ·POS-03.113: Initial Canadian experience of hypofractionated accelerated radiotherapy for low risk localized prostate cancer (pHART 3)

    Página :307

    L. Holden, A. Loblaw, P. Cheung, G. Morton, P. Basran, R. Tirona, M. Cardoso, G. Pang, S. Gardner

    Esquema Esquema
  • ·POS-03.114: Factors affecting the need for endoscopic intervention for debris or stricture after HIFU for prostate cancer

    Página :307-308

    T. Dudderidge, E. Zacharakis, J. Calleary, C. Allen, E. IIling, E. Emberton, H. Ahmed

    Esquema Esquema
  • ·POS-03.115: Tolerance of one session of high intensity focused ultrasound (Ablatherm^®) for localized prostate cancer: National prospective controlled study

    Página :308

    P. Conort, F. Desgrandchamps, V. Ravery, C. Ciofu, A. Bissery, A. Mallet

    Esquema Esquema
  • ·POS-03.116: Comparison between limited versus extended laparoscopic lymphadenectomy in localized prostate cancer: morbidity and efficiency

    Página :308-309

    B. Rousseau, N. Kerfant, A. Erauso, L. Doucet, M. Leloir, C. Deruelle, V. Joulin, A. Valeri, G. Fournier

    Esquema Esquema
  • ·POS-03.117: Robot assisted laparoscopic radical prostatectomy – our initial experience of 58 cases

    Página :309

    R. Nayyar, A.K. Hemal

    Esquema Esquema
  • ·POS-03.118: Influence of diabetes mellitus on the prognosis of prostate cancer patients

    Página :309

    D. Yamada, B. Suyama, T. Hirata, J. Nishiguchi

    Esquema Esquema
  • ·POS-03.119: Risk of developing a prostate neoplasia in a patient with HGPIN undergoing first re-biopsy, applying the saturation needle biopsy technique: a preliminary study

    Página :309

    R. Giulianelli, S. Brunori, B. Gentile, L. Mavilla, G. Vincenti, F. Pisanti, L. Albanesi, T. Shestani

    Esquema Esquema
  • ·POS-03.120: Pure neuroendocrine tumors of the prostate: an unusual entity

    Página :310

    M. Bouacida, A. Sahnoun, H. Jallouli, W. Gadhrib, H. Ketata, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·POS-03.121: Serum prostate specific antigen at presentation in white (European) compared to black (African) men with prostate cancer

    Página :310

    C.F. Heyns, M. Fisher

    Esquema Esquema
  • ·POS-03.122: High serum level PSA can be related to proctological disorders: results of a monoinstitutional survey

    Página :310-311

    M.A. Brausi, G. Verrini, M. Gavioli, G. Peracchia, G. DeLuca, G.L. Simonini, M. Viola, G.D.L. Giliberto

    Esquema Esquema
  • ·POS-03.123: Free to total ratio PSA predict the prognostic to biochemical recurrence in patients submitted to radical prostatectomy

    Página :311

    F.P. da Fonseca, S.C. Zequi, R.A. Coudry, F.A. Soares, A. Lopes

    Esquema Esquema
  • ·POS-03.124: Performance of percent free prostate specific antigen for detecting prostate cancer: a prospective evaluation

    Página :311

    M. Hadj Slimen, M. Gassara, W. Charfi, S. Kchaou, H. Ketata, Y. Ben Hadj Hmida, H. Masmoudi, H. Fakhfakh, A. Bahloul, M.N. Mhiri

    Esquema Esquema
  • ·Abstract Withdrawn

    Página :311

    
  • ·Abstract Withdrawn

    Página :311

    
  • ·Abstract Withdrawn

    Página :311

    
  • ·POS-03.125: Histopathologic outcomes of robotic-assisted laparoscopic radical prostatectomy: an analysis of positive margin status

    Página :311

    D. Arend, K. Shah, K.J. Palmer, R. Thaly, V. Patel

    Esquema Esquema
  • ·POS-03.126: SIOG (International Society of Geriatric Oncology) prostate cancer guidelines proposals in senior adult men

    Página :311-312

    J.P. Droz, L. Balducci, M. Bolla, M. Emberton, J. Fitzpatrick, S. Joniau, M. Kattan, S. Monfardini, J. Moul, A. Naeim, H. van Poppel, F. Saad, C. Sternberg

    Esquema Esquema
  • ·POS-03.127: Histologic tumor grade as an independant prognostic factor in paksitani males with prostate cancer

    Página :312

    F. Abbas, N. Faruqui, K. Sikander, I. Azam

    Esquema Esquema
  • ·POS-03.128: Fractal analysis in the study of prostate cancer neovascular network

    Página :312-313

    P. Kakouri, P. Pavlopoulos, N. Kavantzas, A. Apostolaki, E. Koniaris, S. Bouzoukas

    Esquema Esquema
  • ·POS-03.129: Tacrolimus rescue therapy in corticosteroid-resistant renal allograft rejection

    Página :313

    G.H. Naderi, D. Mehraban, S.M. Kazemeyni, S.R. Yahyazadeh

    Esquema Esquema
  • ·POS-03.130: The effect of successful renal transplantation on erectile dysfunction

    Página :313

    M. Taherimahmoudi, S. Moosavi, A. Mehrsai, M. Nikoobakht, A. Emamzadeh, G. Pourmand

    Esquema Esquema
  • ·POS-03.131: Our experience with endarterectomy and bypass vascular procedures in renal transplantation

    Página :313-314

    D. Basic, D. Milutinovic, J. Hadzi Djokic, M. Djokic, D. Radivojevic, R. Blagojevic, S. Micic

    Esquema Esquema
  • ·POS-03.132: The short time prognosis of kidney transplant recipients with severe heart failure

    Página :314

    D. Tacu, C. Bucsa, E. Kerezsy, L. Domnisor, D. Daia, M. Harza, M. Manu, B. Serbanescu, C. Tacu, I. Sinescu

    Esquema Esquema
  • ·POS-03.133: Risk factors of new onset diabetes mellitus after kidney transplantation

    Página :314

    C. Bucsa, D. Tacu, E. Kerezsy, L. Domnisor, D. Daia, M. Harza, M. Manu, B. Serbanescu, C. Tacu, L. Sinescu

    Esquema Esquema
  • ·POS-03.134: Viable testis after retroperitoneal mass cord ligation in internal ring of inguinal canal in fifteen kidney recipients: Five years of experience

    Página :314

    A. Zomorrodi, A. Buhuli

    Esquema Esquema
  • ·POS-03.135: Risk factors for malignancy in Japanese renal transplant recipients

    Página :315

    T. Abe, T. Imao, N. Ichimaru, S. Takahara, Y. Kokado, M. Okumi, R. Imamura, Y. Isaka, N. Nonomura, A. Okuyama

    Esquema Esquema
  • ·POS-03.136: Mouse model of chronic uraemia: Surgical aspects

    Página :315

    O. Ivanovski, I. Nikolov, Z. Popov

    Esquema Esquema
  • ·POS-03.137: Experience of ileal neobladder by padua procedure

    Página :315

    S. Okada, H. Watanabe, H. Naruyama, R. Ando, Y. Hashimoto, K. Tozawa, S. Sasaki, Y. Hayashi, K. Kohri

    Esquema Esquema
  • ·POS-03.138: Iatrogenic ureteral injury during endoscopic intervention (coloscopy) in a patient with continent urinary diversion with the Mainz Pouch II technique

    Página :315-316

    A. Lekas, A. Balangas, S. Schattka, W. Holtkamp, A. Kollias

    Esquema Esquema
  • ·POS-03.139: Mitrofanoff continent urinary diversions: the quality of life of 75 patients

    Página :316

    M. Hadj Slimen, I. Benabdallah, M. Gassara, W. Gadhrib, W. Chaaben, K. Chabchoub, M. Mhiri

    Esquema Esquema
  • ·POS-03.140: Dorsal onlay buccal mucosa full length urethroplasty – a single center experience

    Página :316

    S. Kulkarni, S. Lambe, A. Bapat, D. Kamat, A. Dhumavat, J. Kulkarni

    Esquema Esquema

• Author Index

  • ·Author Index

    Página :317-320